<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
	<head>
		<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
		<meta http-equiv="Content-Style-Type" content="text/css" />
		<meta name="generator" content="MediaWiki 1.15alpha" />
		<meta name="keywords" content="Diabetes mellitus,Endocrine pathology,Congenital endocrine disorders,Endocrine gland neoplasia,17-beta-hydroxysteroid dehydrogenase deficiency,5-alpha-reductase deficiency,Abdominal aortic aneurysm,Abdominal pain,Academic Press,Acetone,Acidosis" />
		<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Diabetes_mellitus&amp;action=edit" />
		<link rel="edit" title="Edit this page" href="/w/index.php?title=Diabetes_mellitus&amp;action=edit" />
		<link rel="apple-touch-icon" href="http://en.wikipedia.org/apple-touch-icon.png" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
		<link rel="copyright" href="http://www.gnu.org/copyleft/fdl.html" />
		<link rel="alternate" type="application/rss+xml" title="Wikipedia RSS Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=rss" />
		<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
		<title>Diabetes mellitus - Wikipedia, the free encyclopedia</title>
		<link rel="stylesheet" href="/skins-1.5/common/shared.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/common/commonPrint.css?207xx" type="text/css" media="print" />
		<link rel="stylesheet" href="/skins-1.5/monobook/main.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/chick/main.css?207xx" type="text/css" media="handheld" />
		<!--[if lt IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE50Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE55Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 6]><link rel="stylesheet" href="/skins-1.5/monobook/IE60Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 7]><link rel="stylesheet" href="/skins-1.5/monobook/IE70Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Common.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Print.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="print" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Handheld.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="handheld" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Monobook.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=-&amp;action=raw&amp;maxage=2678400&amp;gen=css" type="text/css" />
		<!--[if lt IE 7]><script type="text/javascript" src="/skins-1.5/common/IEFixes.js?207xx"></script>
		<meta http-equiv="imagetoolbar" content="no" /><![endif]-->

		<script type= "text/javascript">/*<![CDATA[*/
		var skin = "monobook";
		var stylepath = "/skins-1.5";
		var wgArticlePath = "/wiki/$1";
		var wgScriptPath = "/w";
		var wgScript = "/w/index.php";
		var wgVariantArticlePath = false;
		var wgActionPaths = {};
		var wgServer = "http://en.wikipedia.org";
		var wgCanonicalNamespace = "";
		var wgCanonicalSpecialPageName = false;
		var wgNamespaceNumber = 0;
		var wgPageName = "Diabetes_mellitus";
		var wgTitle = "Diabetes mellitus";
		var wgAction = "view";
		var wgArticleId = "44677";
		var wgIsArticle = true;
		var wgUserName = null;
		var wgUserGroups = null;
		var wgUserLanguage = "en";
		var wgContentLanguage = "en";
		var wgBreakFrames = false;
		var wgCurRevisionId = 281758282;
		var wgVersion = "1.15alpha";
		var wgEnableAPI = true;
		var wgEnableWriteAPI = true;
		var wgSeparatorTransformTable = ["", ""];
		var wgDigitTransformTable = ["", ""];
		var wgMWSuggestTemplate = "http://en.wikipedia.org/w/api.php?action=opensearch\x26search={searchTerms}\x26namespace={namespaces}\x26suggest";
		var wgDBname = "enwiki";
		var wgSearchNamespaces = [0];
		var wgMWSuggestMessages = ["with suggestions", "no suggestions"];
		var wgRestrictionEdit = [];
		var wgRestrictionMove = ["sysop"];
		/*]]>*/</script>

		<script type="text/javascript" src="/skins-1.5/common/wikibits.js?207xx"><!-- wikibits js --></script>
		<!-- Head Scripts -->
		<script type="text/javascript" src="/skins-1.5/common/ajax.js?207xx"></script>
		<script type="text/javascript" src="/skins-1.5/common/mwsuggest.js?207xx"></script>
<script type="text/javascript">/*<![CDATA[*/
var wgNotice='';var wgNoticeLocal='';
/*]]>*/</script>		<script type="text/javascript" src="http://upload.wikimedia.org/centralnotice/wikipedia/en/centralnotice.js?207xx"></script>
		<script type="text/javascript" src="/w/index.php?title=-&amp;action=raw&amp;gen=js&amp;useskin=monobook"><!-- site js --></script>
	</head>
<body class="mediawiki ltr ns-0 ns-subject page-Diabetes_mellitus skin-monobook">
	<div id="globalWrapper">
		<div id="column-content">
	<div id="content">
		<a name="top" id="top"></a>
		<div id="siteNotice"><script type='text/javascript'>if (wgNotice != '') document.writeln(wgNotice);</script></div>		<h1 id="firstHeading" class="firstHeading">Diabetes mellitus</h1>
		<div id="bodyContent">
			<h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
			<div id="contentSub"></div>
									<div id="jump-to-nav">Jump to: <a href="#column-one">navigation</a>, <a href="#searchInput">search</a></div>			<!-- start content -->
			<div class="dablink">For the disease characterized by excretion of large amounts of very dilute urine, see <a href="/wiki/Diabetes_insipidus" title="Diabetes insipidus">diabetes insipidus</a>. For diabetes mellitus in pets, see <a href="/wiki/Diabetes_in_cats_and_dogs" title="Diabetes in cats and dogs">diabetes in cats and dogs</a>.</div>
<table class="infobox" width="200" cellspacing="0" style="font-size: 95%; text-align:left">
<tr>
<td style="text-align: center; background: lightgrey; font-size: 95%;" colspan="2"><b>Diabetes mellitus</b><br />
<i>Classification and external resources</i></td>
</tr>
<tr>
<th colspan="2" style="text-align: center; font-size: smaller;">
<div class="center">
<div class="floatnone"><a href="/wiki/File:Blue_circle_for_diabetes.svg" class="image" title="Blue circle for diabetes.svg"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/4/43/Blue_circle_for_diabetes.svg/190px-Blue_circle_for_diabetes.svg.png" width="190" height="190" border="0" /></a></div>
</div>
</th>
</tr>
<tr style="line-height: 1;">
<td colspan="2" style="text-align:center;"><small>Universal blue circle symbol for diabetes.<sup id="cite_ref-0" class="reference"><a href="#cite_note-0" title=""><span>[</span>1<span>]</span></a></sup></small></td>
</tr>
<tr>
<th><a href="/wiki/ICD" title="ICD" class="mw-redirect">ICD</a>-<a href="/wiki/List_of_ICD-10_codes" title="List of ICD-10 codes" class="mw-redirect">10</a></th>
<td><a href="/wiki/ICD-10_Chapter_E" title="ICD-10 Chapter E" class="mw-redirect">E</a><a href="http://www.who.int/classifications/apps/icd/icd10online/?ge10.htm+e10" class="external text" title="http://www.who.int/classifications/apps/icd/icd10online/?ge10.htm+e10" rel="nofollow">10.</a>–<a href="/wiki/ICD-10_Chapter_E" title="ICD-10 Chapter E" class="mw-redirect">E</a><a href="http://www.who.int/classifications/apps/icd/icd10online/?ge10.htm+e14" class="external text" title="http://www.who.int/classifications/apps/icd/icd10online/?ge10.htm+e14" rel="nofollow">14.</a></td>
</tr>
<tr>
<th><a href="/wiki/ICD" title="ICD" class="mw-redirect">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9</a></th>
<td><a href="http://www.icd9data.com/getICD9Code.ashx?icd9=250" class="external text" title="http://www.icd9data.com/getICD9Code.ashx?icd9=250" rel="nofollow">250</a></td>
</tr>
<tr>
<th><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></th>
<td><a href="http://www.nlm.nih.gov/medlineplus/ency/article/001214.htm" class="external text" title="http://www.nlm.nih.gov/medlineplus/ency/article/001214.htm" rel="nofollow">001214</a></td>
</tr>
<tr>
<th><a href="/wiki/EMedicine" title="EMedicine">eMedicine</a></th>
<td><a href="http://www.emedicine.com/med/topic546.htm" class="external text" title="http://www.emedicine.com/med/topic546.htm" rel="nofollow">med/546</a>&#160; <a href="http://www.emedicine.com/emerg/topic134.htm#" class="external text" title="http://www.emedicine.com/emerg/topic134.htm#" rel="nofollow">emerg/134</a></td>
</tr>
<tr>
<td><b><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></b></td>
<td colspan="2"><i><a href="http://www.nlm.nih.gov/cgi/mesh/2008/MB_cgi?mode=&amp;term=Diabetes&amp;field=entry#TreeC18.452.394.750" class="external text" title="http://www.nlm.nih.gov/cgi/mesh/2008/MB_cgi?mode=&amp;term=Diabetes&amp;field=entry#TreeC18.452.394.750" rel="nofollow">C18.452.394.750</a></i></td>
</tr>
</table>
<p><b>Diabetes mellitus</b> (<small>IPA</small>: <span title="Pronunciation in IPA" class="IPA"><a href="/wiki/Wikipedia:IPA_for_English" title="Wikipedia:IPA for English">/ˌdaɪəˈbiːtiːz/</a></span> or <span title="Representation in the International Phonetic Alphabet (IPA)" class="IPA">/ˌdaɪəˈbiːtəs/</span>, <span title="Representation in the International Phonetic Alphabet (IPA)" class="IPA">/məˈlaɪtəs/</span> or <span title="Representation in the International Phonetic Alphabet (IPA)" class="IPA">/ˈmɛlətəs/</span>), often referred to simply as <b>diabetes</b> (<a href="/wiki/Ancient_Greek" title="Ancient Greek">Ancient Greek</a>: <span lang="grc" xml:lang="grc">διαβαίνειν</span> "to pass through"), is a <a href="/wiki/Syndrome" title="Syndrome">syndrome</a> of disordered <a href="/wiki/Metabolism" title="Metabolism">metabolism</a>, usually due to a combination of <a href="/wiki/Genetic_disorder" title="Genetic disorder">hereditary</a> and environmental causes, resulting in abnormally high <a href="/wiki/Blood_sugar" title="Blood sugar">blood sugar</a> levels (<a href="/wiki/Hyperglycemia" title="Hyperglycemia">hyperglycemia</a>).<sup id="cite_ref-diag_1-0" class="reference"><a href="#cite_note-diag-1" title=""><span>[</span>2<span>]</span></a></sup> Blood glucose levels are controlled by a complex interaction of multiple chemicals and hormones in the body, including the <a href="/wiki/Hormone" title="Hormone">hormone</a> <a href="/wiki/Insulin" title="Insulin">insulin</a> made in the <a href="/wiki/Beta_cell" title="Beta cell">beta cells</a> of the <a href="/wiki/Pancreas" title="Pancreas">pancreas</a>. Diabetes mellitus refers to the group of diseases that lead to high blood glucose levels due to defects in either insulin secretion or insulin action in the body.<sup id="cite_ref-Rother_2-0" class="reference"><a href="#cite_note-Rother-2" title=""><span>[</span>3<span>]</span></a></sup></p>
<p>Diabetes develops due to a diminished production of <a href="/wiki/Insulin" title="Insulin">insulin</a> (in <i><a href="/wiki/Diabetes_mellitus_type_1" title="Diabetes mellitus type 1">type&#160;1</a></i>) or resistance to its effects (in <i><a href="/wiki/Diabetes_mellitus_type_2" title="Diabetes mellitus type 2">type&#160;2</a></i> and <i><a href="/wiki/Gestational_diabetes" title="Gestational diabetes">gestational</a></i>).<sup id="cite_ref-WHO1999-DefDiagClass_3-0" class="reference"><a href="#cite_note-WHO1999-DefDiagClass-3" title=""><span>[</span>4<span>]</span></a></sup> Both lead to hyperglycemia, which largely causes the acute signs of diabetes: <a href="/wiki/Polyuria" title="Polyuria">excessive urine production</a>, resulting compensatory <a href="/wiki/Polydipsia" title="Polydipsia">thirst and increased fluid intake</a>, blurred vision, unexplained weight loss, <a href="/wiki/Lethargy" title="Lethargy" class="mw-redirect">lethargy</a>, and changes in energy <a href="/wiki/Metabolism" title="Metabolism">metabolism</a>.</p>
<p>All forms of diabetes have been treatable since <a href="/wiki/Insulin" title="Insulin">insulin</a> became medically available in 1921, but there is no cure. The <a href="/wiki/Injection_(medicine)#Subcutaneous_injection" title="Injection (medicine)">injections</a> by a <a href="/wiki/Syringe" title="Syringe">syringe</a>, <a href="/wiki/Insulin_pump" title="Insulin pump">insulin pump</a>, or <a href="/wiki/Insulin_pen" title="Insulin pen">insulin pen</a> deliver insulin, which is a basic <a href="/wiki/Diabetes_type_1#Treatment" title="Diabetes type 1" class="mw-redirect">treatment of type&#160;1</a> diabetes. <a href="/wiki/Diabetes_type_2#Treatment" title="Diabetes type 2" class="mw-redirect">Type&#160;2 is managed</a> with a combination of <a href="/wiki/Diet_(nutrition)" title="Diet (nutrition)">dietary treatment</a>, <a href="/wiki/Physical_exercise" title="Physical exercise">exercise</a>, <a href="/wiki/Anti-diabetic_drug" title="Anti-diabetic drug">medications</a> and insulin supplementation.</p>
<p>Diabetes and its treatments can cause many complications. <a href="/wiki/Acute_(medical)" title="Acute (medical)" class="mw-redirect">Acute</a> complications (<a href="/wiki/Hypoglycemia" title="Hypoglycemia">hypoglycemia</a>, <a href="/wiki/Ketoacidosis" title="Ketoacidosis">ketoacidosis</a>, or <a href="/wiki/Nonketotic_hyperosmolar_coma" title="Nonketotic hyperosmolar coma">nonketotic hyperosmolar coma</a>) may occur if the disease is not adequately controlled. Serious long-term complications include <a href="/wiki/Cardiovascular_disease" title="Cardiovascular disease">cardiovascular disease</a> (doubled risk), <a href="/wiki/Chronic_renal_failure" title="Chronic renal failure" class="mw-redirect">chronic renal failure</a>, <a href="/wiki/Diabetic_retinopathy" title="Diabetic retinopathy">retinal damage</a> (which can lead to <a href="/wiki/Blindness" title="Blindness">blindness</a>), <a href="/wiki/Diabetic_neuropathy" title="Diabetic neuropathy">nerve damage</a> (of several kinds), and microvascular damage, which may cause <a href="/wiki/Erectile_dysfunction" title="Erectile dysfunction">erectile dysfunction</a> and poor wound healing. Poor healing of wounds, particularly of the feet, can lead to <a href="/wiki/Gangrene" title="Gangrene">gangrene</a>, and possibly to <a href="/wiki/Amputation" title="Amputation">amputation</a>. Adequate treatment of diabetes, as well as increased emphasis on <a href="/wiki/Blood_pressure" title="Blood pressure">blood pressure</a> control and lifestyle factors (such as not <a href="/wiki/Tobacco_smoking" title="Tobacco smoking">smoking</a> and maintaining a healthy <a href="/wiki/Human_weight" title="Human weight" class="mw-redirect">body weight</a>), may improve the risk profile of most of the chronic complications. In the developed world, diabetes is the most significant cause of adult blindness in the non-elderly and the leading cause of non-traumatic amputation in adults, and <a href="/wiki/Diabetic_nephropathy" title="Diabetic nephropathy">diabetic nephropathy</a> is the main illness requiring <a href="/wiki/Renal_dialysis" title="Renal dialysis" class="mw-redirect">renal dialysis</a> in the United States.<sup id="cite_ref-4" class="reference"><a href="#cite_note-4" title=""><span>[</span>5<span>]</span></a></sup></p>
<table width="20%" cellpadding="0" cellspacing="0" style="margin:0" align="right" class="toccolours">
<tr>
<th style="background:#ccccff"><b><strong class="selflink">Diabetes mellitus</strong></b>
<hr /></th>
</tr>
<tr>
<th style="background:#ccccff"><b>Types of Diabetes</b></th>
</tr>
<tr>
<td><a href="/wiki/Diabetes_mellitus_type_1" title="Diabetes mellitus type 1">Diabetes mellitus type 1</a><br />
<a href="/wiki/Diabetes_mellitus_type_2" title="Diabetes mellitus type 2">Diabetes mellitus type 2</a><br />
<a href="/wiki/Gestational_diabetes" title="Gestational diabetes">Gestational diabetes</a>
<p><b>Pre-diabetes:</b><br />
<a href="/wiki/Impaired_fasting_glycaemia" title="Impaired fasting glycaemia">Impaired fasting glycaemia</a><br />
<a href="/wiki/Impaired_glucose_tolerance" title="Impaired glucose tolerance">Impaired glucose tolerance</a></p>
</td>
</tr>
<tr>
<th style="background:#ccccff"><b>Disease Management</b></th>
</tr>
<tr>
<td><a href="/wiki/Diabetes_management" title="Diabetes management">Diabetes management</a>:<br />
•<a href="/wiki/Diabetic_diet" title="Diabetic diet">Diabetic diet</a><br />
•<a href="/wiki/Anti-diabetic_drug" title="Anti-diabetic drug">Anti-diabetic drugs</a><br />
•<a href="/wiki/Conventional_insulinotherapy" title="Conventional insulinotherapy">Conventional&#160;insulinotherapy</a><br />
•<a href="/wiki/Intensive_insulinotherapy" title="Intensive insulinotherapy">Intensive insulinotherapy</a></td>
</tr>
<tr>
<th style="background:#ccccff"><b>Treatment</b></th>
</tr>
<tr>
<td><a href="/wiki/Diabetes_type_2#Treatment_goals" title="Diabetes type 2" class="mw-redirect">Treatment goals</a><br />
<a href="/wiki/Cure_for_diabetes_mellitus_type_1#Cure" title="Cure for diabetes mellitus type 1" class="mw-redirect">Cure for diabetes mellitus type 1</a><br />
<a href="/wiki/Blood_glucose_monitoring" title="Blood glucose monitoring">Blood glucose monitoring</a><br />
<a href="/wiki/Diabetic_diet" title="Diabetic diet">Modifying Diet - Diabetic diet</a><br />
<a href="/wiki/Diabetes_type_2#Exercise" title="Diabetes type 2" class="mw-redirect">Exercise</a><br />
<a href="/wiki/Anti-diabetic_drug" title="Anti-diabetic drug">Anti-diabetic drugs</a><br />
<a href="/wiki/Diabetes_type_2#Oral_drugs" title="Diabetes type 2" class="mw-redirect">Oral drugs Commonly Used</a><br />
<a href="/wiki/Diabetes_type_2#Injectable_peptide_analogs" title="Diabetes type 2" class="mw-redirect">Injectable peptide analogs</a><br />
<a href="/wiki/Diabetes_type_2#Insulin_preparations" title="Diabetes type 2" class="mw-redirect">Insulin preparations</a><br />
<a href="/wiki/Diabetes_type_2#Antihypertensive_agents" title="Diabetes type 2" class="mw-redirect">Antihypertensive agents</a><br />
<a href="/wiki/Diabetes_type_2#ACE_inhibitors" title="Diabetes type 2" class="mw-redirect">ACE inhibitors</a><br />
<a href="/wiki/Hypercholesterolemia#Diabetic_patients" title="Hypercholesterolemia">Hypolipidemic agents</a><br />
<a href="/wiki/Diabetes_type_2#Gastric_bypass_surgery" title="Diabetes type 2" class="mw-redirect">Gastric bypass surgery</a></td>
</tr>
<tr>
<th style="background:#ccccff"><b>Other Concerns</b></th>
</tr>
<tr>
<td><a href="/wiki/Cardiovascular_disease" title="Cardiovascular disease">Cardiovascular disease</a>
<p><a href="/wiki/Diabetic_coma" title="Diabetic coma">Diabetic comas</a>:<br />
•<a href="/wiki/Diabetic_hypoglycemia" title="Diabetic hypoglycemia">Diabetic hypoglycemia</a><br />
•<a href="/wiki/Diabetic_ketoacidosis" title="Diabetic ketoacidosis">Diabetic ketoacidosis</a><br />
•<a href="/wiki/Nonketotic_hyperosmolar_coma" title="Nonketotic hyperosmolar coma">Nonketotic hyperosmolar</a></p>
<p><a href="/wiki/Diabetic_myonecrosis" title="Diabetic myonecrosis">Diabetic myonecrosis</a><br />
<a href="/wiki/Diabetic_nephropathy" title="Diabetic nephropathy">Diabetic nephropathy</a><br />
<a href="/wiki/Diabetic_neuropathy" title="Diabetic neuropathy">Diabetic neuropathy</a><br />
<a href="/wiki/Diabetic_retinopathy" title="Diabetic retinopathy">Diabetic retinopathy</a></p>
<p><a href="/wiki/Diabetes_mellitus_and_pregnancy" title="Diabetes mellitus and pregnancy">Diabetes and pregnancy</a></p>
</td>
</tr>
<tr>
<th style="background:#ccccff"><b>Blood tests</b></th>
</tr>
<tr>
<td><a href="/wiki/Blood_sugar" title="Blood sugar">Blood sugar</a><br />
<a href="/wiki/Fructosamine" title="Fructosamine">Fructosamine</a><br />
<a href="/wiki/Glucose_tolerance_test" title="Glucose tolerance test">Glucose tolerance test</a><br />
<a href="/wiki/Glycosylated_hemoglobin" title="Glycosylated hemoglobin">Glycosylated hemoglobin</a></td>
</tr>
</table>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#Classification"><span class="tocnumber">1</span> <span class="toctext">Classification</span></a>
<ul>
<li class="toclevel-2"><a href="#Type.C2.A01_diabetes"><span class="tocnumber">1.1</span> <span class="toctext">Type&#160;1 diabetes</span></a></li>
<li class="toclevel-2"><a href="#Type_2_diabetes"><span class="tocnumber">1.2</span> <span class="toctext">Type 2 diabetes</span></a></li>
<li class="toclevel-2"><a href="#Gestational_diabetes"><span class="tocnumber">1.3</span> <span class="toctext">Gestational diabetes</span></a></li>
<li class="toclevel-2"><a href="#Other_types"><span class="tocnumber">1.4</span> <span class="toctext">Other types</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Signs_and_symptoms"><span class="tocnumber">2</span> <span class="toctext">Signs and symptoms</span></a></li>
<li class="toclevel-1"><a href="#Genetics"><span class="tocnumber">3</span> <span class="toctext">Genetics</span></a></li>
<li class="toclevel-1"><a href="#Pathophysiology"><span class="tocnumber">4</span> <span class="toctext">Pathophysiology</span></a></li>
<li class="toclevel-1"><a href="#Diagnosis"><span class="tocnumber">5</span> <span class="toctext">Diagnosis</span></a></li>
<li class="toclevel-1"><a href="#Screening"><span class="tocnumber">6</span> <span class="toctext">Screening</span></a></li>
<li class="toclevel-1"><a href="#Prevention"><span class="tocnumber">7</span> <span class="toctext">Prevention</span></a></li>
<li class="toclevel-1"><a href="#Treatment_and_management"><span class="tocnumber">8</span> <span class="toctext">Treatment and management</span></a></li>
<li class="toclevel-1"><a href="#Cure"><span class="tocnumber">9</span> <span class="toctext">Cure</span></a>
<ul>
<li class="toclevel-2"><a href="#Cures_for_type_1_diabetes"><span class="tocnumber">9.1</span> <span class="toctext">Cures for type 1 diabetes</span></a></li>
<li class="toclevel-2"><a href="#Cures_for_type_2_diabetes"><span class="tocnumber">9.2</span> <span class="toctext">Cures for type 2 diabetes</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Prognosis"><span class="tocnumber">10</span> <span class="toctext">Prognosis</span></a>
<ul>
<li class="toclevel-2"><a href="#Acute_complications"><span class="tocnumber">10.1</span> <span class="toctext">Acute complications</span></a></li>
<li class="toclevel-2"><a href="#Chronic_complications"><span class="tocnumber">10.2</span> <span class="toctext">Chronic complications</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Epidemiology"><span class="tocnumber">11</span> <span class="toctext">Epidemiology</span></a></li>
<li class="toclevel-1"><a href="#History"><span class="tocnumber">12</span> <span class="toctext">History</span></a></li>
<li class="toclevel-1"><a href="#Social_issues"><span class="tocnumber">13</span> <span class="toctext">Social issues</span></a></li>
<li class="toclevel-1"><a href="#See_also"><span class="tocnumber">14</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1"><a href="#References"><span class="tocnumber">15</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">16</span> <span class="toctext">External links</span></a></li>
</ul>
</td>
</tr>
</table>
<script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script>
<p><a name="Classification" id="Classification"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Diabetes_mellitus&amp;action=edit&amp;section=1" title="Edit section: Classification">edit</a>]</span> <span class="mw-headline">Classification</span></h2>
<p>The term <i>diabetes</i>, without qualification, usually refers to diabetes mellitus, which is associated with excessive sweet urine (known as "<a href="/wiki/Glycosuria" title="Glycosuria">glycosuria</a>") but there are several rarer conditions also named diabetes. The most common of these is <a href="/wiki/Diabetes_insipidus" title="Diabetes insipidus">diabetes insipidus</a> in which the urine is not sweet (insipidus meaning "without taste" in Latin); it can be caused by either <a href="/wiki/Kidney" title="Kidney">kidney</a> (nephrogenic DI) or <a href="/wiki/Pituitary_gland" title="Pituitary gland">pituitary gland</a> (central DI) damage. It is a noninfectious disease. Among the body systems affected are the nerve, digestive, circulatory, endocrine and urinary systems.</p>
<p>The World Health Organization projects that the number of diabetics will exceed 350 million by 2030. Governments and other healthcare providers around the world are investing in health education, diagnosis and treatments for this chronic, debilitating - but controllable - disorder</p>
<p>The term "type&#160;1 diabetes" has universally replaced several former terms, including childhood-onset diabetes, juvenile diabetes, and insulin-dependent diabetes mellitus (IDDM). Likewise, the term "type&#160;2 diabetes" has replaced several former terms, including adult-onset diabetes, obesity-related diabetes, and non-insulin-dependent diabetes mellitus (NIDDM). Beyond these two types, there is no agreed-upon standard nomenclature. Various sources have defined "type 3 diabetes" as, among others, <a href="/wiki/Gestational_diabetes" title="Gestational diabetes">gestational diabetes</a>,<sup id="cite_ref-5" class="reference"><a href="#cite_note-5" title=""><span>[</span>6<span>]</span></a></sup> insulin-resistant type&#160;1 diabetes (or "double diabetes"), type&#160;2 diabetes which has progressed to require injected insulin, and <a href="/wiki/Latent_autoimmune_diabetes" title="Latent autoimmune diabetes">latent autoimmune diabetes</a> of adults (or LADA or "<a href="/wiki/Diabetes_Type_1.5" title="Diabetes Type 1.5" class="mw-redirect">type&#160;1.5</a>" diabetes.<sup id="cite_ref-6" class="reference"><a href="#cite_note-6" title=""><span>[</span>7<span>]</span></a></sup>) There is also <a href="/wiki/Maturity_onset_diabetes_of_the_young" title="Maturity onset diabetes of the young">maturity onset diabetes of the young</a> (MODY) which is a group of several single gene (monogenic) disorders with strong family histories that present as type&#160;2 diabetes before 30 years of age.</p>
<p><a name="Type.C2.A01_diabetes" id="Type.C2.A01_diabetes"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Diabetes_mellitus&amp;action=edit&amp;section=2" title="Edit section: Type&amp;nbsp;1 diabetes">edit</a>]</span> <span class="mw-headline">Type&#160;1 diabetes</span></h3>
<div class="rellink noprint relarticle mainarticle">Main article: <a href="/wiki/Diabetes_mellitus_type_1" title="Diabetes mellitus type 1">Diabetes mellitus type 1</a></div>
<p><a href="/wiki/Type_1_diabetes_mellitus" title="Type 1 diabetes mellitus" class="mw-redirect">Type 1 diabetes mellitus</a> is characterized by loss of the insulin-producing <a href="/wiki/Beta_cell" title="Beta cell">beta cells</a> of the <a href="/wiki/Islets_of_Langerhans" title="Islets of Langerhans">islets of Langerhans</a> in the pancreas leading to a deficiency of insulin. This type of diabetes can be further classified as immune-mediated or idiopathic. The majority of type 1 diabetes is of the immune-mediated variety, where beta cell loss is a <a href="/wiki/T-cell" title="T-cell" class="mw-redirect">T-cell</a> mediated <a href="/wiki/Autoimmunity" title="Autoimmunity">autoimmune</a> attack.<sup id="cite_ref-Rother_2-1" class="reference"><a href="#cite_note-Rother-2" title=""><span>[</span>3<span>]</span></a></sup> There is no known preventive measure which can be taken against type&#160;1 diabetes; it is about 10% of diabetes mellitus cases in North America and Europe (though this varies by geographical location), and is a higher percentage in some other areas. Most affected people are otherwise healthy and of a healthy weight when onset occurs. Sensitivity and responsiveness to insulin are usually normal, especially in the early stages. Type&#160;1 diabetes can affect children or adults but was traditionally termed "juvenile diabetes" because it represents a majority of the diabetes cases in children.</p>
<p>The principal treatment of type&#160;1 diabetes, even in its earliest stages, is the delivery of artificial insulin via injection combined with careful monitoring of blood glucose levels using blood testing monitors. Without insulin, <a href="/wiki/Diabetic_ketoacidosis" title="Diabetic ketoacidosis">diabetic ketoacidosis</a> often develops which may result in coma or death. Treatment emphasis is now also placed on lifestyle adjustments (diet and exercise) though these cannot reverse the progress of the disease. Apart from the common <a href="/wiki/Subcutaneous" title="Subcutaneous" class="mw-redirect">subcutaneous</a> injections, it is also possible to deliver insulin by a <a href="/wiki/Insulin_pump" title="Insulin pump">pump</a>, which allows continuous infusion of insulin 24 hours a day at preset levels, and the ability to program doses (a <a href="/wiki/Bolus_(medicine)" title="Bolus (medicine)">bolus</a>) of insulin as needed at meal times. An inhaled form of insulin was approved by the FDA in January 2006, although it was discontinued for business reasons in October 2007.<sup id="cite_ref-7" class="reference"><a href="#cite_note-7" title=""><span>[</span>8<span>]</span></a></sup><sup id="cite_ref-8" class="reference"><a href="#cite_note-8" title=""><span>[</span>9<span>]</span></a></sup> Non-insulin treatments, such as <a href="/wiki/Monoclonal_antibodies" title="Monoclonal antibodies">monoclonal antibodies</a> and <a href="/wiki/Stem-cell" title="Stem-cell" class="mw-redirect">stem-cell</a> based therapies, are effective in animal models but have not yet completed clinical trials in humans.<sup id="cite_ref-9" class="reference"><a href="#cite_note-9" title=""><span>[</span>10<span>]</span></a></sup></p>
<p>Type&#160;1 treatment must be continued indefinitely in essentially all cases. Treatment need not significantly impair normal activities, if sufficient patient training, awareness, appropriate care, discipline in testing and dosing of insulin is taken. However, treatment is burdensome for patients; insulin is replaced in a non-physiological manner, and this approach is therefore far from ideal. The average glucose level for the type&#160;1 patient should be as close to normal (80–120&#160;mg/dl, 4–6&#160;mmol/l) as is <i>safely</i> possible. Some physicians suggest up to 140–150&#160;mg/dl (7-7.5&#160;mmol/l) for those having trouble with lower values, such as frequent hypoglycemic events. Values above 400&#160;mg/dl (20&#160;mmol/l) are sometimes accompanied by discomfort and frequent urination leading to <a href="/wiki/Dehydration" title="Dehydration">dehydration</a>. Values above 600&#160;mg/dl (30&#160;mmol/l) usually require medical treatment and may lead to <a href="/wiki/Ketoacidosis" title="Ketoacidosis">ketoacidosis</a>, although they are not immediately life-threatening. However, low levels of blood glucose, called <a href="/wiki/Hypoglycemia" title="Hypoglycemia">hypoglycemia</a>, may lead to seizures or episodes of unconsciousness and absolutely must be treated immediately, via emergency high-glucose gel placed in the patient's mouth, intravenous administration of dextrose, or an injection of <a href="/wiki/Glucagon" title="Glucagon">glucagon</a>.</p>
<p><a name="Type_2_diabetes" id="Type_2_diabetes"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Diabetes_mellitus&amp;action=edit&amp;section=3" title="Edit section: Type 2 diabetes">edit</a>]</span> <span class="mw-headline">Type 2 diabetes</span></h3>
<div class="rellink noprint relarticle mainarticle">Main article: <a href="/wiki/Diabetes_mellitus_type_2" title="Diabetes mellitus type 2">diabetes mellitus type 2</a></div>
<p>Type&#160;2 diabetes mellitus is characterized differently and is due to insulin resistance or reduced insulin sensitivity, combined with relatively reduced insulin secretion which in some cases becomes absolute. The defective responsiveness of body tissues to insulin almost certainly involves the <a href="/wiki/Insulin_receptor" title="Insulin receptor">insulin receptor</a> in cell membranes. However, the specific defects are not known. Diabetes mellitus due to a known specific defect are classified separately. Type 2 diabetes is the most common type.</p>
<p>In the early stage of type 2 diabetes, the predominant abnormality is reduced insulin sensitivity, characterized by elevated levels of insulin in the blood. At this stage hyperglycemia can be reversed by a variety of measures and <a href="/wiki/Anti-diabetic_drug" title="Anti-diabetic drug">medications</a> that improve insulin sensitivity or reduce glucose production by the <a href="/wiki/Liver" title="Liver">liver</a>. As the disease progresses, the impairment of insulin secretion worsens, and therapeutic replacement of insulin often becomes necessary.</p>
<p>There are numerous theories as to the exact cause and mechanism in type&#160;2 diabetes. <a href="/wiki/Central_obesity" title="Central obesity" class="mw-redirect">Central obesity</a> (fat concentrated around the waist in relation to abdominal organs, but not subcutaneous fat) is known to predispose individuals to insulin resistance. Abdominal fat is especially active hormonally, secreting a group of hormones called <a href="/wiki/Adipokine" title="Adipokine">adipokines</a> that may possibly impair glucose tolerance. Obesity is found in approximately 55% of patients diagnosed with type&#160;2 diabetes.<sup id="cite_ref-10" class="reference"><a href="#cite_note-10" title=""><span>[</span>11<span>]</span></a></sup> Other factors include aging (about 20% of elderly patients in North America have diabetes) and family history (type&#160;2 is much more common in those with close relatives who have had it). In the last decade, type&#160;2 diabetes has increasingly begun to affect children and adolescents, likely in connection with the increased prevalence of childhood obesity seen in recent decades in some places.<sup id="cite_ref-11" class="reference"><a href="#cite_note-11" title=""><span>[</span>12<span>]</span></a></sup> Environmental exposures may contribute to recent increases in the rate of type 2 diabetes. A positive correlation has been found between the concentration in the urine of <a href="/wiki/Bisphenol_A" title="Bisphenol A">bisphenol A</a>, a constituent of polycarbonate plastic, and the incidence of type 2 diabetes.<sup id="cite_ref-12" class="reference"><a href="#cite_note-12" title=""><span>[</span>13<span>]</span></a></sup></p>
<p>Type&#160;2 diabetes may go unnoticed for years because visible symptoms are typically mild, non-existent or sporadic, and usually there are no <a href="/wiki/Diabetic_ketoacidosis" title="Diabetic ketoacidosis">ketoacidotic episodes</a>. However, severe long-term complications can result from unnoticed type&#160;2 diabetes, including <a href="/wiki/Renal_failure" title="Renal failure">renal failure</a> due to <a href="/wiki/Diabetic_nephropathy" title="Diabetic nephropathy">diabetic nephropathy</a>, vascular disease (including <a href="/wiki/Coronary_artery_disease" title="Coronary artery disease">coronary artery disease</a>), vision damage due to <a href="/wiki/Diabetic_retinopathy" title="Diabetic retinopathy">diabetic retinopathy</a>, loss of sensation or pain due to <a href="/wiki/Diabetic_neuropathy" title="Diabetic neuropathy">diabetic neuropathy</a>, liver damage from <a href="/wiki/Non-alcoholic_steatohepatitis" title="Non-alcoholic steatohepatitis" class="mw-redirect">non-alcoholic steatohepatitis</a> and heart failure from <a href="/wiki/Diabetic_cardiomyopathy" title="Diabetic cardiomyopathy">diabetic cardiomyopathy</a>.</p>
<p>Type&#160;2 diabetes is usually first treated by increasing physical activity, decreasing <a href="/wiki/Carbohydrate" title="Carbohydrate">carbohydrate</a> intake, and <a href="/wiki/Weight_loss" title="Weight loss">losing weight</a>. These can restore insulin sensitivity even when the weight loss is modest, for example around 5&#160;kg (10 to 15&#160;lb), most especially when it is in abdominal fat deposits. It is sometimes possible to achieve long-term, satisfactory glucose control with these measures alone. However, the underlying tendency to insulin resistance is not lost, and so attention to diet, exercise, and weight loss must continue. The usual next step, if necessary, is treatment with oral <a href="/wiki/Antidiabetic_drug" title="Antidiabetic drug" class="mw-redirect">antidiabetic drugs</a>. Insulin production is initially only moderately impaired in type&#160;2 diabetes, so oral medication (often used in various combinations) can be used to improve insulin production (e.g., <a href="/wiki/Sulfonylureas" title="Sulfonylureas" class="mw-redirect">sulfonylureas</a>), to regulate inappropriate release of glucose by the liver and attenuate insulin resistance to some extent (e.g., <a href="/wiki/Metformin" title="Metformin">metformin</a>), and to substantially attenuate insulin resistance (e.g., <a href="/wiki/Thiazolidinedione" title="Thiazolidinedione">thiazolidinediones</a>). According to one study, overweight patients treated with metformin compared with diet alone, had <a href="/wiki/Relative_risk_reduction" title="Relative risk reduction">relative risk reductions</a> of 32% for any diabetes endpoint, 42% for diabetes related death and 36% for all cause mortality and stroke.<sup id="cite_ref-13" class="reference"><a href="#cite_note-13" title=""><span>[</span>14<span>]</span></a></sup> Oral medication may eventually fail due to further impairment of beta cell insulin secretion. At this point, insulin therapy is necessary to maintain normal or near normal glucose levels.</p>
<p><a name="Gestational_diabetes" id="Gestational_diabetes"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Diabetes_mellitus&amp;action=edit&amp;section=4" title="Edit section: Gestational diabetes">edit</a>]</span> <span class="mw-headline">Gestational diabetes</span></h3>
<div class="rellink noprint relarticle mainarticle">Main article: <a href="/wiki/Gestational_diabetes" title="Gestational diabetes">Gestational diabetes</a></div>
<p>Gestational diabetes mellitus (GDM) resembles type&#160;2 diabetes in several respects, involving a combination of relatively inadequate insulin secretion and responsiveness. It occurs in about 2%–5% of all <a href="/wiki/Pregnancy" title="Pregnancy">pregnancies</a> and may improve or disappear after delivery. Gestational diabetes is fully treatable but requires careful medical supervision throughout the pregnancy. About 20%–50% of affected women develop type&#160;2 diabetes later in life.</p>
<p>Even though it may be transient, untreated gestational diabetes can damage the health of the fetus or mother. Risks to the baby include <a href="/wiki/Macrosomia" title="Macrosomia" class="mw-redirect">macrosomia</a> (high birth weight), congenital cardiac and central nervous system anomalies, and skeletal muscle malformations. Increased fetal insulin may inhibit fetal <a href="/wiki/Surfactant" title="Surfactant">surfactant</a> production and cause <a href="/wiki/Infant_respiratory_distress_syndrome" title="Infant respiratory distress syndrome">respiratory distress syndrome</a>. <a href="/wiki/Hyperbilirubinemia" title="Hyperbilirubinemia" class="mw-redirect">Hyperbilirubinemia</a> may result from red blood cell destruction. In severe cases, perinatal death may occur, most commonly as a result of poor placental perfusion due to vascular impairment. <a href="/wiki/Induction_(birth)" title="Induction (birth)">Induction</a> may be indicated with decreased placental function. A <a href="/wiki/Caesarean_section" title="Caesarean section">cesarean section</a> may be performed if there is marked fetal distress or an increased risk of injury associated with <a href="/wiki/Macrosomia" title="Macrosomia" class="mw-redirect">macrosomia</a>, such as <a href="/wiki/Shoulder_dystocia" title="Shoulder dystocia">shoulder dystocia</a>.</p>
<p>A 2008 study completed in the U.S. found that more American women are entering pregnancy with preexisting diabetes. In fact the rate of diabetes in expectant mothers has more than doubled in the past 6 years.<sup id="cite_ref-14" class="reference"><a href="#cite_note-14" title=""><span>[</span>15<span>]</span></a></sup> This is particularly problematic as diabetes raises the risk of complications during pregnancy, as well as increasing the potential that the children of diabetic mothers will also become diabetic in the future.</p>
<p><a name="Other_types" id="Other_types"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Diabetes_mellitus&amp;action=edit&amp;section=5" title="Edit section: Other types">edit</a>]</span> <span class="mw-headline">Other types</span></h3>
<p>Most cases of diabetes mellitus fall into the two broad etiologic categories of type 1 or type 2 diabetes. However, many types of diabetes mellitus have known specific causes, and thus fall into separate categories as diabetes due to a specific cause. As more research is done into diabetes, many patients who were previously diagnosed as type 1 or type 2 diabetes will be reclassified as diabetes due to their known specific cause.</p>
<p>Some cases of diabetes are caused by the body's tissue receptors not responding to insulin (even when insulin levels are normal, which is what separates it from type&#160;2 diabetes); this form is very uncommon. Genetic mutations (<a href="/wiki/Autosomal_dominant" title="Autosomal dominant" class="mw-redirect">autosomal</a> or <a href="/wiki/Mitochondrial" title="Mitochondrial" class="mw-redirect">mitochondrial</a>) can lead to defects in beta cell function. Abnormal insulin action may also have been genetically determined in some cases. Any disease that causes extensive damage to the pancreas may lead to diabetes (for example, <a href="/wiki/Chronic_pancreatitis" title="Chronic pancreatitis">chronic pancreatitis</a> and <a href="/wiki/Cystic_fibrosis" title="Cystic fibrosis">cystic fibrosis</a>). Diseases associated with excessive secretion of insulin-antagonistic hormones can cause diabetes (which is typically resolved once the hormone excess is removed). Many drugs impair insulin secretion and some toxins damage pancreatic beta cells. The <a href="/wiki/ICD" title="ICD" class="mw-redirect">ICD</a>-10 (1992) diagnostic entity, <i>malnutrition-related diabetes mellitus</i> (MRDM or MMDM, ICD-10 code E12), was deprecated by the <a href="/wiki/World_Health_Organization" title="World Health Organization">World Health Organization</a> when the current taxonomy was introduced in 1999.<sup id="cite_ref-WHO1999-DefDiagClass_3-1" class="reference"><a href="#cite_note-WHO1999-DefDiagClass-3" title=""><span>[</span>4<span>]</span></a></sup></p>
<p><a name="Signs_and_symptoms" id="Signs_and_symptoms"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Diabetes_mellitus&amp;action=edit&amp;section=6" title="Edit section: Signs and symptoms">edit</a>]</span> <span class="mw-headline">Signs and symptoms</span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:262px;"><a href="/wiki/File:Main_symptoms_of_diabetes.png" class="image" title="Overview of the most significant symptoms of diabetes."><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/2/28/Main_symptoms_of_diabetes.png/260px-Main_symptoms_of_diabetes.png" width="260" height="288" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Main_symptoms_of_diabetes.png" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Overview of the most significant symptoms of diabetes.</div>
</div>
</div>
<p>The classical triad of diabetes symptoms is <a href="/wiki/Polyuria" title="Polyuria">polyuria</a>, <a href="/wiki/Polydipsia" title="Polydipsia">polydipsia</a> and <a href="/wiki/Polyphagia" title="Polyphagia">polyphagia</a>, which are, respectively, frequent urination, increased thirst and consequent increased fluid intake, and increased appetite. Symptoms may develop quite rapidly (weeks or months) in type&#160;1 diabetes, particularly in children. However, in type&#160;2 diabetes symptoms usually develop much more slowly and may be subtle or completely absent. Type&#160;1 diabetes may also cause a rapid yet significant weight loss (despite normal or even increased eating) and irreducible <a href="/wiki/Mental_fatigue" title="Mental fatigue" class="mw-redirect">mental fatigue</a>. All of these symptoms except weight loss can also manifest in type&#160;2 diabetes in patients whose diabetes is poorly controlled.</p>
<p>When the glucose concentration in the blood is raised beyond its <a href="/wiki/Renal_threshold" title="Renal threshold">renal threshold</a>, <a href="/wiki/Reabsorption" title="Reabsorption">reabsorption</a> of glucose in the <a href="/wiki/Proximal_tubule" title="Proximal tubule">proximal renal tubuli</a> is incomplete, and part of the glucose remains in the <a href="/wiki/Urine" title="Urine">urine</a> (<a href="/wiki/Glycosuria" title="Glycosuria">glycosuria</a>). This increases the <a href="/wiki/Osmotic_pressure" title="Osmotic pressure">osmotic pressure</a> of the urine and inhibits reabsorption of water by the kidney, resulting in increased urine production (<a href="/wiki/Polyuria" title="Polyuria">polyuria</a>) and increased fluid loss. Lost blood volume will be replaced osmotically from water held in body cells and other body compartments, causing <a href="/wiki/Dehydration" title="Dehydration">dehydration</a> and increased thirst.</p>
<p>Prolonged high blood glucose causes glucose absorption, which leads to changes in the shape of the lenses of the eyes, resulting in vision changes; sustained sensible glucose control usually returns the lens to its original shape. Blurred vision is a common complaint leading to a diabetes diagnosis; type&#160;1 should always be suspected in cases of rapid vision change, whereas with type&#160;2 change is generally more gradual, but should still be suspected.</p>
<p>Patients (usually with type&#160;1 diabetes) may also initially present with diabetic ketoacidosis (DKA), an extreme state of metabolic dysregulation characterized by the smell of <a href="/wiki/Acetone" title="Acetone">acetone</a> on the patient's breath; a rapid, deep breathing known as <a href="/wiki/Kussmaul_breathing" title="Kussmaul breathing">Kussmaul breathing</a>; <a href="/wiki/Polyuria" title="Polyuria">polyuria</a>; nausea; vomiting and <a href="/wiki/Abdominal_pain" title="Abdominal pain">abdominal pain</a>; and any of many altered states of consciousness or arousal (such as hostility and mania or, equally, confusion and lethargy). In severe DKA, <a href="/wiki/Coma" title="Coma">coma</a> may follow, progressing to death. Diabetic ketoacidosis is a medical emergency and requires immediate hospitalization.</p>
<p>A rarer but equally severe possibility is <a href="/wiki/Nonketotic_hyperosmolar_coma" title="Nonketotic hyperosmolar coma">hyperosmolar nonketotic state</a>, which is more common in type&#160;2 diabetes and is mainly the result of dehydration due to loss of body water. Often, the patient has been drinking extreme amounts of sugar-containing drinks, leading to a <a href="/wiki/Positive_feedback" title="Positive feedback">vicious circle</a> in regard to the water loss.</p>
<p><a name="Genetics" id="Genetics"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Diabetes_mellitus&amp;action=edit&amp;section=7" title="Edit section: Genetics">edit</a>]</span> <span class="mw-headline">Genetics</span></h2>
<p>Both type&#160;1 and type&#160;2 diabetes are at least partly inherited. Type&#160;1 diabetes appears to be triggered by some (mainly viral) infections, or less commonly, by stress or environmental exposure (such as exposure to certain chemicals or drugs). There is a genetic element in individual susceptibility to some of these triggers which has been traced to particular <a href="/wiki/Human_leukocyte_antigen" title="Human leukocyte antigen">HLA</a> <a href="/wiki/Genotype" title="Genotype">genotypes</a> (i.e., the genetic "self" identifiers relied upon by the immune system). However, even in those who have inherited the susceptibility, type&#160;1 diabetes mellitus seems to require an environmental trigger. A small proportion of people with type&#160;1 diabetes carry a <a href="/wiki/Mutation" title="Mutation">mutated gene</a> that causes <a href="/wiki/Maturity_onset_diabetes_of_the_young" title="Maturity onset diabetes of the young">maturity onset diabetes of the young</a> (MODY).</p>
<p>There is a stronger inheritance pattern for type&#160;2 diabetes. Those with first-degree relatives with type&#160;2 have a much higher risk of developing type&#160;2, increasing with the number of those relatives. <a href="/wiki/Concordance_(genetics)" title="Concordance (genetics)">Concordance</a> among <a href="/wiki/Twin#Identical_twins" title="Twin">monozygotic twins</a> is close to 100%, and about 25% of those with the disease have a family history of diabetes. Genes significantly associated with developing type 2 diabetes, include <i><a href="/wiki/TCF7L2" title="TCF7L2">TCF7L2</a></i>, <i><a href="/wiki/PPARG" title="PPARG" class="mw-redirect">PPARG</a></i>, <i><a href="/wiki/FTO" title="FTO">FTO</a></i>, <i><a href="/wiki/KCNJ11" title="KCNJ11">KCNJ11</a></i>, <i><a href="/wiki/NOTCH2" title="NOTCH2">NOTCH2</a></i>, <i><a href="/wiki/WFS1" title="WFS1">WFS1</a></i>, <i><a href="/w/index.php?title=CDKAL1&amp;action=edit&amp;redlink=1" class="new" title="CDKAL1 (page does not exist)">CDKAL1</a></i>, <i><a href="/wiki/IGF2BP2" title="IGF2BP2">IGF2BP2</a></i>, <i><a href="/wiki/SLC30A8" title="SLC30A8">SLC30A8</a></i>, <i><a href="/wiki/JAZF1" title="JAZF1">JAZF1</a></i>, and <i><a href="/wiki/HHEX" title="HHEX">HHEX</a></i>.<sup id="cite_ref-15" class="reference"><a href="#cite_note-15" title=""><span>[</span>16<span>]</span></a></sup> <i>KCNJ11</i> (<a href="/wiki/Inward-rectifier_potassium_ion_channel" title="Inward-rectifier potassium ion channel">potassium inwardly rectifying channel</a>, subfamily J, member 11), encodes the islet ATP-sensitive potassium channel Kir6.2, and <i>TCF7L2</i> (transcription factor 7–like 2) regulates <a href="/wiki/Proglucagon" title="Proglucagon">proglucagon</a> gene expression and thus the production of <a href="/wiki/Glucagon-like_peptide-1" title="Glucagon-like peptide-1">glucagon-like peptide-1</a>.<sup id="cite_ref-Rother_2-2" class="reference"><a href="#cite_note-Rother-2" title=""><span>[</span>3<span>]</span></a></sup> Moreover, obesity (which is an independent risk factor for type&#160;2 diabetes) is strongly inherited.<sup id="cite_ref-16" class="reference"><a href="#cite_note-16" title=""><span>[</span>17<span>]</span></a></sup></p>
<p><a href="/wiki/Genetic_disorder" title="Genetic disorder">Monogenic</a> forms, e.g. <a href="/wiki/Maturity_onset_diabetes_of_the_young" title="Maturity onset diabetes of the young">MODY</a>, constitute 1-5&#160;% of all cases.<sup id="cite_ref-17" class="reference"><a href="#cite_note-17" title=""><span>[</span>18<span>]</span></a></sup></p>
<p>Various hereditary conditions may feature diabetes, for example <a href="/wiki/Myotonic_dystrophy" title="Myotonic dystrophy">myotonic dystrophy</a> and <a href="/wiki/Friedreich%27s_ataxia" title="Friedreich's ataxia">Friedreich's ataxia</a>. <a href="/wiki/Wolfram%27s_syndrome" title="Wolfram's syndrome" class="mw-redirect">Wolfram's syndrome</a> is an <a href="/wiki/Autosomal_recessive" title="Autosomal recessive" class="mw-redirect">autosomal recessive</a> <a href="/wiki/Neurodegenerative_disorder" title="Neurodegenerative disorder" class="mw-redirect">neurodegenerative disorder</a> that first becomes evident in childhood. It consists of diabetes insipidus, diabetes mellitus, optic atrophy, and deafness, hence the acronym DIDMOAD.<sup id="cite_ref-AMN_18-0" class="reference"><a href="#cite_note-AMN-18" title=""><span>[</span>19<span>]</span></a></sup></p>
<p><a name="Pathophysiology" id="Pathophysiology"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Diabetes_mellitus&amp;action=edit&amp;section=8" title="Edit section: Pathophysiology">edit</a>]</span> <span class="mw-headline">Pathophysiology</span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:402px;"><a href="/wiki/File:Glucose-insulin-release.png" class="image" title="Mechanism of insulin release in normal pancreatic beta cells. Insulin production is more or less constant within the beta cells, irrespective of blood glucose levels. It is stored within vacuoles pending release, via exocytosis, which is primarily triggered by food, chiefly food containing absorbable glucose. The chief trigger is a rise in blood glucose levels after eating"><img alt="" src="http://upload.wikimedia.org/wikipedia/en/thumb/2/21/Glucose-insulin-release.png/400px-Glucose-insulin-release.png" width="400" height="259" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Glucose-insulin-release.png" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Mechanism of insulin release in normal pancreatic beta cells. Insulin production is more or less constant within the beta cells, irrespective of blood glucose levels. It is stored within vacuoles pending release, via exocytosis, which is primarily triggered by food, chiefly food containing absorbable glucose. The chief trigger is a rise in blood glucose levels after eating</div>
</div>
</div>
<p>Insulin is the principal hormone that regulates uptake of <a href="/wiki/Glucose" title="Glucose">glucose</a> from the blood into most cells (primarily muscle and fat cells, but not central nervous system cells). Therefore deficiency of insulin or the insensitivity of its <a href="/wiki/Receptor_(biochemistry)" title="Receptor (biochemistry)">receptors</a> plays a central role in all forms of diabetes mellitus.</p>
<p>Most of the carbohydrates in food are converted within a few hours to the <a href="/wiki/Monosaccharide" title="Monosaccharide">monosaccharide</a> <a href="/wiki/Glucose" title="Glucose">glucose</a>, the principal carbohydrate found in blood and used by the body as fuel. The most significant exceptions are <a href="/wiki/Fructose" title="Fructose">fructose</a>, most disaccharides (except <a href="/wiki/Sucrose" title="Sucrose">sucrose</a> and in some people <a href="/wiki/Lactose" title="Lactose">lactose</a>), and all more complex polysaccharides, with the outstanding exception of <a href="/wiki/Starch" title="Starch">starch</a>. Insulin is released into the blood by beta cells (β-cells), found in the Islets of Langerhans in the pancreas, in response to rising levels of blood glucose, typically after eating. Insulin is used by about two-thirds of the body's cells to absorb glucose from the blood for use as fuel, for conversion to other needed molecules, or for storage.</p>
<p>Insulin is also the principal control signal for conversion of glucose to <a href="/wiki/Glycogen" title="Glycogen">glycogen</a> for internal storage in liver and muscle cells. Lowered glucose levels result both in the reduced release of insulin from the beta cells and in the reverse conversion of glycogen to glucose when glucose levels fall. This is mainly controlled by the hormone <a href="/wiki/Glucagon" title="Glucagon">glucagon</a> which acts in an opposite manner to insulin. Glucose thus recovered by the liver re-enters the bloodstream; muscle cells lack the necessary export mechanism.</p>
<p>Higher insulin levels increase some <a href="/wiki/Anabolism" title="Anabolism">anabolic</a> ("building up") processes such as cell growth and duplication, <a href="/wiki/Protein_biosynthesis" title="Protein biosynthesis">protein synthesis</a>, and <a href="/wiki/Lipid" title="Lipid">fat</a> storage. Insulin (or its lack) is the principal signal in converting many of the bidirectional processes of metabolism from a <a href="/wiki/Catabolism" title="Catabolism">catabolic</a> to an anabolic direction, and vice versa. In particular, a low insulin level is the trigger for entering or leaving ketosis (the fat burning metabolic phase).</p>
<p>If the amount of insulin available is insufficient, if cells respond poorly to the effects of insulin (insulin insensitivity or <a href="/wiki/Insulin_resistance" title="Insulin resistance">resistance</a>), or if the insulin itself is defective, then glucose will not be absorbed properly by those body cells that require it nor will it be stored appropriately in the liver and muscles. The net effect is persistent high levels of blood glucose, poor protein synthesis, and other metabolic derangements, such as <a href="/wiki/Acidosis" title="Acidosis">acidosis</a>.</p>
<p><a name="Diagnosis" id="Diagnosis"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Diabetes_mellitus&amp;action=edit&amp;section=9" title="Edit section: Diagnosis">edit</a>]</span> <span class="mw-headline">Diagnosis</span></h2>
<p>The diagnosis of type&#160;1 diabetes, and many cases of type&#160;2, is usually prompted by recent-onset symptoms of excessive urination (<a href="/wiki/Polyuria" title="Polyuria">polyuria</a>) and excessive thirst (polydipsia), often accompanied by weight loss. These symptoms typically worsen over days to weeks; about a quarter of people with new type&#160;1 diabetes have developed some degree of diabetic <a href="/wiki/Ketoacidosis" title="Ketoacidosis">ketoacidosis</a> by the time the diabetes is recognized. The diagnosis of other types of diabetes is usually made in other ways. These include ordinary health screening; detection of hyperglycemia during other medical investigations; and secondary symptoms such as vision changes or unexplainable fatigue. Diabetes is often detected when a person suffers a problem that is frequently caused by diabetes, such as a <a href="/wiki/Myocardial_infarction" title="Myocardial infarction">heart attack</a>, <a href="/wiki/Stroke" title="Stroke">stroke</a>, <a href="/wiki/Neuropathy" title="Neuropathy">neuropathy</a>, poor wound healing or a foot ulcer, certain eye problems, certain <a href="/wiki/Fungal_infection" title="Fungal infection" class="mw-redirect">fungal infections</a>, or delivering a baby with <a href="/wiki/Macrosomia" title="Macrosomia" class="mw-redirect">macrosomia</a> or <a href="/wiki/Hypoglycemia" title="Hypoglycemia">hypoglycemia</a>.</p>
<p>Diabetes mellitus is characterized by recurrent or persistent hyperglycemia, and is diagnosed by demonstrating any one of the following:<sup id="cite_ref-WHO1999-DefDiagClass_3-2" class="reference"><a href="#cite_note-WHO1999-DefDiagClass-3" title=""><span>[</span>4<span>]</span></a></sup></p>
<ul>
<li>fasting plasma glucose level at or above 126&#160;mg/dL (7.0&#160;mmol/l).</li>
<li><a href="/wiki/Plasma_glucose" title="Plasma glucose" class="mw-redirect">plasma glucose</a> at or above 200&#160;mg/dL (11.1&#160;mmol/l) two hours after a 75&#160;g oral glucose load as in a <a href="/wiki/Glucose_tolerance_test" title="Glucose tolerance test">glucose tolerance test</a>.</li>
<li>symptoms of hyperglycemia and casual plasma glucose at or above 200&#160;mg/dL (11.1&#160;mmol/l).</li>
</ul>
<p>A positive result, in the absence of unequivocal hyperglycemia, should be confirmed by a repeat of any of the above-listed methods on a different day. Most physicians prefer to measure a fasting glucose level because of the ease of measurement and the considerable time commitment of formal glucose tolerance testing, which takes two hours to complete. According to the current definition, two fasting glucose measurements above 126&#160;mg/dL (7.0&#160;mmol/l) is considered diagnostic for diabetes mellitus.</p>
<p>Patients with fasting glucose levels from 100 to 125&#160;mg/dL (6.1 and 7.0&#160;mmol/l) are considered to have <a href="/wiki/Impaired_fasting_glycemia" title="Impaired fasting glycemia" class="mw-redirect">impaired fasting glucose</a>. Patients with plasma glucose at or above 140&#160;mg/dL or 7.8&#160;mmol/l, but not over 200, two hours after a 75 g oral glucose load are considered to have <a href="/wiki/Impaired_glucose_tolerance" title="Impaired glucose tolerance">impaired glucose tolerance</a>. Of these two pre-diabetic states, the latter in particular is a major risk factor for progression to full-blown diabetes mellitus as well as cardiovascular disease.<sup id="cite_ref-19" class="reference"><a href="#cite_note-19" title=""><span>[</span>20<span>]</span></a></sup></p>
<p>While not used for diagnosis, an elevated level of glucose irreversibly bound to <a href="/wiki/Hemoglobin" title="Hemoglobin">hemoglobin</a> (termed <a href="/wiki/Glycosylated_hemoglobin" title="Glycosylated hemoglobin">glycosylated hemoglobin</a> or <i>HbA1c</i>) of 6.0% or higher (the 2003 revised U.S. standard) is considered abnormal by most labs; HbA1c is primarily used as a treatment-tracking test reflecting average blood glucose levels over the preceding 90 days (approximately). However, some physicians may order this test at the time of diagnosis to track changes over time. The current recommended goal for HbA1c in patients with diabetes is &lt;7.0%, which is considered good <a href="/wiki/Diabetes_management#Glycemic_control" title="Diabetes management">glycemic control</a>, although some guidelines are stricter (&lt;6.5%). People with diabetes who have HbA1c levels within this range have a significantly lower incidence of complications from diabetes, including <a href="/wiki/Retinopathy" title="Retinopathy">retinopathy</a> and <a href="/wiki/Diabetic_nephropathy" title="Diabetic nephropathy">diabetic nephropathy</a>.<sup id="cite_ref-pmid17510078_20-0" class="reference"><a href="#cite_note-pmid17510078-20" title=""><span>[</span>21<span>]</span></a></sup><sup id="cite_ref-21" class="reference"><a href="#cite_note-21" title=""><span>[</span>22<span>]</span></a></sup></p>
<p><a name="Screening" id="Screening"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Diabetes_mellitus&amp;action=edit&amp;section=10" title="Edit section: Screening">edit</a>]</span> <span class="mw-headline">Screening</span></h2>
<p>Diabetes screening is recommended for many people at various stages of life, and for those with any of several <a href="/wiki/Risk_factors" title="Risk factors" class="mw-redirect">risk factors</a>. The screening test varies according to circumstances and local policy, and may be a random blood glucose test, a fasting blood glucose test, a blood glucose test two hours after 75&#160;g of glucose, or an even more formal <a href="/wiki/Glucose_tolerance_test" title="Glucose tolerance test">glucose tolerance test</a>. Many healthcare providers recommend universal screening for adults at age 40 or 50, and often periodically thereafter. Earlier screening is typically recommended for those with risk factors such as obesity, <a href="/wiki/Family_history_(medicine)" title="Family history (medicine)">family history</a> of diabetes, high-risk <a href="/wiki/Ethnicity" title="Ethnicity" class="mw-redirect">ethnicity</a> (<a href="/wiki/Hispanic" title="Hispanic">Hispanic</a>, <a href="/wiki/Indigenous_peoples_of_the_Americas" title="Indigenous peoples of the Americas">Native American</a>, <a href="/wiki/African_diaspora" title="African diaspora">Afro-Caribbean</a>, <a href="/wiki/Pacific_Islander" title="Pacific Islander">Pacific Islander</a>).<sup id="cite_ref-pmid17215197_22-0" class="reference"><a href="#cite_note-pmid17215197-22" title=""><span>[</span>23<span>]</span></a></sup><sup id="cite_ref-pmid10889785_23-0" class="reference"><a href="#cite_note-pmid10889785-23" title=""><span>[</span>24<span>]</span></a></sup></p>
<p>Many medical conditions are associated with diabetes and warrant screening. A partial list includes: high blood pressure, <a href="/wiki/Dyslipidemia" title="Dyslipidemia">elevated cholesterol levels</a>, coronary artery disease, past gestational diabetes, <a href="/wiki/Polycystic_ovary_syndrome" title="Polycystic ovary syndrome">polycystic ovary syndrome</a>, chronic pancreatitis, <a href="/wiki/Fatty_liver" title="Fatty liver">fatty liver</a>, <a href="/wiki/Hemochromatosis" title="Hemochromatosis" class="mw-redirect">hemochromatosis</a>, <a href="/wiki/Cystic_fibrosis" title="Cystic fibrosis">cystic fibrosis</a>, several mitochondrial neuropathies and myopathies, <a href="/wiki/Myotonic_dystrophy" title="Myotonic dystrophy">myotonic dystrophy</a>, <a href="/wiki/Friedreich%27s_ataxia" title="Friedreich's ataxia">Friedreich's ataxia</a>, some of the inherited forms of neonatal hyperinsulinism. The risk of diabetes is higher with chronic use of several medications, including high-dose <a href="/wiki/Glucocorticoid" title="Glucocorticoid">glucocorticoids</a>, some <a href="/wiki/Chemotherapy" title="Chemotherapy">chemotherapy</a> agents (especially <a href="/wiki/L-asparaginase" title="L-asparaginase" class="mw-redirect">L-asparaginase</a>), as well as some of the antipsychotics and mood stabilizers (especially <a href="/wiki/Phenothiazine" title="Phenothiazine">phenothiazines</a> and some <a href="/wiki/Atypical_antipsychotics" title="Atypical antipsychotics" class="mw-redirect">atypical antipsychotics</a>).</p>
<p>People with a confirmed diagnosis of diabetes are tested routinely for complications. This includes yearly urine testing for <a href="/wiki/Microalbuminuria" title="Microalbuminuria">microalbuminuria</a> and examination of the <a href="/wiki/Retina" title="Retina">retina</a> of the eye for retinopathy.</p>
<p><a name="Prevention" id="Prevention"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Diabetes_mellitus&amp;action=edit&amp;section=11" title="Edit section: Prevention">edit</a>]</span> <span class="mw-headline">Prevention</span></h2>
<p>Type&#160;1 diabetes risk is known to depend upon a genetic predisposition based on <a href="/wiki/Human_leukocyte_antigen" title="Human leukocyte antigen">HLA</a> types (particularly types DR3 and DR4), an unknown environmental trigger (suspected to be an infection, although none has proven definitive in all cases), and an uncontrolled <a href="/wiki/Autoimmune" title="Autoimmune" class="mw-redirect">autoimmune</a> response that attacks the insulin producing <a href="/wiki/Beta_cells" title="Beta cells" class="mw-redirect">beta cells</a>.<sup id="cite_ref-24" class="reference"><a href="#cite_note-24" title=""><span>[</span>25<span>]</span></a></sup> Some research has suggested that <a href="/wiki/Breastfeeding" title="Breastfeeding">breastfeeding</a> decreased the risk in later life;<sup id="cite_ref-25" class="reference"><a href="#cite_note-25" title=""><span>[</span>26<span>]</span></a></sup><sup id="cite_ref-26" class="reference"><a href="#cite_note-26" title=""><span>[</span>27<span>]</span></a></sup> various other nutritional risk factors are being studied, but no firm evidence has been found.<sup id="cite_ref-27" class="reference"><a href="#cite_note-27" title=""><span>[</span>28<span>]</span></a></sup> Giving children 2000 IU of <a href="/wiki/Vitamin_D" title="Vitamin D">Vitamin D</a> during their first year of life is associated with reduced risk of type&#160;1 diabetes, though the causal relationship is obscure.<sup id="cite_ref-28" class="reference"><a href="#cite_note-28" title=""><span>[</span>29<span>]</span></a></sup></p>
<p>Children with antibodies to beta cell proteins (ie, at early stages of an immune reaction to them) but no overt diabetes, and treated with vitamin B-3 (<a href="/wiki/Niacin" title="Niacin">niacin</a>), had less than half the diabetes onset incidence in a 7-year time span as did the general population, and an even lower incidence relative to those with antibodies as above, but who received no vitamin B3.<sup id="cite_ref-pmid8961125_29-0" class="reference"><a href="#cite_note-pmid8961125-29" title=""><span>[</span>30<span>]</span></a></sup></p>
<p>Type&#160;2 diabetes risk can be reduced in many cases by making changes in diet and increasing physical activity.<sup id="cite_ref-pmid17098085_30-0" class="reference"><a href="#cite_note-pmid17098085-30" title=""><span>[</span>31<span>]</span></a></sup><sup id="cite_ref-Knowler_31-0" class="reference"><a href="#cite_note-Knowler-31" title=""><span>[</span>32<span>]</span></a></sup> The <a href="/wiki/American_Diabetes_Association" title="American Diabetes Association">American Diabetes Association</a> (ADA) recommends maintaining a healthy weight, getting at least 2½ hours of exercise per week (several brisk sustained walks appear sufficient), having a modest fat intake, and eating sufficient fiber (eg, from whole grains). The ADA does not recommend <a href="/wiki/Alcohol_consumption_and_health" title="Alcohol consumption and health" class="mw-redirect">alcohol consumption</a> as a preventive, but it is interesting to note that moderate alcohol intake may reduce the risk (though heavy consumption absolutely and clearly increases damage to bodily systems significantly); a similarly confused connection between low dose alcohol consumption and heart disease is termed the <a href="/wiki/French_Paradox" title="French Paradox" class="mw-redirect">French Paradox</a>.</p>
<p>There is inadequate evidence that eating foods of low <a href="/wiki/Glycemic_index" title="Glycemic index">glycemic index</a> is clinically helpful despite recommendations and suggested diets emphasizing this approach.<sup id="cite_ref-32" class="reference"><a href="#cite_note-32" title=""><span>[</span>33<span>]</span></a></sup></p>
<p>There are numerous studies which suggest connections between some aspects of Type II diabetes with ingestion of certain foods or with some drugs. Some studies have shown delayed progression to diabetes in predisposed patients through prophylactic use of metformin,<sup id="cite_ref-Knowler_31-1" class="reference"><a href="#cite_note-Knowler-31" title=""><span>[</span>32<span>]</span></a></sup> <a href="/wiki/Rosiglitazone" title="Rosiglitazone">rosiglitazone</a>,<sup id="cite_ref-33" class="reference"><a href="#cite_note-33" title=""><span>[</span>34<span>]</span></a></sup> or <a href="/wiki/Valsartan" title="Valsartan">valsartan</a>.<sup id="cite_ref-34" class="reference"><a href="#cite_note-34" title=""><span>[</span>35<span>]</span></a></sup> In patients on <a href="/wiki/Hydroxychloroquine" title="Hydroxychloroquine">hydroxychloroquine</a> for <a href="/wiki/Rheumatoid_arthritis" title="Rheumatoid arthritis">rheumatoid arthritis</a>, incidence of diabetes was reduced by 77% though causal mechanisms are unclear.<sup id="cite_ref-35" class="reference"><a href="#cite_note-35" title=""><span>[</span>36<span>]</span></a></sup> Breastfeeding may also be associated with the prevention of type&#160;2 of the disease in mothers.<sup id="cite_ref-JAMA2005-Stuebe_36-0" class="reference"><a href="#cite_note-JAMA2005-Stuebe-36" title=""><span>[</span>37<span>]</span></a></sup> Clear evidence for these and any of many other connections between foods and supplements and diabetes is sparse to date; none, despite secondary claims for (or against), is sufficiently well established to justify as a standard clinical approach.</p>
<p><a name="Treatment_and_management" id="Treatment_and_management"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Diabetes_mellitus&amp;action=edit&amp;section=12" title="Edit section: Treatment and management">edit</a>]</span> <span class="mw-headline">Treatment and management</span></h2>
<div class="rellink noprint relarticle mainarticle">Main article: <a href="/wiki/Diabetes_management" title="Diabetes management">Diabetes management</a></div>
<p>Diabetes mellitus is currently a <a href="/wiki/Chronic_disease" title="Chronic disease" class="mw-redirect">chronic disease</a>, without a cure, and medical emphasis must necessarily be on managing/avoiding possible short-term as well as long-term diabetes-related problems. There is an exceptionally important role for patient education, dietetic support, sensible exercise, self monitoring of blood glucose, with the goal of keeping both short-term blood glucose levels, and long term levels as well, <a href="/wiki/Diabetes_management#Glycemic_control" title="Diabetes management">within acceptable bounds</a>. Careful control is needed to reduce the risk of long term complications. This is theoretically achievable with combinations of diet, exercise and weight loss (type&#160;2), various oral diabetic drugs (type&#160;2 only), and insulin use (type&#160;1 and for type&#160;2 not responding to oral medications, mostly those with extended duration diabetes). In addition, given the associated higher risks of cardiovascular disease, lifestyle modifications should be undertaken to control blood pressure<sup id="cite_ref-37" class="reference"><a href="#cite_note-37" title=""><span>[</span>38<span>]</span></a></sup> and cholesterol by exercising more, smoking less or ideally <a href="/wiki/Smoking_cessation" title="Smoking cessation">not at all</a>, consuming an appropriate <a href="/wiki/Diabetic_diet" title="Diabetic diet">diet</a>, wearing <a href="/wiki/Diabetic_sock" title="Diabetic sock">diabetic socks</a>, wearing diabetic shoes, and if necessary, taking any of several drugs to reduce blood pressure. Many type&#160;1 treatments include combination use of regular or NPH insulin, and/or synthetic insulin analogs (eg, Humalog, Novolog or Apidra) in combinations such as Lantus/Levemir and Humalog, Novolog or Apidra. Another type&#160;1 treatment option is the use of the insulin pump (eg, from Deltec Cozmo, Animas, Medtronic Minimed, Insulet Omnipod, or ACCU-CHEK). A <a href="/wiki/Blood_lancet" title="Blood lancet">blood lancet</a> is used to pierce the skin (typically of a finger), in order to draw blood to test it for sugar levels.</p>
<p>In countries using a <a href="/wiki/General_practitioner" title="General practitioner">general practitioner</a> system, such as the <a href="/wiki/United_Kingdom" title="United Kingdom">United Kingdom</a>, care may take place mainly outside hospitals, with hospital-based specialist care used only in case of complications, difficult blood sugar control, or research projects. In other circumstances, general practitioners and specialists share care of a patient in a team approach. <a href="/wiki/Optometry" title="Optometry">Optometrists</a>, <a href="/wiki/Podiatry" title="Podiatry">podiatrists</a>/chiropodists, <a href="/wiki/Dietitian" title="Dietitian">dietitians</a>, <a href="/wiki/Physical_therapy" title="Physical therapy">physiotherapists</a>, nursing specialists (eg, DSNs (Diabetic Specialist Nurse)), <a href="/wiki/Nurse_practitioner" title="Nurse practitioner">nurse practitioners</a>, or <a href="/wiki/Certified_diabetes_educator" title="Certified diabetes educator">Certified Diabetes Educators</a>, may jointly provide multidisciplinary expertise. In countries where patients must provide their own health care (i.e., in the developed world, the US, and in much of the undeveloped world), the impact of out-of-pocket costs of adequate diabetic care can be very high. In addition to the medications and supplies needed, patients are often advised to receive regular consultation from a physician (e.g., at least every three to six months).</p>
<p><a href="/wiki/Peer_support" title="Peer support">Peer support</a> links people living with diabetes. Within peer support, people with a common illness share knowledge and experience that others, including many health workers, do not have. Peer support is frequent, ongoing, accessible and flexible and can take many forms—phone calls, text messaging, group meetings, home visits, and even grocery shopping. It complements and enhances other health care services by creating the emotional, social and practical assistance necessary for managing disease and staying healthy.</p>
<p><a name="Cure" id="Cure"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Diabetes_mellitus&amp;action=edit&amp;section=13" title="Edit section: Cure">edit</a>]</span> <span class="mw-headline">Cure</span></h2>
<p><a name="Cures_for_type_1_diabetes" id="Cures_for_type_1_diabetes"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Diabetes_mellitus&amp;action=edit&amp;section=14" title="Edit section: Cures for type 1 diabetes">edit</a>]</span> <span class="mw-headline">Cures for type 1 diabetes</span></h3>
<div class="rellink noprint relarticle mainarticle">Main article: <a href="/wiki/Cure_for_diabetes_mellitus_type_1" title="Cure for diabetes mellitus type 1" class="mw-redirect">Cure for diabetes mellitus type 1</a></div>
<p>There is no practical cure, at this time, for type&#160;1 diabetes. The fact that type&#160;1 diabetes is due to the failure of one of the cell types of a single organ with a relatively simple function (i.e. the failure of the beta cells in the Islets of Langerhans) has led to the study of several possible schemes to cure this form of diabetes mostly by replacing the pancreas or just the beta cells.<sup id="cite_ref-Vinik_38-0" class="reference"><a href="#cite_note-Vinik-38" title=""><span>[</span>39<span>]</span></a></sup> Only those type&#160;1 diabetics who have received either a pancreas or a kidney-pancreas transplant (often when they have developed diabetic kidney disease (ie, nephropathy) and become insulin-independent) may now be considered "cured" from their diabetes. A simultaneous pancreas-kidney transplant is a promising solution, showing similar or improved survival rates over a kidney transplant alone.<sup id="cite_ref-Stratta_39-0" class="reference"><a href="#cite_note-Stratta-39" title=""><span>[</span>40<span>]</span></a></sup> Still, they generally remain on long-term <a href="/wiki/Immunosuppressive_drug" title="Immunosuppressive drug">immunosuppressive drugs</a> and there is a possibility that the immune system will mount a <a href="/wiki/Host_versus_graft" title="Host versus graft" class="mw-redirect">host versus graft</a> response against the transplanted organ.<sup id="cite_ref-Vinik_38-1" class="reference"><a href="#cite_note-Vinik-38" title=""><span>[</span>39<span>]</span></a></sup></p>
<p>Transplants of exogenous beta cells have been performed experimentally in both mice and humans, but this measure is not yet practical in regular clinical practice partly due to the limited number of beta cell donors. Thus far, like any such transplant, it has provoked an immune reaction and long-term immunosuppressive drugs have been needed to protect the transplanted tissue.<sup id="cite_ref-40" class="reference"><a href="#cite_note-40" title=""><span>[</span>41<span>]</span></a></sup> An alternative technique has been proposed to place transplanted beta cells in a semi-permeable container, isolating and protecting them from the immune system. <a href="/wiki/Stem_cell_research" title="Stem cell research" class="mw-redirect">Stem cell research</a> has also been suggested as a potential avenue for a cure since it may permit regrowth of Islet cells which are genetically part of the treated individual, thus perhaps eliminating the need for immuno-suppressants.<sup id="cite_ref-Vinik_38-2" class="reference"><a href="#cite_note-Vinik-38" title=""><span>[</span>39<span>]</span></a></sup> This has been done in mice, and a 2007 trial of 15 newly diagnosed patients with type&#160;1 diabetes treated with <a href="/wiki/Stem_cell" title="Stem cell">stem cells</a> raised from their own <a href="/wiki/Bone_marrow" title="Bone marrow">bone marrow</a> after <a href="/wiki/Immune_suppression" title="Immune suppression" class="mw-redirect">immune suppression</a> showed that the majority did not require any insulin treatment for prolonged periods of time.<sup id="cite_ref-41" class="reference"><a href="#cite_note-41" title=""><span>[</span>42<span>]</span></a></sup></p>
<p>Microscopic or nanotechnological approaches are under investigation as well, in one proposed case with implanted stores of insulin metered out by a rapid response valve sensitive to blood glucose levels. At least two approaches have been demonstrated <i>in vitro</i>. These are, in some sense, closed-loop insulin pumps.</p>
<p><a name="Cures_for_type_2_diabetes" id="Cures_for_type_2_diabetes"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Diabetes_mellitus&amp;action=edit&amp;section=15" title="Edit section: Cures for type 2 diabetes">edit</a>]</span> <span class="mw-headline">Cures for type 2 diabetes</span></h3>
<p>Type 2 has had no definitive cure, although recently it has been shown that a type of <a href="/wiki/Gastric_bypass_surgery" title="Gastric bypass surgery">gastric bypass surgery</a> can normalize blood glucose levels in 80-100% of severely obese patients with diabetes. The precise causal mechanisms are being intensively researched; its results are not simply attributable to weight loss, as the improvement in blood sugars precedes any change in body mass. This approach may become a standard treatment for some people with type&#160;2 diabetes in the relatively near future.<sup id="cite_ref-pmid12409659_42-0" class="reference"><a href="#cite_note-pmid12409659-42" title=""><span>[</span>43<span>]</span></a></sup> This surgery has the additional benefit of reducing the death rate from all causes by up to 40% in severely obese people.<sup id="cite_ref-pmid17715409_43-0" class="reference"><a href="#cite_note-pmid17715409-43" title=""><span>[</span>44<span>]</span></a></sup> A small number of normal to moderately obese patients with type&#160;2 diabetes have successfully undergone similar operations.<sup id="cite_ref-pmid17386401_44-0" class="reference"><a href="#cite_note-pmid17386401-44" title=""><span>[</span>45<span>]</span></a></sup><sup id="cite_ref-NS_45-0" class="reference"><a href="#cite_note-NS-45" title=""><span>[</span>46<span>]</span></a></sup></p>
<p><a name="Prognosis" id="Prognosis"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Diabetes_mellitus&amp;action=edit&amp;section=16" title="Edit section: Prognosis">edit</a>]</span> <span class="mw-headline">Prognosis</span></h2>
<p>Patient education, understanding, and participation is vital since the complications of diabetes are far less common and less severe in people who have well-<a href="/wiki/Diabetes_management#Glycemic_control" title="Diabetes management">controlled</a> blood sugar levels.<sup id="cite_ref-46" class="reference"><a href="#cite_note-46" title=""><span>[</span>47<span>]</span></a></sup><sup id="cite_ref-47" class="reference"><a href="#cite_note-47" title=""><span>[</span>48<span>]</span></a></sup> Wider health problems accelerate the deleterious effects of diabetes. These include <a href="/wiki/Tobacco_smoking" title="Tobacco smoking">smoking</a>, <a href="/wiki/Hypercholesterolemia" title="Hypercholesterolemia">elevated cholesterol</a> levels, <a href="/wiki/Obesity" title="Obesity">obesity</a>, <a href="/wiki/Hypertension" title="Hypertension">high blood pressure</a>, and lack of regular <a href="/wiki/Exercise" title="Exercise" class="mw-redirect">exercise</a>. According to a study, women with high <a href="/wiki/Blood_pressure" title="Blood pressure">blood pressure</a> have a threefold risk of developing diabetes.</p>
<p>Anecdotal evidence suggests that some of those with type&#160;2 diabetes who exercise regularly, lose weight, and eat healthy diets may be able to keep some of the disease or some of the effects of the disease in 'remission.' Certainly these tips can help prevent people predisposed to type&#160;2 diabetes and those at pre-diabetic stages from actually developing the disorder as it helps restore insulin sensitivity. However patients should talk to their doctors about this for real expectations before undertaking it (esp. to avoid hypoglycemia or other complications); few people actually seem to go into total 'remission,' but some may find they need less of their insulin medications since the body tends to have lower insulin requirements during and shortly following exercise. Regardless of whether it works that way or not for an individual, there are certainly other benefits to this healthy lifestyle for both diabetics and nondiabetics.</p>
<p>The way diabetes is managed changes with age. Insulin production decreases because of age-related impairment of pancreatic beta cells. Additionally, insulin resistance increases because of the loss of lean tissue and the accumulation of fat, particularly intra-abdominal fat, and the decreased tissue sensitivity to insulin. Glucose tolerance progressively declines with age, leading to a high prevalence of type&#160;2 diabetes and postchallenge hyperglycemia in the older population.<sup id="cite_ref-health_48-0" class="reference"><a href="#cite_note-health-48" title=""><span>[</span>49<span>]</span></a></sup> Age-related glucose intolerance in humans is often accompanied by insulin resistance, but circulating insulin levels are similar to those of younger people.<sup id="cite_ref-ajp_49-0" class="reference"><a href="#cite_note-ajp-49" title=""><span>[</span>50<span>]</span></a></sup> Treatment goals for older patients with diabetes vary with the individual, and take into account health status, as well as life expectancy, level of dependence, and willingness to adhere to a treatment regimen.<sup id="cite_ref-nidkk_50-0" class="reference"><a href="#cite_note-nidkk-50" title=""><span>[</span>51<span>]</span></a></sup></p>
<p><a name="Acute_complications" id="Acute_complications"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Diabetes_mellitus&amp;action=edit&amp;section=17" title="Edit section: Acute complications">edit</a>]</span> <span class="mw-headline">Acute complications</span></h3>
<div class="rellink noprint relarticle mainarticle">Main articles: <a href="/wiki/Diabetic_ketoacidosis" title="Diabetic ketoacidosis">Diabetic ketoacidosis</a>, <a href="/wiki/Nonketotic_hyperosmolar_coma" title="Nonketotic hyperosmolar coma">nonketotic hyperosmolar coma</a>, <a href="/wiki/Hypoglycemia" title="Hypoglycemia">hypoglycemia</a>, and <a href="/wiki/Diabetic_coma" title="Diabetic coma">diabetic coma</a></div>
<dl>
<dt>Diabetic ketoacidosis</dt>
</dl>
<p><a href="/wiki/Diabetic_ketoacidosis" title="Diabetic ketoacidosis">Diabetic ketoacidosis</a> (DKA) is an acute and dangerous complication that is always a <a href="/wiki/Medical_emergency" title="Medical emergency">medical emergency</a>. Low insulin levels cause the <a href="/wiki/Liver" title="Liver">liver</a> to turn to fat for fuel (ie, <a href="/wiki/Ketosis" title="Ketosis">ketosis</a>); <a href="/wiki/Ketone_bodies" title="Ketone bodies">ketone bodies</a> are intermediate substrates in that metabolic sequence. This is normal when periodic, but can become a serious problem if sustained. Elevated levels of ketone bodies in the blood decrease the blood's <a href="/wiki/PH" title="PH">pH</a>, leading to DKA. On presentation at hospital, the patient in DKA is typically dehydrated, and breathing rapidly and deeply. Abdominal pain is common and may be severe. The <a href="/wiki/Level_of_consciousness" title="Level of consciousness">level of consciousness</a> is typically normal until late in the process, when lethargy may progress to coma. Ketoacidosis can easily become severe enough to cause <a href="/wiki/Hypotension" title="Hypotension">hypotension</a>, <a href="/wiki/Shock_(circulatory)" title="Shock (circulatory)">shock</a>, and death. Urine analysis will reveal significant levels of ketone bodies (which have exceeded their <a href="/wiki/Renal_threshold" title="Renal threshold">renal threshold</a> blood levels to appear in the urine, often before other overt symptoms). Prompt, proper treatment usually results in full recovery, though death can result from inadequate or delayed treatment, or from complications (eg, brain <a href="/wiki/Edema" title="Edema">edema</a>). DKA is always a medical emergency and requires medical attention. Ketoacidosis is much more common in type&#160;1 diabetes than type&#160;2.</p>
<dl>
<dt>Hyperglycemia hyperosmolar state</dt>
</dl>
<p><a href="/wiki/Nonketotic_hyperosmolar_coma" title="Nonketotic hyperosmolar coma">Hyperosmolar nonketotic state</a> (HNS) is an acute complication sharing many symptoms with DKA, but an entirely different origin and different treatment. A person with very high (usually considered to be above 300&#160;mg/dl (16&#160;mmol/l)) blood glucose levels, water is <a href="/wiki/Osmosis" title="Osmosis">osmotically</a> drawn out of cells into the blood and the kidneys eventually begin to dump glucose into the urine. This results in loss of water and an increase in blood <a href="/wiki/Osmolarity" title="Osmolarity">osmolarity</a>. If fluid is not replaced (by mouth or intravenously), the osmotic effect of high glucose levels, combined with the loss of water, will eventually lead to <a href="/wiki/Dehydration" title="Dehydration">dehydration</a>. The body's cells become progressively dehydrated as water is taken from them and excreted. Electrolyte imbalances are also common and are always dangerous. As with DKA, urgent medical treatment is necessary, commonly beginning with fluid volume replacement. Lethargy may ultimately progress to a coma, though this is more common in type&#160;2 diabetes than type&#160;1.</p>
<dl>
<dt>Hypoglycemia</dt>
</dl>
<p><a href="/wiki/Hypoglycemia" title="Hypoglycemia">Hypoglycemia</a>, or abnormally low blood glucose, is an acute complication of several diabetes treatments. It is rare otherwise, either in diabetic or non-diabetic patients. The patient may become agitated, sweaty, and have many symptoms of <a href="/wiki/Autonomic_nervous_system" title="Autonomic nervous system">sympathetic</a> activation of the autonomic nervous system resulting in feelings akin to dread and immobilized panic. Consciousness can be altered or even lost in extreme cases, leading to coma, <a href="/wiki/Seizure" title="Seizure">seizures</a>, or even brain damage and death. In patients with diabetes, this may be caused by several factors, such as too much or incorrectly timed insulin, too much or incorrectly timed exercise (exercise decreases insulin requirements) or not enough food (specifically glucose containing carbohydrates). The variety of interactions makes cause identification difficult in many instances.</p>
<p>It is more accurate to note that <a href="/wiki/Iatrogenic" title="Iatrogenic" class="mw-redirect">iatrogenic</a> hypoglycemia is typically the result of the interplay of absolute (or relative) insulin excess and compromised glucose counterregulation in type&#160;1 and advanced type&#160;2 diabetes. Decrements in insulin, increments in glucagon, and, absent the latter, increments in epinephrine are the primary glucose counterregulatory factors that normally prevent or (more or less rapidly) correct hypoglycemia. In insulin-deficient diabetes (exogenous) insulin levels do not decrease as glucose levels fall, and the combination of deficient glucagon and epinephrine responses causes defective glucose counterregulation.</p>
<p>Furthermore, reduced sympathoadrenal responses can cause hypoglycemia unawareness. The concept of hypoglycemia-associated autonomic failure (HAAF) in diabetes posits that recent incidents of hypoglycemia causes both defective glucose counterregulation and hypoglycemia unawareness. By shifting glycemic thresholds for the sympathoadrenal (including epinephrine) and the resulting neurogenic responses to lower plasma glucose concentrations, antecedent hypoglycemia leads to a vicious cycle of recurrent hypoglycemia and further impairment of glucose counterregulation. In many cases (but not all), short-term avoidance of hypoglycemia reverses hypoglycemia unawareness in affected patients, although this is easier in theory than in clinical experience.</p>
<p>In most cases, hypoglycemia is treated with sugary drinks or food. In severe cases, an injection of <a href="/wiki/Glucagon" title="Glucagon">glucagon</a> (a hormone with effects largely opposite to those of insulin) or an <a href="/wiki/Intravenous" title="Intravenous" class="mw-redirect">intravenous</a> infusion of <a href="/wiki/Dextrose" title="Dextrose" class="mw-redirect">dextrose</a> is used for treatment, but usually only if the person is unconscious. In any given incident, glucagon will only work once as it uses stored liver glycogen as a glucose source; in the absence of such stores, glucagon is largely ineffective. In hospitals, intravenous dextrose is often used.</p>
<p><a name="Chronic_complications" id="Chronic_complications"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Diabetes_mellitus&amp;action=edit&amp;section=18" title="Edit section: Chronic complications">edit</a>]</span> <span class="mw-headline">Chronic complications</span></h3>
<dl>
<dt>Vascular disease</dt>
</dl>
<p>Chronic elevation of blood glucose level leads to damage of <a href="/wiki/Blood_vessel" title="Blood vessel">blood vessels</a> (<a href="/wiki/Angiopathy" title="Angiopathy">angiopathy</a>). The <a href="/wiki/Endothelial_cell" title="Endothelial cell" class="mw-redirect">endothelial cells</a> lining the blood vessels take in more glucose than normal, since they don't depend on insulin. They then form more surface <a href="/wiki/Glycoprotein" title="Glycoprotein">glycoproteins</a> than normal, and cause the <a href="/wiki/Basement_membrane" title="Basement membrane">basement membrane</a> to grow thicker and weaker. In diabetes, the resulting problems are grouped under "<a href="/wiki/Microvascular_disease" title="Microvascular disease" class="mw-redirect">microvascular disease</a>" (due to damage to small blood vessels) and "<a href="/wiki/Macrovascular_disease" title="Macrovascular disease">macrovascular disease</a>" (due to damage to the <a href="/wiki/Artery" title="Artery">arteries</a>).</p>
<div class="thumb tright">
<div class="thumbinner" style="width:182px;"><a href="/wiki/File:Fundus_photo_showing_scatter_laser_surgery_for_diabetic_retinopathy_EDA09.JPG" class="image" title="Image of fundus showing scatter laser surgery for diabetic retinopathy"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/3/3f/Fundus_photo_showing_scatter_laser_surgery_for_diabetic_retinopathy_EDA09.JPG/180px-Fundus_photo_showing_scatter_laser_surgery_for_diabetic_retinopathy_EDA09.JPG" width="180" height="115" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Fundus_photo_showing_scatter_laser_surgery_for_diabetic_retinopathy_EDA09.JPG" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Image of <a href="/wiki/Fundus_(eye)" title="Fundus (eye)">fundus</a> showing scatter <a href="/wiki/Laser_scalpel" title="Laser scalpel">laser surgery</a> for <a href="/wiki/Diabetic_retinopathy" title="Diabetic retinopathy">diabetic retinopathy</a></div>
</div>
</div>
<p>The damage to small blood vessels leads to a <a href="/wiki/Microangiopathy" title="Microangiopathy">microangiopathy</a>, which can cause one or more of the following:</p>
<ul>
<li><i><a href="/wiki/Diabetic_retinopathy" title="Diabetic retinopathy">Diabetic retinopathy</a></i>, growth of friable and poor-quality new blood vessels in the <a href="/wiki/Retina" title="Retina">retina</a> as well as <a href="/wiki/Macular_edema" title="Macular edema">macular edema</a> (swelling of the <a href="/wiki/Macula" title="Macula">macula</a>), which can lead to severe <a href="/wiki/Vision_loss" title="Vision loss">vision loss</a> or blindness. Retinal damage (from microangiopathy) makes it the most common cause of blindness among non-elderly adults in the US.</li>
<li><i><a href="/wiki/Diabetic_neuropathy" title="Diabetic neuropathy">Diabetic neuropathy</a></i>, abnormal and decreased sensation, usually in a 'glove and stocking' distribution starting with the feet but potentially in other nerves, later often fingers and hands. When combined with damaged blood vessels this can lead to <i><a href="/wiki/Diabetic_foot" title="Diabetic foot">diabetic foot</a></i> (see below). Other forms of diabetic neuropathy may present as mononeuritis or <a href="/wiki/Autonomic_neuropathy" title="Autonomic neuropathy">autonomic neuropathy</a>. <a href="/wiki/Diabetic_amyotrophy" title="Diabetic amyotrophy">Diabetic amyotrophy</a> is muscle weakness due to neuropathy.</li>
<li><i><a href="/wiki/Diabetic_nephropathy" title="Diabetic nephropathy">Diabetic nephropathy</a></i>, damage to the <a href="/wiki/Kidney" title="Kidney">kidney</a> which can lead to chronic renal failure, eventually requiring <a href="/wiki/Dialysis" title="Dialysis">dialysis</a>. Diabetes mellitus is the most common cause of adult kidney failure worldwide in the developed world.</li>
<li><i><a href="/wiki/Diabetic_cardiomyopathy" title="Diabetic cardiomyopathy">Diabetic cardiomyopathy</a></i>, damage to the heart, leading to diastolic dysfunction and eventually <a href="/wiki/Heart_failure" title="Heart failure">heart failure</a>.</li>
</ul>
<p><a href="/wiki/Macrovascular_disease" title="Macrovascular disease">Macrovascular disease</a> leads to cardiovascular disease, to which accelerated <a href="/wiki/Atherosclerosis" title="Atherosclerosis">atherosclerosis</a> is a contributor:</p>
<ul>
<li><a href="/wiki/Coronary_artery_disease" title="Coronary artery disease">Coronary artery disease</a>, leading to <a href="/wiki/Angina_pectoris" title="Angina pectoris">angina</a> or <a href="/wiki/Myocardial_infarction" title="Myocardial infarction">myocardial infarction</a> ("heart attack")</li>
<li><a href="/wiki/Stroke" title="Stroke">Stroke</a> (mainly the ischemic type)</li>
<li><a href="/wiki/Peripheral_artery_occlusive_disease" title="Peripheral artery occlusive disease" class="mw-redirect">Peripheral vascular disease</a>, which contributes to <a href="/wiki/Intermittent_claudication" title="Intermittent claudication">intermittent claudication</a> (exertion-related leg and foot pain) as well as diabetic foot.</li>
<li><a href="/wiki/Diabetic_myonecrosis" title="Diabetic myonecrosis">Diabetic myonecrosis</a> ('muscle wasting')</li>
</ul>
<p>Diabetic foot, often due to a combination of sensory neuropathy (numbness or insensitivity) and vascular damage, increases rates of <a href="/wiki/Skin_ulcer" title="Skin ulcer" class="mw-redirect">skin ulcers</a> and <a href="/wiki/Infection" title="Infection">infection</a> and, in serious cases, <a href="/wiki/Necrosis" title="Necrosis">necrosis</a> and gangrene. It is why diabetics are prone to leg and foot infections and why it takes longer for them to heal from leg and foot wounds. It is the most common cause of non-traumatic adult amputation, usually of toes and or feet, in the developed world.</p>
<p><a href="/wiki/Carotid_artery_stenosis" title="Carotid artery stenosis">Carotid artery stenosis</a> does not occur more often in diabetes, and there appears to be a lower prevalence of <a href="/wiki/Abdominal_aortic_aneurysm" title="Abdominal aortic aneurysm">abdominal aortic aneurysm</a>. However, diabetes does cause higher morbidity, mortality and operative risks with these conditions.<sup id="cite_ref-51" class="reference"><a href="#cite_note-51" title=""><span>[</span>52<span>]</span></a></sup></p>
<p>Diabetic encephalopathy<sup id="cite_ref-52" class="reference"><a href="#cite_note-52" title=""><span>[</span>53<span>]</span></a></sup> is the increased cognitive decline and risk of <a href="/wiki/Dementia" title="Dementia">dementia</a> observed in diabetes. Various mechanisms are proposed, including alterations to the vascular supply of the brain and the interaction of insulin with the brain itself.<sup id="cite_ref-cspd_53-0" class="reference"><a href="#cite_note-cspd-53" title=""><span>[</span>54<span>]</span></a></sup>.</p>
<p><a name="Epidemiology" id="Epidemiology"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Diabetes_mellitus&amp;action=edit&amp;section=19" title="Edit section: Epidemiology">edit</a>]</span> <span class="mw-headline">Epidemiology</span></h2>
<p>In 2000, according to the World Health Organization, at least 171 million people worldwide suffer from diabetes, or 2.8% of the population.<sup id="cite_ref-Wild2004_54-0" class="reference"><a href="#cite_note-Wild2004-54" title=""><span>[</span>55<span>]</span></a></sup> Its incidence is increasing rapidly, and it is estimated that by the year 2030, this number will almost double.<sup id="cite_ref-Wild2004_54-1" class="reference"><a href="#cite_note-Wild2004-54" title=""><span>[</span>55<span>]</span></a></sup> Diabetes mellitus occurs throughout the world, but is more common (especially type&#160;2) in the more developed countries. The greatest increase in prevalence is, however, expected to occur in Asia and Africa, where most patients will likely be found by 2030.<sup id="cite_ref-Wild2004_54-2" class="reference"><a href="#cite_note-Wild2004-54" title=""><span>[</span>55<span>]</span></a></sup> The increase in incidence of diabetes in developing countries follows the trend of urbanization and lifestyle changes, perhaps most importantly a "Western-style" diet. This has suggested an environmental (i.e., dietary) effect, but there is little understanding of the mechanism(s) at present, though there is much speculation, some of it most compellingly presented.<sup id="cite_ref-Wild2004_54-3" class="reference"><a href="#cite_note-Wild2004-54" title=""><span>[</span>55<span>]</span></a></sup></p>
<p>For at least 20 years, diabetes rates in North America have been increasing substantially. In 2008 there were about 24 million people with diabetes in the United States alone, from those 5.7 million people remain undiagnosed. Other 57 million people are estimated to have pre-diabetes.<sup id="cite_ref-55" class="reference"><a href="#cite_note-55" title=""><span>[</span>56<span>]</span></a></sup></p>
<p>The <a href="/wiki/Centers_for_Disease_Control" title="Centers for Disease Control" class="mw-redirect">Centers for Disease Control</a> has termed the change an <a href="/wiki/Epidemic" title="Epidemic">epidemic</a>.<sup id="cite_ref-56" class="reference"><a href="#cite_note-56" title=""><span>[</span>57<span>]</span></a></sup> The <a href="/wiki/National_Diabetes_Information_Clearinghouse" title="National Diabetes Information Clearinghouse" class="mw-redirect">National Diabetes Information Clearinghouse</a> estimates that diabetes costs $132 billion in the United States alone every year. About 5%–10% of diabetes cases in North America are type&#160;1, with the rest being type&#160;2. The fraction of type&#160;1 in other parts of the world differs; this is likely due to both differences in the rate of type&#160;1 and differences in the rate of other types, most prominently type&#160;2. Most of this difference is not currently understood. The American Diabetes Association point out the 2003 assessment of the National Center for Chronic Disease Prevention and Health Promotion (Centers for Disease Control and Prevention) that 1 in 3 Americans born after 2000 will develop diabetes in their lifetime.<sup id="cite_ref-57" class="reference"><a href="#cite_note-57" title=""><span>[</span>58<span>]</span></a></sup><sup id="cite_ref-AA2005-Stats_58-0" class="reference"><a href="#cite_note-AA2005-Stats-58" title=""><span>[</span>59<span>]</span></a></sup></p>
<p>According to the American Diabetes Association, approximately 18.3% (8.6 million) of Americans age 60 and older have diabetes.<sup id="cite_ref-dlife_59-0" class="reference"><a href="#cite_note-dlife-59" title=""><span>[</span>60<span>]</span></a></sup> Diabetes mellitus prevalence increases with age, and the numbers of older persons with diabetes are expected to grow as the elderly population increases in number. The National Health and Nutrition Examination Survey (NHANES III) demonstrated that, in the population over 65 years old, 18% to 20% have diabetes, with 40% having either diabetes or its precursor form of <a href="/wiki/Impaired_glucose_tolerance" title="Impaired glucose tolerance">impaired glucose tolerance</a>.<sup id="cite_ref-health_48-1" class="reference"><a href="#cite_note-health-48" title=""><span>[</span>49<span>]</span></a></sup></p>
<p>Indigenous populations in first world countries have a higher prevalence and increasing incidence of diabetes than their corresponding non-indigenous populations. In Australia the age-standardised prevalence of self-reported diabetes in Indigenous Australians is almost 4 times that of non-indigenous Australians.<sup id="cite_ref-60" class="reference"><a href="#cite_note-60" title=""><span>[</span>61<span>]</span></a></sup> Preventative community health programs such as <a href="/wiki/Sugar_Man_(diabetes_education)" title="Sugar Man (diabetes education)">Sugar Man (diabetes education)</a> are showing some success in tackling this problem.</p>
<p><a name="History" id="History"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Diabetes_mellitus&amp;action=edit&amp;section=20" title="Edit section: History">edit</a>]</span> <span class="mw-headline">History</span></h2>
<p>The term <i>diabetes</i> (<a href="/wiki/Greek_language" title="Greek language">Greek</a>: <span lang="el" xml:lang="el">διαβήτης</span>, <i>diabētēs</i>) was coined by <a href="/wiki/Aretaeus_of_Cappadocia" title="Aretaeus of Cappadocia">Aretaeus of Cappadocia</a>. It was derived from the Greek verb διαβαίνειν, <i>diabaínein</i>, itself formed from the prefix <i>dia</i>-, "across, apart," and the verb <i>bainein</i>, "to walk, stand." The verb <i>diabeinein</i> meant "to stride, walk, or stand with legs asunder"; hence, its derivative <i>diabētēs</i> meant "one that straddles," or specifically "a compass, siphon." The sense "siphon" gave rise to the use of <i>diabētēs</i> as the name for a disease involving the discharge of excessive amounts of urine. Diabetes is first recorded in English, in the form diabete, in a medical text written around 1425. In 1675, <a href="/wiki/Thomas_Willis" title="Thomas Willis">Thomas Willis</a> added the word <i>mellitus</i>, from the <a href="/wiki/Latin_(language)" title="Latin (language)" class="mw-redirect">Latin</a> meaning "honey", a reference to the sweet taste of the urine. This sweet taste had been noticed in urine by the ancient Greeks, Chinese, Egyptians, Indians, and Persians. In 1776, <a href="/w/index.php?title=Matthew_Dobson&amp;action=edit&amp;redlink=1" class="new" title="Matthew Dobson (page does not exist)">Matthew Dobson</a> confirmed that the sweet taste was because of an excess of a kind of sugar in the urine and blood of people with diabetes.<sup id="cite_ref-61" class="reference"><a href="#cite_note-61" title=""><span>[</span>62<span>]</span></a></sup></p>
<p>Diabetes mellitus appears to have been a death sentence in the ancient era. Hippocrates makes no mention of it, which may indicate that he felt the disease was incurable. Aretaeus did attempt to treat it but could not give a good prognosis; he commented that "life (with diabetes) is short, disgusting and painful."<sup id="cite_ref-62" class="reference"><a href="#cite_note-62" title=""><span>[</span>63<span>]</span></a></sup></p>
<p><a href="/wiki/Sushruta" title="Sushruta">Sushruta</a> (6th century BCE) identified diabetes and classified it as <i>Medhumeha</i>.<sup id="cite_ref-Dwivedi.26Dwivedi07_63-0" class="reference"><a href="#cite_note-Dwivedi.26Dwivedi07-63" title=""><span>[</span>64<span>]</span></a></sup> He further identified it with <a href="/wiki/Obesity" title="Obesity">obesity</a> and <a href="/wiki/Sedentary" title="Sedentary" class="mw-redirect">sedentary</a> lifestyle, advising exercises to help cure it.<sup id="cite_ref-Dwivedi.26Dwivedi07_63-1" class="reference"><a href="#cite_note-Dwivedi.26Dwivedi07-63" title=""><span>[</span>64<span>]</span></a></sup> The ancient <a href="/wiki/India" title="India">Indians</a> tested for diabetes by observing whether <a href="/wiki/Ant" title="Ant">ants</a> were attracted to a person's urine, and called the ailment "sweet urine disease" (Madhumeha). The Korean, Chinese, and Japanese words for diabetes are based on the same ideographs (糖尿病) which mean "sugar urine disease". In medieval <a href="/wiki/History_of_Iran" title="History of Iran">Persia</a>, <a href="/wiki/Avicenna" title="Avicenna">Avicenna</a> (980-1037) provided a detailed account on diabetes mellitus in <i><a href="/wiki/The_Canon_of_Medicine" title="The Canon of Medicine">The Canon of Medicine</a></i>, "describing the abnormal appetite and the collapse of sexual functions and he documented the sweet taste of diabetic urine." Like Aretaeus before him, Avicenna recognized a primary and secondary diabetes. He also described diabetic <a href="/wiki/Gangrene" title="Gangrene">gangrene</a>, and treated diabetes using a mixture of <a href="/wiki/Lupin" title="Lupin">lupine</a>, <a href="/wiki/Trigonella" title="Trigonella">trigonella</a> (<a href="/wiki/Fenugreek" title="Fenugreek">fenugreek</a>), and <a href="/wiki/Zedoary" title="Zedoary">zedoary</a> seed, which produces a considerable reduction in the excretion of sugar, a treatment which is still prescribed in modern times. Avicenna also "described diabetes insipidus very precisely for the first time", though it was later <a href="/wiki/Johann_Peter_Frank" title="Johann Peter Frank">Johann Peter Frank</a> (1745-1821) who first differentiated between diabetes mellitus and diabetes insipidus.<sup id="cite_ref-64" class="reference"><a href="#cite_note-64" title=""><span>[</span>65<span>]</span></a></sup></p>
<p>Although diabetes has been recognized since <a href="/wiki/Ancient_history" title="Ancient history">antiquity</a>, and treatments of various efficacy have been known in various regions since the <a href="/wiki/Middle_Ages" title="Middle Ages">Middle Ages</a>, and in <a href="/wiki/Snake_oil" title="Snake oil">legend</a> for much longer, pathogenesis of diabetes has only been understood experimentally since about 1900.<sup id="cite_ref-FASEBJ2002-Patlak_65-0" class="reference"><a href="#cite_note-FASEBJ2002-Patlak-65" title=""><span>[</span>66<span>]</span></a></sup> The discovery of a role for the pancreas in diabetes is generally ascribed to <a href="/wiki/Joseph_von_Mering" title="Joseph von Mering">Joseph von Mering</a> and <a href="/wiki/Oskar_Minkowski" title="Oskar Minkowski">Oskar Minkowski</a>, who in 1889 found that dogs whose pancreas was removed developed all the signs and symptoms of diabetes and died shortly afterwards.<sup id="cite_ref-66" class="reference"><a href="#cite_note-66" title=""><span>[</span>67<span>]</span></a></sup> In 1910, Sir <a href="/wiki/Edward_Albert_Sharpey-Schafer" title="Edward Albert Sharpey-Schafer">Edward Albert Sharpey-Schafer</a> suggested that people with diabetes were deficient in a single chemical that was normally produced by the pancreas—he proposed calling this substance <i>insulin</i>, from the Latin <i>insula</i>, meaning island, in reference to the insulin-producing <a href="/wiki/Islets_of_Langerhans" title="Islets of Langerhans">islets of Langerhans</a> in the pancreas.<sup id="cite_ref-FASEBJ2002-Patlak_65-1" class="reference"><a href="#cite_note-FASEBJ2002-Patlak-65" title=""><span>[</span>66<span>]</span></a></sup></p>
<p>The endocrine role of the pancreas in metabolism, and indeed the existence of insulin, was not further clarified until 1921, when Sir <a href="/wiki/Frederick_Grant_Banting" title="Frederick Grant Banting" class="mw-redirect">Frederick Grant Banting</a> and <a href="/wiki/Charles_Herbert_Best" title="Charles Herbert Best" class="mw-redirect">Charles Herbert Best</a> repeated the work of Von Mering and Minkowski, and went further to demonstrate they could reverse induced diabetes in dogs by giving them an extract from the pancreatic islets of Langerhans of healthy dogs.<sup id="cite_ref-CanadMedAssocJ1922-Banting_67-0" class="reference"><a href="#cite_note-CanadMedAssocJ1922-Banting-67" title=""><span>[</span>68<span>]</span></a></sup> Banting, Best, and colleagues (especially the chemist <a href="/wiki/James_Collip" title="James Collip">Collip</a>) went on to purify the hormone insulin from bovine pancreases at the <a href="/wiki/University_of_Toronto" title="University of Toronto">University of Toronto</a>. This led to the availability of an effective treatment—insulin injections—and the first patient was treated in 1922. For this, Banting and laboratory director MacLeod received the <a href="/wiki/Nobel_Prize_in_Physiology_or_Medicine" title="Nobel Prize in Physiology or Medicine">Nobel Prize in Physiology or Medicine</a> in 1923; both shared their Prize money with others in the team who were not recognized, in particular Best and Collip. Banting and Best made the patent available without charge and did not attempt to control commercial production. <a href="/wiki/Insulin" title="Insulin">Insulin</a> production and therapy rapidly spread around the world, largely as a result of this decision. Banting is honored by <a href="/wiki/World_Diabetes_Day" title="World Diabetes Day">World Diabetes Day</a> which is held on his birthday, November 14.</p>
<p>The distinction between what is now known as type&#160;1 diabetes and type&#160;2 diabetes was first clearly made by Sir <a href="/wiki/Harold_Percival_Himsworth" title="Harold Percival Himsworth">Harold Percival (Harry) Himsworth</a>, and published in January 1936.<sup id="cite_ref-Lancet1936-Himsworth_68-0" class="reference"><a href="#cite_note-Lancet1936-Himsworth-68" title=""><span>[</span>69<span>]</span></a></sup></p>
<p>Despite the availability of treatment, diabetes has remained a major cause of death. For instance, <a href="/wiki/Statistics" title="Statistics">statistics</a> reveal that the cause-specific <a href="/wiki/Mortality_rate" title="Mortality rate">mortality rate</a> during 1927 amounted to about 47.7 per 100,000 population in <a href="/wiki/Malta" title="Malta">Malta</a>.<sup id="cite_ref-69" class="reference"><a href="#cite_note-69" title=""><span>[</span>70<span>]</span></a></sup></p>
<p>Other landmark discoveries include:<sup id="cite_ref-FASEBJ2002-Patlak_65-2" class="reference"><a href="#cite_note-FASEBJ2002-Patlak-65" title=""><span>[</span>66<span>]</span></a></sup></p>
<ul>
<li>identification of the first of the <a href="/wiki/Sulfonylurea" title="Sulfonylurea">sulfonylureas</a> in 1942</li>
<li>reintroduction of the use of <a href="/wiki/Biguanides" title="Biguanides" class="mw-redirect">biguanides</a> for Type&#160;2 diabetes in the late 1950s. The initial <a href="/wiki/Phenformin" title="Phenformin">phenformin</a> was withdrawn worldwide (in the U.S. in 1977) due to its potential for sometimes fatal lactic acidosis and <a href="/wiki/Metformin" title="Metformin">metformin</a> was first marketed in France in 1979, but not until 1994 in the US.</li>
<li>the determination of the <a href="/wiki/Amino_acid_sequence" title="Amino acid sequence" class="mw-redirect">amino acid sequence</a> of insulin (by Sir <a href="/wiki/Frederick_Sanger" title="Frederick Sanger">Frederick Sanger</a>, for which he received a Nobel Prize)</li>
<li>the <a href="/wiki/Radioimmunoassay" title="Radioimmunoassay">radioimmunoassay</a> for insulin, as discovered by <a href="/wiki/Rosalyn_Yalow" title="Rosalyn Yalow" class="mw-redirect">Rosalyn Yalow</a> and <a href="/wiki/Solomon_Berson" title="Solomon Berson">Solomon Berson</a> (gaining Yalow the 1977 Nobel Prize in Physiology or Medicine)<sup id="cite_ref-70" class="reference"><a href="#cite_note-70" title=""><span>[</span>71<span>]</span></a></sup></li>
<li>the three-dimensional structure of insulin (<a href="/wiki/Protein_Data_Bank" title="Protein Data Bank">PDB</a> <a href="http://www.rcsb.org/pdb/explore/explore.do?structureId=2INS" class="external text" title="http://www.rcsb.org/pdb/explore/explore.do?structureId=2INS" rel="nofollow">2INS</a>)</li>
<li>Dr <a href="/wiki/Gerald_Reaven" title="Gerald Reaven">Gerald Reaven</a>'s identification of the constellation of symptoms now called <a href="/wiki/Metabolic_syndrome" title="Metabolic syndrome">metabolic syndrome</a> in 1988</li>
<li>demonstration that intensive <a href="/wiki/Diabetes_management#Glycemic_control" title="Diabetes management">glycemic control</a> in type&#160;1 diabetes reduces chronic side effects more as glucose levels approach 'normal' in a large longitudinal study,<sup id="cite_ref-71" class="reference"><a href="#cite_note-71" title=""><span>[</span>72<span>]</span></a></sup> and also in type&#160;2 diabetics in other large studies</li>
<li>identification of the first <a href="/wiki/Thiazolidinedione" title="Thiazolidinedione">thiazolidinedione</a> as an effective insulin sensitizer during the 1990s</li>
</ul>
<p>In 1980, U.S. biotech company Genentech developed human insulin. The insulin is isolated from genetically altered bacteria (the bacteria contain the human gene for synthesizing human insulin), which produce large quantities of insulin. Scientists then purify the insulin and distribute it to pharmacies for use by diabetes patients.</p>
<p><a name="Social_issues" id="Social_issues"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Diabetes_mellitus&amp;action=edit&amp;section=21" title="Edit section: Social issues">edit</a>]</span> <span class="mw-headline">Social issues</span></h2>
<p>The 1990 "St Vincent Declaration"<sup id="cite_ref-72" class="reference"><a href="#cite_note-72" title=""><span>[</span>73<span>]</span></a></sup><sup id="cite_ref-73" class="reference"><a href="#cite_note-73" title=""><span>[</span>74<span>]</span></a></sup> was the result of international efforts to improve the care accorded to those with diabetes. Doing so is important both in terms of quality of life and life expectancy but also economically - expenses due to diabetes have been shown to be a major drain on health - and productivity-related resources for healthcare systems and governments.</p>
<p>Several countries established more and less successful national diabetes programmes to improve treatment of the disease.<sup id="cite_ref-EO005-Dubois.26Bankauskaite_74-0" class="reference"><a href="#cite_note-EO005-Dubois.26Bankauskaite-74" title=""><span>[</span>75<span>]</span></a></sup></p>
<p>A study shows that diabetic patients with neuropathic symptoms such as <a href="/wiki/Paresthesia" title="Paresthesia">numbness</a> or tingling in feet or hands are twice more likely to be <a href="/wiki/Unemployed" title="Unemployed" class="mw-redirect">unemployed</a> than those without the symptoms.<sup id="cite_ref-pmid17563611_75-0" class="reference"><a href="#cite_note-pmid17563611-75" title=""><span>[</span>76<span>]</span></a></sup></p>
<p><a name="See_also" id="See_also"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Diabetes_mellitus&amp;action=edit&amp;section=22" title="Edit section: See also">edit</a>]</span> <span class="mw-headline">See also</span></h2>
<ul>
<li><a href="/wiki/Neuropathic_ulcer" title="Neuropathic ulcer">Neuropathic ulcer</a></li>
<li><a href="/wiki/Glossary_of_terms_associated_with_diabetes" title="Glossary of terms associated with diabetes" class="mw-redirect">List of terms associated with diabetes</a></li>
<li><a href="/wiki/Blood_sugar" title="Blood sugar">Blood sugar</a></li>
</ul>
<p><a name="References" id="References"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Diabetes_mellitus&amp;action=edit&amp;section=23" title="Edit section: References">edit</a>]</span> <span class="mw-headline">References</span></h2>
<div class="references-small references-column-count references-column-count-2" style="-moz-column-count:2; column-count:2;">
<ol class="references">
<li id="cite_note-0"><b><a href="#cite_ref-0" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.diabetesbluecircle.org" class="external text" title="http://www.diabetesbluecircle.org" rel="nofollow">"Diabetes Blue Circle Symbol"</a>. International Diabetes Federation. 17 March 2006<span class="printonly">. <a href="http://www.diabetesbluecircle.org" class="external free" title="http://www.diabetesbluecircle.org" rel="nofollow">http://www.diabetesbluecircle.org</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Diabetes+Blue+Circle+Symbol&amp;rft.atitle=&amp;rft.date=17+March+2006&amp;rft.pub=International+Diabetes+Federation&amp;rft_id=http%3A%2F%2Fwww.diabetesbluecircle.org&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-diag-1"><b><a href="#cite_ref-diag_1-0" title="">^</a></b> <cite style="font-style:normal" class="book" id="CITEREFL_M_Tierney.2C_S_J_McPhee2002">L M Tierney, S J McPhee, M A Papadakis (2002). <i>Current medical Diagnosis &amp; Treatment. International edition</i>. New York: Lange Medical Books/McGraw-Hill. pp.&#160;1203–1215. <a href="/wiki/Special:BookSources/0071376887" class="internal">ISBN 0-07-137688-7</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Current+medical+Diagnosis+%26+Treatment.+International+edition&amp;rft.aulast=L+M+Tierney%2C+S+J+McPhee&amp;rft.aufirst=M+A+Papadakis&amp;rft.au=L+M+Tierney%2C+S+J+McPhee%2C+M+A+Papadakis&amp;rft.date=2002&amp;rft.pages=pp.%26nbsp%3B1203%E2%80%931215&amp;rft.place=New+York&amp;rft.pub=Lange+Medical+Books%2FMcGraw-Hill&amp;rft.isbn=0-07-137688-7&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Rother-2">^ <a href="#cite_ref-Rother_2-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Rother_2-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Rother_2-2" title=""><sup><i><b>c</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFRother2007">Rother, KI (2007). "<a href="http://content.nejm.org/cgi/content/full/356/15/1499" class="external text" title="http://content.nejm.org/cgi/content/full/356/15/1499" rel="nofollow">Diabetes Treatment — Bridging the Divide</a>". <i>N Engl J Med</i> <b>356</b> (15): 1499–1501. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJMp078030" class="external text" title="http://dx.doi.org/10.1056%2FNEJMp078030" rel="nofollow">10.1056/NEJMp078030</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17429082" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17429082">PMID 17429082</a><span class="printonly">. <a href="http://content.nejm.org/cgi/content/full/356/15/1499" class="external free" title="http://content.nejm.org/cgi/content/full/356/15/1499" rel="nofollow">http://content.nejm.org/cgi/content/full/356/15/1499</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Diabetes+Treatment+%E2%80%94+Bridging+the+Divide&amp;rft.jtitle=N+Engl+J+Med&amp;rft.aulast=Rother&amp;rft.aufirst=KI&amp;rft.au=Rother%2C+KI&amp;rft.date=2007&amp;rft.volume=356&amp;rft.issue=15&amp;rft.pages=1499%E2%80%931501&amp;rft_id=info:doi/10.1056%2FNEJMp078030&amp;rft_id=info:pmid/17429082&amp;rft_id=http%3A%2F%2Fcontent.nejm.org%2Fcgi%2Fcontent%2Ffull%2F356%2F15%2F1499&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-WHO1999-DefDiagClass-3">^ <a href="#cite_ref-WHO1999-DefDiagClass_3-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-WHO1999-DefDiagClass_3-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-WHO1999-DefDiagClass_3-2" title=""><sup><i><b>c</b></i></sup></a> <cite style="font-style:normal" class="web" id="CITEREF.5B.5BWorld_Health_Organisation.5D.5D_Department_of_Noncommunicable_Disease_Surveillance1999"><a href="/wiki/World_Health_Organisation" title="World Health Organisation" class="mw-redirect">World Health Organisation</a> Department of Noncommunicable Disease Surveillance (1999). <a href="http://whqlibdoc.who.int/hq/1999/WHO_NCD_NCS_99.2.pdf" class="external text" title="http://whqlibdoc.who.int/hq/1999/WHO_NCD_NCS_99.2.pdf" rel="nofollow">"Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications"</a> (PDF)<span class="printonly">. <a href="http://whqlibdoc.who.int/hq/1999/WHO_NCD_NCS_99.2.pdf" class="external free" title="http://whqlibdoc.who.int/hq/1999/WHO_NCD_NCS_99.2.pdf" rel="nofollow">http://whqlibdoc.who.int/hq/1999/WHO_NCD_NCS_99.2.pdf</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Definition%2C+Diagnosis+and+Classification+of+Diabetes+Mellitus+and+its+Complications&amp;rft.atitle=&amp;rft.aulast=%5B%5BWorld+Health+Organisation%5D%5D+Department+of+Noncommunicable+Disease+Surveillance&amp;rft.au=%5B%5BWorld+Health+Organisation%5D%5D+Department+of+Noncommunicable+Disease+Surveillance&amp;rft.date=1999&amp;rft_id=http%3A%2F%2Fwhqlibdoc.who.int%2Fhq%2F1999%2FWHO_NCD_NCS_99.2.pdf&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-4"><b><a href="#cite_ref-4" title="">^</a></b> <cite style="font-style:normal" class="web" id="CITEREFMailloux2007">Mailloux, Lionel (2007-02-13). <a href="http://patients.uptodate.com/topic.asp?file=dialysis/15147" class="external text" title="http://patients.uptodate.com/topic.asp?file=dialysis/15147" rel="nofollow">"UpToDate Dialysis in diabetic nephropathy"</a>. UpToDate<span class="printonly">. <a href="http://patients.uptodate.com/topic.asp?file=dialysis/15147" class="external free" title="http://patients.uptodate.com/topic.asp?file=dialysis/15147" rel="nofollow">http://patients.uptodate.com/topic.asp?file=dialysis/15147</a></span><span class="reference-accessdate">. Retrieved on 2007-12-07</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=UpToDate+Dialysis+in+diabetic+nephropathy&amp;rft.atitle=&amp;rft.aulast=Mailloux&amp;rft.aufirst=Lionel&amp;rft.au=Mailloux%2C+Lionel&amp;rft.date=2007-02-13&amp;rft.pub=UpToDate&amp;rft_id=http%3A%2F%2Fpatients.uptodate.com%2Ftopic.asp%3Ffile%3Ddialysis%2F15147&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-5"><b><a href="#cite_ref-5" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.diabetes.org/other-types.jsp" class="external text" title="http://www.diabetes.org/other-types.jsp" rel="nofollow">"Other "types" of diabetes"</a>. <a href="/wiki/American_Diabetes_Association" title="American Diabetes Association">American Diabetes Association</a>. August 25, 2005<span class="printonly">. <a href="http://www.diabetes.org/other-types.jsp" class="external free" title="http://www.diabetes.org/other-types.jsp" rel="nofollow">http://www.diabetes.org/other-types.jsp</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Other+%22types%22+of+diabetes&amp;rft.atitle=&amp;rft.date=August+25%2C+2005&amp;rft.pub=%5B%5BAmerican+Diabetes+Association%5D%5D&amp;rft_id=http%3A%2F%2Fwww.diabetes.org%2Fother-types.jsp&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-6"><b><a href="#cite_ref-6" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://autoimmune.pathology.jhmi.edu/diseases.cfm?systemID=3&amp;DiseaseID=23" class="external text" title="http://autoimmune.pathology.jhmi.edu/diseases.cfm?systemID=3&amp;DiseaseID=23" rel="nofollow">"Diseases: Johns Hopkins Autoimmune Disease Research Center"</a><span class="printonly">. <a href="http://autoimmune.pathology.jhmi.edu/diseases.cfm?systemID=3&amp;DiseaseID=23" class="external free" title="http://autoimmune.pathology.jhmi.edu/diseases.cfm?systemID=3&amp;DiseaseID=23" rel="nofollow">http://autoimmune.pathology.jhmi.edu/diseases.cfm?systemID=3&amp;DiseaseID=23</a></span><span class="reference-accessdate">. Retrieved on 2007-09-23</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Diseases%3A+Johns+Hopkins+Autoimmune+Disease+Research+Center&amp;rft.atitle=&amp;rft_id=http%3A%2F%2Fautoimmune.pathology.jhmi.edu%2Fdiseases.cfm%3FsystemID%3D3%26DiseaseID%3D23&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-7"><b><a href="#cite_ref-7" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.fda.gov/bbs/topics/news/2006/NEW01304.html" class="external text" title="http://www.fda.gov/bbs/topics/news/2006/NEW01304.html" rel="nofollow">"FDA Approves First Ever Inhaled Insulin Combination Product for Treatment of Diabetes"</a><span class="printonly">. <a href="http://www.fda.gov/bbs/topics/news/2006/NEW01304.html" class="external free" title="http://www.fda.gov/bbs/topics/news/2006/NEW01304.html" rel="nofollow">http://www.fda.gov/bbs/topics/news/2006/NEW01304.html</a></span><span class="reference-accessdate">. Retrieved on 2007-09-09</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=FDA+Approves+First+Ever+Inhaled+Insulin+Combination+Product+for+Treatment+of+Diabetes&amp;rft.atitle=&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2Fbbs%2Ftopics%2Fnews%2F2006%2FNEW01304.html&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-8"><b><a href="#cite_ref-8" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.mannkindcorp.com/pressreleasetext.aspx?releaseID=1198182" class="external text" title="http://www.mannkindcorp.com/pressreleasetext.aspx?releaseID=1198182" rel="nofollow">"MannKind Unveils Proposed Trade Name at Dedication of Danbury Manufacturing Facility"</a><span class="printonly">. <a href="http://www.mannkindcorp.com/pressreleasetext.aspx?releaseID=1198182" class="external free" title="http://www.mannkindcorp.com/pressreleasetext.aspx?releaseID=1198182" rel="nofollow">http://www.mannkindcorp.com/pressreleasetext.aspx?releaseID=1198182</a></span><span class="reference-accessdate">. Retrieved on 2008-10-23</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=MannKind+Unveils+Proposed+Trade+Name+at+Dedication+of+Danbury+Manufacturing+Facility&amp;rft.atitle=&amp;rft_id=http%3A%2F%2Fwww.mannkindcorp.com%2Fpressreleasetext.aspx%3FreleaseID%3D1198182&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-9"><b><a href="#cite_ref-9" title="">^</a></b> <cite style="font-style:normal" class="web" id="CITEREFBaillie2008">Baillie, K (2008-07-05). <a href="http://www.cliniclog.com/type_1_diabetes_trials.php" class="external text" title="http://www.cliniclog.com/type_1_diabetes_trials.php" rel="nofollow">"ClinicLog article on current diabetes trials."</a>. ClinicLog.com<span class="printonly">. <a href="http://www.cliniclog.com/type_1_diabetes_trials.php" class="external free" title="http://www.cliniclog.com/type_1_diabetes_trials.php" rel="nofollow">http://www.cliniclog.com/type_1_diabetes_trials.php</a></span><span class="reference-accessdate">. Retrieved on 2008-07-23</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=ClinicLog+article+on+current+diabetes+trials.&amp;rft.atitle=&amp;rft.aulast=Baillie&amp;rft.aufirst=K&amp;rft.au=Baillie%2C+K&amp;rft.date=2008-07-05&amp;rft.pub=ClinicLog.com&amp;rft_id=http%3A%2F%2Fwww.cliniclog.com%2Ftype_1_diabetes_trials.php&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-10"><b><a href="#cite_ref-10" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFEberhartOgden_C.2C_Engelgau_M.2C_Cadwell_B.2C_Hedley_AA.2C_Saydah_SH2004">Eberhart, MS; Ogden C, Engelgau M, Cadwell B, Hedley AA, Saydah SH (19 November 2004). "<a href="http://www.cdc.gov/mmwR/preview/mmwrhtml/mm5345a2.htm" class="external text" title="http://www.cdc.gov/mmwR/preview/mmwrhtml/mm5345a2.htm" rel="nofollow">Prevalence of Overweight and Obesity Among Adults with Diagnosed Diabetes --- United States, 1988--1994 and 1999--2002</a>". <i>Morbidity and Mortality Weekly Report</i> (Centers for Disease Control and Prevention) <b>53</b> (45): 1066–1068<span class="printonly">. <a href="http://www.cdc.gov/mmwR/preview/mmwrhtml/mm5345a2.htm" class="external free" title="http://www.cdc.gov/mmwR/preview/mmwrhtml/mm5345a2.htm" rel="nofollow">http://www.cdc.gov/mmwR/preview/mmwrhtml/mm5345a2.htm</a></span><span class="reference-accessdate">. Retrieved on 2007-03-11</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Prevalence+of+Overweight+and+Obesity+Among+Adults+with+Diagnosed+Diabetes+---+United+States%2C+1988--1994+and+1999--2002&amp;rft.jtitle=Morbidity+and+Mortality+Weekly+Report&amp;rft.aulast=Eberhart&amp;rft.aufirst=MS&amp;rft.au=Eberhart%2C+MS&amp;rft.au=Ogden+C%2C+Engelgau+M%2C+Cadwell+B%2C+Hedley+AA%2C+Saydah+SH&amp;rft.date=19+November+2004&amp;rft.volume=53&amp;rft.issue=45&amp;rft.pages=1066%E2%80%931068&amp;rft.pub=Centers+for+Disease+Control+and+Prevention&amp;rft_id=http%3A%2F%2Fwww.cdc.gov%2FmmwR%2Fpreview%2Fmmwrhtml%2Fmm5345a2.htm&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-11"><b><a href="#cite_ref-11" title="">^</a></b> <cite style="font-style:normal" class="book" id="CITEREFArlan_Rosenbloom2003">Arlan Rosenbloom, Janet H Silverstein (2003). <i>Type&#160;2 Diabetes in Children and Adolescents: A Clinician's Guide to Diagnosis, Epidemiology, Pathogenesis, Prevention, and Treatment</i>. American Diabetes Association,U.S.. pp.&#160;1. <a href="/wiki/Special:BookSources/9781580401555" class="internal">ISBN 978-1580401555</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Type%26nbsp%3B2+Diabetes+in+Children+and+Adolescents%3A+A+Clinician%27s+Guide+to+Diagnosis%2C+Epidemiology%2C+Pathogenesis%2C+Prevention%2C+and+Treatment&amp;rft.aulast=Arlan+Rosenbloom&amp;rft.aufirst=Janet+H+Silverstein&amp;rft.au=Arlan+Rosenbloom%2C+Janet+H+Silverstein&amp;rft.date=2003&amp;rft.pages=pp.%26nbsp%3B1&amp;rft.pub=American+Diabetes+Association%2CU.S.&amp;rft.isbn=978-1580401555&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-12"><b><a href="#cite_ref-12" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLangTamara_S._Galloway.2C_Alan_Scarlett.2C_William_E._Henley.2C_Michael_Depledge.2C_Robert_B._Wallace.2C_and_David_Melzer2008">Lang, Iain A.; Tamara S. Galloway, Alan Scarlett, William E. Henley, Michael Depledge, Robert B. Wallace, and David Melzer (2008). "Association of Urinary Bisphenol A Concentration with Medical Disorders and Laboratory Abnormalities in Adults". <i>Journal of the American Medical Association</i> <b>300</b> (1): 1303–1310.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Association+of+Urinary+Bisphenol+A+Concentration+with+Medical+Disorders+and+Laboratory+Abnormalities+in+Adults&amp;rft.jtitle=Journal+of+the+American+Medical+Association&amp;rft.aulast=Lang&amp;rft.aufirst=Iain+A.&amp;rft.au=Lang%2C+Iain+A.&amp;rft.au=Tamara+S.+Galloway%2C+Alan+Scarlett%2C+William+E.+Henley%2C+Michael+Depledge%2C+Robert+B.+Wallace%2C+and+David+Melzer&amp;rft.date=2008&amp;rft.volume=300&amp;rft.issue=1&amp;rft.pages=1303%E2%80%931310&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-13"><b><a href="#cite_ref-13" title="">^</a></b> <cite style="font-style:normal" class="">"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type&#160;2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group". <i>Lancet</i> <b>352</b> (9131): 854–65. 1998. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0140-6736%2898%2907037-8" class="external text" title="http://dx.doi.org/10.1016%2FS0140-6736%2898%2907037-8" rel="nofollow">10.1016/S0140-6736(98)07037-8</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9742977" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9742977">PMID 9742977</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Effect+of+intensive+blood-glucose+control+with+metformin+on+complications+in+overweight+patients+with+type%26nbsp%3B2+diabetes+%28UKPDS+34%29.+UK+Prospective+Diabetes+Study+%28UKPDS%29+Group&amp;rft.jtitle=Lancet&amp;rft.date=1998&amp;rft.volume=352&amp;rft.issue=9131&amp;rft.pages=854%E2%80%9365&amp;rft_id=info:doi/10.1016%2FS0140-6736%2898%2907037-8&amp;rft_id=info:pmid/9742977&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-14"><b><a href="#cite_ref-14" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLawrence_JM.2C_Contreras_R.2C_Chen_W.2C_Sacks_DA2008">Lawrence JM, Contreras R, Chen W, Sacks DA (May 2008). "Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a racially/ethnically diverse population of pregnant women, 1999-2005". <i>Diabetes Care</i> <b>31</b> (5): 899–904. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.2337%2Fdc07-2345" class="external text" title="http://dx.doi.org/10.2337%2Fdc07-2345" rel="nofollow">10.2337/dc07-2345</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18223030" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18223030">PMID 18223030</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Trends+in+the+prevalence+of+preexisting+diabetes+and+gestational+diabetes+mellitus+among+a+racially%2Fethnically+diverse+population+of+pregnant+women%2C+1999-2005&amp;rft.jtitle=Diabetes+Care&amp;rft.aulast=Lawrence+JM%2C+Contreras+R%2C+Chen+W%2C+Sacks+DA&amp;rft.au=Lawrence+JM%2C+Contreras+R%2C+Chen+W%2C+Sacks+DA&amp;rft.date=May+2008&amp;rft.volume=31&amp;rft.issue=5&amp;rft.pages=899%E2%80%93904&amp;rft_id=info:doi/10.2337%2Fdc07-2345&amp;rft_id=info:pmid/18223030&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-15"><b><a href="#cite_ref-15" title="">^</a></b> <cite style="font-style:normal" class="">"<a href="http://content.nejm.org/cgi/content/short/359/21/2220?query=TOC" class="external text" title="http://content.nejm.org/cgi/content/short/359/21/2220?query=TOC" rel="nofollow">Clinical risk factors, DNA variants, and the development of type 2 diabetes</a>". <i>N Engl J Med</i> <b>359</b> (21): 2220–2232. 2008<span class="printonly">. <a href="http://content.nejm.org/cgi/content/short/359/21/2220?query=TOC" class="external free" title="http://content.nejm.org/cgi/content/short/359/21/2220?query=TOC" rel="nofollow">http://content.nejm.org/cgi/content/short/359/21/2220?query=TOC</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Clinical+risk+factors%2C+DNA+variants%2C+and+the+development+of+type+2+diabetes&amp;rft.jtitle=N+Engl+J+Med&amp;rft.date=2008&amp;rft.volume=359&amp;rft.issue=21&amp;rft.pages=2220%26ndash%3B2232&amp;rft_id=http%3A%2F%2Fcontent.nejm.org%2Fcgi%2Fcontent%2Fshort%2F359%2F21%2F2220%3Fquery%3DTOC&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-16"><b><a href="#cite_ref-16" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFWalley_AJ.2C_Blakemore_AI.2C_Froguel_P2006">Walley AJ, Blakemore AI, Froguel P (2006). "Genetics of obesity and the prediction of risk for health". <i>Hum. Mol. Genet.</i> <b>15 Spec No 2</b>: R124–30. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1093%2Fhmg%2Fddl215" class="external text" title="http://dx.doi.org/10.1093%2Fhmg%2Fddl215" rel="nofollow">10.1093/hmg/ddl215</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16987875" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16987875">PMID 16987875</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Genetics+of+obesity+and+the+prediction+of+risk+for+health&amp;rft.jtitle=Hum.+Mol.+Genet.&amp;rft.aulast=Walley+AJ%2C+Blakemore+AI%2C+Froguel+P&amp;rft.au=Walley+AJ%2C+Blakemore+AI%2C+Froguel+P&amp;rft.date=2006&amp;rft.volume=15+Spec+No+2&amp;rft.pages=R124%E2%80%9330&amp;rft_id=info:doi/10.1093%2Fhmg%2Fddl215&amp;rft_id=info:pmid/16987875&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-17"><b><a href="#cite_ref-17" title="">^</a></b> <cite style="font-style:normal" class="news">"<a href="http://www.diabetes.niddk.nih.gov/dm/pubs/mody/" class="external text" title="http://www.diabetes.niddk.nih.gov/dm/pubs/mody/" rel="nofollow">Monogenic Forms of Diabetes: Neonatal Diabetes Mellitus and Maturity-onset Diabetes of the Young</a>". <i>National Diabetes Information Clearinghouse (NDIC)</i> (National Institute of Diabetes and Digestive and Kidney Diseases, NIH)<span class="printonly">. <a href="http://www.diabetes.niddk.nih.gov/dm/pubs/mody/" class="external free" title="http://www.diabetes.niddk.nih.gov/dm/pubs/mody/" rel="nofollow">http://www.diabetes.niddk.nih.gov/dm/pubs/mody/</a></span><span class="reference-accessdate">. Retrieved on 2008-08-04</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Monogenic+Forms+of+Diabetes%3A+Neonatal+Diabetes+Mellitus+and+Maturity-onset+Diabetes+of+the+Young&amp;rft.jtitle=National+Diabetes+Information+Clearinghouse+%28NDIC%29&amp;rft.pub=National+Institute+of+Diabetes+and+Digestive+and+Kidney+Diseases%2C+NIH&amp;rft_id=http%3A%2F%2Fwww.diabetes.niddk.nih.gov%2Fdm%2Fpubs%2Fmody%2F&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-AMN-18"><b><a href="#cite_ref-AMN_18-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBarrett_TG2001">Barrett TG (2001). "Mitochondrial diabetes, DIDMOAD and other inherited diabetes syndromes". <i>Best Pract. Res. Clin. Endocrinol. Metab.</i> <b>15</b> (3): 325–43. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1053%2Fbeem.2001.0149" class="external text" title="http://dx.doi.org/10.1053%2Fbeem.2001.0149" rel="nofollow">10.1053/beem.2001.0149</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11554774" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11554774">PMID 11554774</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Mitochondrial+diabetes%2C+DIDMOAD+and+other+inherited+diabetes+syndromes&amp;rft.jtitle=Best+Pract.+Res.+Clin.+Endocrinol.+Metab.&amp;rft.aulast=Barrett+TG&amp;rft.au=Barrett+TG&amp;rft.date=2001&amp;rft.volume=15&amp;rft.issue=3&amp;rft.pages=325%E2%80%9343&amp;rft_id=info:doi/10.1053%2Fbeem.2001.0149&amp;rft_id=info:pmid/11554774&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-19"><b><a href="#cite_ref-19" title="">^</a></b> <cite style="font-style:normal" class="web" id="CITEREFSantaguida_PL.2C_Balion_C.2C_Hunt_D.2C_Morrison_K.2C_Gerstein_H.2C_Raina_P.2C_Booker_L.2C_Yazdi_H">Santaguida PL, Balion C, Hunt D, Morrison K, Gerstein H, Raina P, Booker L, Yazdi H. <a href="http://www.ahrq.gov/clinic/epcsums/impglusum.htm" class="external text" title="http://www.ahrq.gov/clinic/epcsums/impglusum.htm" rel="nofollow">"Diagnosis, Prognosis, and Treatment of Impaired Glucose Tolerance and Impaired Fasting Glucose"</a>. <i>Summary of Evidence Report/Technology Assessment, No. 128</i>. <a href="/wiki/Agency_for_Healthcare_Research_and_Quality" title="Agency for Healthcare Research and Quality">Agency for Healthcare Research and Quality</a><span class="printonly">. <a href="http://www.ahrq.gov/clinic/epcsums/impglusum.htm" class="external free" title="http://www.ahrq.gov/clinic/epcsums/impglusum.htm" rel="nofollow">http://www.ahrq.gov/clinic/epcsums/impglusum.htm</a></span><span class="reference-accessdate">. Retrieved on 2008-07-20</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Diagnosis%2C+Prognosis%2C+and+Treatment+of+Impaired+Glucose+Tolerance+and+Impaired+Fasting+Glucose&amp;rft.atitle=Summary+of+Evidence+Report%2FTechnology+Assessment%2C+No.+128&amp;rft.aulast=Santaguida+PL%2C+Balion+C%2C+Hunt+D%2C+Morrison+K%2C+Gerstein+H%2C+Raina+P%2C+Booker+L%2C+Yazdi+H&amp;rft.au=Santaguida+PL%2C+Balion+C%2C+Hunt+D%2C+Morrison+K%2C+Gerstein+H%2C+Raina+P%2C+Booker+L%2C+Yazdi+H&amp;rft.pub=%5B%5BAgency+for+Healthcare+Research+and+Quality%5D%5D&amp;rft_id=http%3A%2F%2Fwww.ahrq.gov%2Fclinic%2Fepcsums%2Fimpglusum.htm&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17510078-20"><b><a href="#cite_ref-pmid17510078_20-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSnidermanBhopal_R.2C_Prabhakaran_D.2C_Sarrafzadegan_N.2C_Tchernof_A2007">Sniderman, AD; Bhopal R, Prabhakaran D, Sarrafzadegan N, Tchernof A (2007). "Why might South Asians be so susceptible to central obesity and its atherogenic consequences? The adipose tissue overflow hypothesis". <i>International journal of epidemiology</i> <b>36</b> (1): 220–225. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1093%2Fije%2Fdyl245" class="external text" title="http://dx.doi.org/10.1093%2Fije%2Fdyl245" rel="nofollow">10.1093/ije/dyl245</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17510078" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17510078">PMID 17510078</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Why+might+South+Asians+be+so+susceptible+to+central+obesity+and+its+atherogenic+consequences%3F+The+adipose+tissue+overflow+hypothesis&amp;rft.jtitle=International+journal+of+epidemiology&amp;rft.aulast=Sniderman&amp;rft.aufirst=AD&amp;rft.au=Sniderman%2C+AD&amp;rft.au=Bhopal+R%2C+Prabhakaran+D%2C+Sarrafzadegan+N%2C+Tchernof+A&amp;rft.date=2007&amp;rft.volume=36&amp;rft.issue=1&amp;rft.pages=220%E2%80%93225&amp;rft_id=info:doi/10.1093%2Fije%2Fdyl245&amp;rft_id=info:pmid/17510078&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-21"><b><a href="#cite_ref-21" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFGenuth_S2006">Genuth S (Jan-Feb 2006). "Insights from the diabetes control and complications trial/epidemiology of diabetes interventions and complications study on the use of intensive glycemic treatment to reduce the risk of complications of type&#160;1 diabetes". <i>Endocr Pract</i> <b>12</b> (Suppl 1): 34–41. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a href="http://worldcat.org/issn/1530-891X" class="external text" title="http://worldcat.org/issn/1530-891X" rel="nofollow">1530-891X</a>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16627378" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16627378">PMID 16627378</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Insights+from+the+diabetes+control+and+complications+trial%2Fepidemiology+of+diabetes+interventions+and+complications+study+on+the+use+of+intensive+glycemic+treatment+to+reduce+the+risk+of+complications+of+type%26nbsp%3B1+diabetes&amp;rft.jtitle=Endocr+Pract&amp;rft.aulast=Genuth+S&amp;rft.au=Genuth+S&amp;rft.date=Jan-Feb+2006&amp;rft.volume=12&amp;rft.issue=Suppl+1&amp;rft.pages=34%E2%80%9341&amp;rft_id=info:pmid/16627378&amp;rft.issn=1530-891X&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17215197-22"><b><a href="#cite_ref-pmid17215197_22-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLee_CM.2C_Huxley_RR.2C_Lam_TH.2C_Martiniuk_AL.2C_Ueshema_H.2C_Pan_WH.2C_Welborn_T.2C_Woodward_M.3B_Asia_Pacific_Cohort_Studies_Collaboration2007">Lee CM, Huxley RR, Lam TH, Martiniuk AL, Ueshema H, Pan WH, Welborn T, Woodward M; Asia Pacific Cohort Studies Collaboration (2007). "Prevalence of diabetes mellitus and population attributable fractions for coronary heart disease and stroke mortality in the WHO South-East Asia and Western Pacific regions". <i>Asia Pac J Clin Nutr</i> <b>16</b> (1): 187–92. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17215197" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17215197">PMID 17215197</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Prevalence+of+diabetes+mellitus+and+population+attributable+fractions+for+coronary+heart+disease+and+stroke+mortality+in+the+WHO+South-East+Asia+and+Western+Pacific+regions&amp;rft.jtitle=Asia+Pac+J+Clin+Nutr&amp;rft.aulast=Lee+CM%2C+Huxley+RR%2C+Lam+TH%2C+Martiniuk+AL%2C+Ueshema+H%2C+Pan+WH%2C+Welborn+T%2C+Woodward+M%3B+Asia+Pacific+Cohort+Studies+Collaboration&amp;rft.au=Lee+CM%2C+Huxley+RR%2C+Lam+TH%2C+Martiniuk+AL%2C+Ueshema+H%2C+Pan+WH%2C+Welborn+T%2C+Woodward+M%3B+Asia+Pacific+Cohort+Studies+Collaboration&amp;rft.date=2007&amp;rft.volume=16&amp;rft.issue=1&amp;rft.pages=187%E2%80%9392&amp;rft_id=info:pmid/17215197&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid10889785-23"><b><a href="#cite_ref-pmid10889785_23-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSeidell_JC2000">Seidell JC (2000). "Obesity, insulin resistance and diabetes--a worldwide epidemic". <i>Br. J. Nutr.</i> <b>83 Suppl 1</b>: S5–8. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10889785" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10889785">PMID 10889785</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Obesity%2C+insulin+resistance+and+diabetes--a+worldwide+epidemic&amp;rft.jtitle=Br.+J.+Nutr.&amp;rft.aulast=Seidell+JC&amp;rft.au=Seidell+JC&amp;rft.date=2000&amp;rft.volume=83+Suppl+1&amp;rft.pages=S5%E2%80%938&amp;rft_id=info:pmid/10889785&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-24"><b><a href="#cite_ref-24" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFDaneman_D2006">Daneman D (2006). "Type&#160;1 diabetes". <i>Lancet</i> <b>367</b> (9513): 847–58. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0140-6736%2806%2968341-4" class="external text" title="http://dx.doi.org/10.1016%2FS0140-6736%2806%2968341-4" rel="nofollow">10.1016/S0140-6736(06)68341-4</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16530579" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16530579">PMID 16530579</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Type%26nbsp%3B1+diabetes&amp;rft.jtitle=Lancet&amp;rft.aulast=Daneman+D&amp;rft.au=Daneman+D&amp;rft.date=2006&amp;rft.volume=367&amp;rft.issue=9513&amp;rft.pages=847%E2%80%9358&amp;rft_id=info:doi/10.1016%2FS0140-6736%2806%2968341-4&amp;rft_id=info:pmid/16530579&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-25"><b><a href="#cite_ref-25" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBorch-Johnsen_K.2C_Joner_G.2C_Mandrup-Poulsen_T.2C_Christy_M.2C_Zachau-Christiansen_B.2C_Kastrup_K.2C_Nerup_J1984">Borch-Johnsen K, Joner G, Mandrup-Poulsen T, Christy M, Zachau-Christiansen B, Kastrup K, Nerup J (1984). "Relation between breast-feeding and incidence rates of insulin-dependent diabetes mellitus. A hypothesis". <i>Lancet</i> <b>2</b> (8411): 1083–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0140-6736%2884%2991517-4" class="external text" title="http://dx.doi.org/10.1016%2FS0140-6736%2884%2991517-4" rel="nofollow">10.1016/S0140-6736(84)91517-4</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/6150150" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/6150150">PMID 6150150</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Relation+between+breast-feeding+and+incidence+rates+of+insulin-dependent+diabetes+mellitus.+A+hypothesis&amp;rft.jtitle=Lancet&amp;rft.aulast=Borch-Johnsen+K%2C+Joner+G%2C+Mandrup-Poulsen+T%2C+Christy+M%2C+Zachau-Christiansen+B%2C+Kastrup+K%2C+Nerup+J&amp;rft.au=Borch-Johnsen+K%2C+Joner+G%2C+Mandrup-Poulsen+T%2C+Christy+M%2C+Zachau-Christiansen+B%2C+Kastrup+K%2C+Nerup+J&amp;rft.date=1984&amp;rft.volume=2&amp;rft.issue=8411&amp;rft.pages=1083%E2%80%936&amp;rft_id=info:doi/10.1016%2FS0140-6736%2884%2991517-4&amp;rft_id=info:pmid/6150150&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-26"><b><a href="#cite_ref-26" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFNaim_Shehadeh.2C_Raanan_Shamir.2C_Moshe_Berant.2C_Amos_Etzioni2001">Naim Shehadeh, Raanan Shamir, Moshe Berant, Amos Etzioni (2001). "<a href="http://www.blackwell-synergy.com/doi/abs/10.1034/j.1399-5448.2001.20406.x?journalCode=pdi" class="external text" title="http://www.blackwell-synergy.com/doi/abs/10.1034/j.1399-5448.2001.20406.x?journalCode=pdi" rel="nofollow">Insulin in human milk and the prevention of type&#160;1 diabetes</a>". <i>Pediatric Diabetes</i> <b>2</b> (4): 175–177. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1034%2Fj.1399-5448.2001.20406.x" class="external text" title="http://dx.doi.org/10.1034%2Fj.1399-5448.2001.20406.x" rel="nofollow">10.1034/j.1399-5448.2001.20406.x</a></span><span class="printonly">. <a href="http://www.blackwell-synergy.com/doi/abs/10.1034/j.1399-5448.2001.20406.x?journalCode=pdi" class="external free" title="http://www.blackwell-synergy.com/doi/abs/10.1034/j.1399-5448.2001.20406.x?journalCode=pdi" rel="nofollow">http://www.blackwell-synergy.com/doi/abs/10.1034/j.1399-5448.2001.20406.x?journalCode=pdi</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Insulin+in+human+milk+and+the+prevention+of+type%26nbsp%3B1+diabetes&amp;rft.jtitle=Pediatric+Diabetes&amp;rft.aulast=Naim+Shehadeh%2C+Raanan+Shamir%2C+Moshe+Berant%2C+Amos+Etzioni&amp;rft.au=Naim+Shehadeh%2C+Raanan+Shamir%2C+Moshe+Berant%2C+Amos+Etzioni&amp;rft.date=2001&amp;rft.volume=2&amp;rft.issue=4&amp;rft.pages=175%E2%80%93177&amp;rft_id=info:doi/10.1034%2Fj.1399-5448.2001.20406.x&amp;rft_id=http%3A%2F%2Fwww.blackwell-synergy.com%2Fdoi%2Fabs%2F10.1034%2Fj.1399-5448.2001.20406.x%3FjournalCode%3Dpdi&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-27"><b><a href="#cite_ref-27" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFVirtanen_S.2C_Knip_M2003">Virtanen S, Knip M (2003). "Nutritional risk predictors of beta cell autoimmunity and type&#160;1 diabetes at a young age". <i>Am J Clin Nutr</i> <b>78</b> (6): 1053–67. <a href="http://www.ncbi.nlm.nih.gov/pubmed/14668264" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/14668264">PMID 14668264</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Nutritional+risk+predictors+of+beta+cell+autoimmunity+and+type%26nbsp%3B1+diabetes+at+a+young+age&amp;rft.jtitle=Am+J+Clin+Nutr&amp;rft.aulast=Virtanen+S%2C+Knip+M&amp;rft.au=Virtanen+S%2C+Knip+M&amp;rft.date=2003&amp;rft.volume=78&amp;rft.issue=6&amp;rft.pages=1053%E2%80%9367&amp;rft_id=info:pmid/14668264&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-28"><b><a href="#cite_ref-28" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHypp.C3.B6nen_E.2C_L.C3.A4.C3.A4r.C3.A4_E.2C_Reunanen_A.2C_J.C3.A4rvelin_MR.2C_Virtanen_SM2001">Hyppönen E, Läärä E, Reunanen A, Järvelin MR, Virtanen SM (2001). "Intake of vitamin D and risk of type&#160;1 diabetes: a birth-cohort study". <i>Lancet</i> <b>358</b>: 1500. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0140-6736%2801%2906580-1" class="external text" title="http://dx.doi.org/10.1016%2FS0140-6736%2801%2906580-1" rel="nofollow">10.1016/S0140-6736(01)06580-1</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11705562" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11705562">PMID 11705562</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Intake+of+vitamin+D+and+risk+of+type%26nbsp%3B1+diabetes%3A+a+birth-cohort+study&amp;rft.jtitle=Lancet&amp;rft.aulast=Hypp%C3%B6nen+E%2C+L%C3%A4%C3%A4r%C3%A4+E%2C+Reunanen+A%2C+J%C3%A4rvelin+MR%2C+Virtanen+SM&amp;rft.au=Hypp%C3%B6nen+E%2C+L%C3%A4%C3%A4r%C3%A4+E%2C+Reunanen+A%2C+J%C3%A4rvelin+MR%2C+Virtanen+SM&amp;rft.date=2001&amp;rft.volume=358&amp;rft.pages=1500&amp;rft_id=info:doi/10.1016%2FS0140-6736%2801%2906580-1&amp;rft_id=info:pmid/11705562&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid8961125-29"><b><a href="#cite_ref-pmid8961125_29-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFElliott_RB.2C_Pilcher_CC.2C_Fergusson_DM.2C_Stewart_AW1996">Elliott RB, Pilcher CC, Fergusson DM, Stewart AW (Sep-Oct 1996). "A population based strategy to prevent insulin-dependent diabetes using nicotinamide". <i>J. Pediatr. Endocrinol. Metab.</i> <b>9</b> (5): 501–9. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8961125" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/8961125">PMID 8961125</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+population+based+strategy+to+prevent+insulin-dependent+diabetes+using+nicotinamide&amp;rft.jtitle=J.+Pediatr.+Endocrinol.+Metab.&amp;rft.aulast=Elliott+RB%2C+Pilcher+CC%2C+Fergusson+DM%2C+Stewart+AW&amp;rft.au=Elliott+RB%2C+Pilcher+CC%2C+Fergusson+DM%2C+Stewart+AW&amp;rft.date=Sep-Oct+1996&amp;rft.volume=9&amp;rft.issue=5&amp;rft.pages=501%E2%80%939&amp;rft_id=info:pmid/8961125&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17098085-30"><b><a href="#cite_ref-pmid17098085_30-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFLindstr.C3.B6m_J.2C_Ilanne-Parikka_P.2C_Peltonen_M.2C_Aunola_S.2C_Eriksson_J.2C_Hemi.C3.B6_K.2C_H.C3.A4m.C3.A4l.C3.A4inen_H.2C_H.C3.A4rk.C3.B6nen_P.2C_Kein.C3.A4nen-Kiukaanniemi_S.2C_Laakso_M.2C_Louheranta_A.2C_Mannelin_M.2C_Paturi_M.2C_Sundvall_J.2C_Valle_T.2C_Uusitupa_M.2C_Tuomilehto_J2006">Lindström J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson J, Hemiö K, Hämäläinen H, Härkönen P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Mannelin M, Paturi M, Sundvall J, Valle T, Uusitupa M, Tuomilehto J (2006). "Sustained reduction in the incidence of type&#160;2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study". <i>Lancet</i> <b>368</b> (9548): 1673–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0140-6736%2806%2969701-8" class="external text" title="http://dx.doi.org/10.1016%2FS0140-6736%2806%2969701-8" rel="nofollow">10.1016/S0140-6736(06)69701-8</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17098085" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17098085">PMID 17098085</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Sustained+reduction+in+the+incidence+of+type%26nbsp%3B2+diabetes+by+lifestyle+intervention%3A+follow-up+of+the+Finnish+Diabetes+Prevention+Study&amp;rft.jtitle=Lancet&amp;rft.aulast=Lindstr%C3%B6m+J%2C+Ilanne-Parikka+P%2C+Peltonen+M%2C+Aunola+S%2C+Eriksson+J%2C+Hemi%C3%B6+K%2C+H%C3%A4m%C3%A4l%C3%A4inen+H%2C+H%C3%A4rk%C3%B6nen+P%2C+Kein%C3%A4nen-Kiukaanniemi+S%2C+Laakso+M%2C+Louheranta+A%2C+Mannelin+M%2C+Paturi+M%2C+Sundvall+J%2C+Valle+T%2C+Uusitupa+M%2C+Tuomilehto+J&amp;rft.au=Lindstr%C3%B6m+J%2C+Ilanne-Parikka+P%2C+Peltonen+M%2C+Aunola+S%2C+Eriksson+J%2C+Hemi%C3%B6+K%2C+H%C3%A4m%C3%A4l%C3%A4inen+H%2C+H%C3%A4rk%C3%B6nen+P%2C+Kein%C3%A4nen-Kiukaanniemi+S%2C+Laakso+M%2C+Louheranta+A%2C+Mannelin+M%2C+Paturi+M%2C+Sundvall+J%2C+Valle+T%2C+Uusitupa+M%2C+Tuomilehto+J&amp;rft.date=2006&amp;rft.volume=368&amp;rft.issue=9548&amp;rft.pages=1673%E2%80%939&amp;rft_id=info:doi/10.1016%2FS0140-6736%2806%2969701-8&amp;rft_id=info:pmid/17098085&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Knowler-31">^ <a href="#cite_ref-Knowler_31-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Knowler_31-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFKnowler_W.2C_Barrett-Connor_E.2C_Fowler_S.2C_Hamman_R.2C_Lachin_J.2C_Walker_E.2C_Nathan_D2002">Knowler W, Barrett-Connor E, Fowler S, Hamman R, Lachin J, Walker E, Nathan D (2002). "Reduction in the incidence of type&#160;2 diabetes with lifestyle intervention or metformin". <i>N Engl J Med</i> <b>346</b> (6): 393–403. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJMoa012512" class="external text" title="http://dx.doi.org/10.1056%2FNEJMoa012512" rel="nofollow">10.1056/NEJMoa012512</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11832527" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11832527">PMID 11832527</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Reduction+in+the+incidence+of+type%26nbsp%3B2+diabetes+with+lifestyle+intervention+or+metformin&amp;rft.jtitle=N+Engl+J+Med&amp;rft.aulast=Knowler+W%2C+Barrett-Connor+E%2C+Fowler+S%2C+Hamman+R%2C+Lachin+J%2C+Walker+E%2C+Nathan+D&amp;rft.au=Knowler+W%2C+Barrett-Connor+E%2C+Fowler+S%2C+Hamman+R%2C+Lachin+J%2C+Walker+E%2C+Nathan+D&amp;rft.date=2002&amp;rft.volume=346&amp;rft.issue=6&amp;rft.pages=393%E2%80%93403&amp;rft_id=info:doi/10.1056%2FNEJMoa012512&amp;rft_id=info:pmid/11832527&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-32"><b><a href="#cite_ref-32" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBantle_JP.2C_Wylie-Rosett_J.2C_Albright_AL.2C_.27.27et_al.27.272006">Bantle JP, Wylie-Rosett J, Albright AL, <i>et al</i> (2006). "<a href="http://care.diabetesjournals.org/cgi/content/full/29/9/2140" class="external text" title="http://care.diabetesjournals.org/cgi/content/full/29/9/2140" rel="nofollow">Nutrition recommendations and interventions for diabetes--2006: a position statement of the American Diabetes Association</a>". <i>Diabetes Care</i> <b>29</b> (9): 2140–57. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.2337%2Fdc06-9914" class="external text" title="http://dx.doi.org/10.2337%2Fdc06-9914" rel="nofollow">10.2337/dc06-9914</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16936169" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16936169">PMID 16936169</a><span class="printonly">. <a href="http://care.diabetesjournals.org/cgi/content/full/29/9/2140" class="external free" title="http://care.diabetesjournals.org/cgi/content/full/29/9/2140" rel="nofollow">http://care.diabetesjournals.org/cgi/content/full/29/9/2140</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Nutrition+recommendations+and+interventions+for+diabetes--2006%3A+a+position+statement+of+the+American+Diabetes+Association&amp;rft.jtitle=Diabetes+Care&amp;rft.aulast=Bantle+JP%2C+Wylie-Rosett+J%2C+Albright+AL%2C+%27%27et+al%27%27&amp;rft.au=Bantle+JP%2C+Wylie-Rosett+J%2C+Albright+AL%2C+%27%27et+al%27%27&amp;rft.date=2006&amp;rft.volume=29&amp;rft.issue=9&amp;rft.pages=2140%E2%80%9357&amp;rft_id=info:doi/10.2337%2Fdc06-9914&amp;rft_id=info:pmid/16936169&amp;rft_id=http%3A%2F%2Fcare.diabetesjournals.org%2Fcgi%2Fcontent%2Ffull%2F29%2F9%2F2140&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-33"><b><a href="#cite_ref-33" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFGerstein_H.2C_Yusuf_S.2C_Bosch_J.2C_Pogue_J.2C_Sheridan_P.2C_Dinccag_N.2C_Hanefeld_M.2C_Hoogwerf_B.2C_Laakso_M.2C_Mohan_V.2C_Shaw_J.2C_Zinman_B.2C_Holman_R2006">Gerstein H, Yusuf S, Bosch J, Pogue J, Sheridan P, Dinccag N, Hanefeld M, Hoogwerf B, Laakso M, Mohan V, Shaw J, Zinman B, Holman R (2006). "Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial". <i>Lancet</i> <b>368</b> (9541): 1096–105. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0140-6736%2806%2969420-8" class="external text" title="http://dx.doi.org/10.1016%2FS0140-6736%2806%2969420-8" rel="nofollow">10.1016/S0140-6736(06)69420-8</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16997664" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16997664">PMID 16997664</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Effect+of+rosiglitazone+on+the+frequency+of+diabetes+in+patients+with+impaired+glucose+tolerance+or+impaired+fasting+glucose%3A+a+randomised+controlled+trial&amp;rft.jtitle=Lancet&amp;rft.aulast=Gerstein+H%2C+Yusuf+S%2C+Bosch+J%2C+Pogue+J%2C+Sheridan+P%2C+Dinccag+N%2C+Hanefeld+M%2C+Hoogwerf+B%2C+Laakso+M%2C+Mohan+V%2C+Shaw+J%2C+Zinman+B%2C+Holman+R&amp;rft.au=Gerstein+H%2C+Yusuf+S%2C+Bosch+J%2C+Pogue+J%2C+Sheridan+P%2C+Dinccag+N%2C+Hanefeld+M%2C+Hoogwerf+B%2C+Laakso+M%2C+Mohan+V%2C+Shaw+J%2C+Zinman+B%2C+Holman+R&amp;rft.date=2006&amp;rft.volume=368&amp;rft.issue=9541&amp;rft.pages=1096%E2%80%93105&amp;rft_id=info:doi/10.1016%2FS0140-6736%2806%2969420-8&amp;rft_id=info:pmid/16997664&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-34"><b><a href="#cite_ref-34" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKjeldsen_SE.2C_Julius_S.2C_Mancia_G.2C_McInnes_GT.2C_Hua_T.2C_Weber_MA.2C_Coca_A.2C_Ekman_S.2C_Girerd_X.2C_Jamerson_K.2C_Larochelle_P.2C_Macdonald_TM.2C_Schmieder_RE.2C_Schork_MA.2C_Stolt_P.2C_Viskoper_R.2C_Widimsky_J.2C_Zanchetti_A.3B_for_the_VALUE_Trial_Investigators2006">Kjeldsen SE, Julius S, Mancia G, McInnes GT, Hua T, Weber MA, Coca A, Ekman S, Girerd X, Jamerson K, Larochelle P, Macdonald TM, Schmieder RE, Schork MA, Stolt P, Viskoper R, Widimsky J, Zanchetti A; for the VALUE Trial Investigators (2006). "Effects of valsartan compared to amlodipine on preventing type&#160;2 diabetes in high-risk hypertensive patients: the VALUE trial". <i>J Hypertens</i> <b>24</b> (7): 1405–1412. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1097%2F01.hjh.0000234122.55895.5b" class="external text" title="http://dx.doi.org/10.1097%2F01.hjh.0000234122.55895.5b" rel="nofollow">10.1097/01.hjh.0000234122.55895.5b</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16794491" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16794491">PMID 16794491</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Effects+of+valsartan+compared+to+amlodipine+on+preventing+type%26nbsp%3B2+diabetes+in+high-risk+hypertensive+patients%3A+the+VALUE+trial&amp;rft.jtitle=J+Hypertens&amp;rft.aulast=Kjeldsen+SE%2C+Julius+S%2C+Mancia+G%2C+McInnes+GT%2C+Hua+T%2C+Weber+MA%2C+Coca+A%2C+Ekman+S%2C+Girerd+X%2C+Jamerson+K%2C+Larochelle+P%2C+Macdonald+TM%2C+Schmieder+RE%2C+Schork+MA%2C+Stolt+P%2C+Viskoper+R%2C+Widimsky+J%2C+Zanchetti+A%3B+for+the+VALUE+Trial+Investigators&amp;rft.au=Kjeldsen+SE%2C+Julius+S%2C+Mancia+G%2C+McInnes+GT%2C+Hua+T%2C+Weber+MA%2C+Coca+A%2C+Ekman+S%2C+Girerd+X%2C+Jamerson+K%2C+Larochelle+P%2C+Macdonald+TM%2C+Schmieder+RE%2C+Schork+MA%2C+Stolt+P%2C+Viskoper+R%2C+Widimsky+J%2C+Zanchetti+A%3B+for+the+VALUE+Trial+Investigators&amp;rft.date=2006&amp;rft.volume=24&amp;rft.issue=7&amp;rft.pages=1405%E2%80%931412&amp;rft_id=info:doi/10.1097%2F01.hjh.0000234122.55895.5b&amp;rft_id=info:pmid/16794491&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-35"><b><a href="#cite_ref-35" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFWasko_MC.2C_Hubert_HB.2C_Lingala_VB.2C_.27.27et_al.27.272007">Wasko MC, Hubert HB, Lingala VB, <i>et al</i> (2007). "Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis". <i>JAMA</i> <b>298</b> (2): 187–93. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1001%2Fjama.298.2.187" class="external text" title="http://dx.doi.org/10.1001%2Fjama.298.2.187" rel="nofollow">10.1001/jama.298.2.187</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17622600" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17622600">PMID 17622600</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Hydroxychloroquine+and+risk+of+diabetes+in+patients+with+rheumatoid+arthritis&amp;rft.jtitle=JAMA&amp;rft.aulast=Wasko+MC%2C+Hubert+HB%2C+Lingala+VB%2C+%27%27et+al%27%27&amp;rft.au=Wasko+MC%2C+Hubert+HB%2C+Lingala+VB%2C+%27%27et+al%27%27&amp;rft.date=2007&amp;rft.volume=298&amp;rft.issue=2&amp;rft.pages=187%E2%80%9393&amp;rft_id=info:doi/10.1001%2Fjama.298.2.187&amp;rft_id=info:pmid/17622600&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-JAMA2005-Stuebe-36"><b><a href="#cite_ref-JAMA2005-Stuebe_36-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFStuebe_AM.2C_Rich-Edwards_JW.2C_Willett_WC.2C_Manson_JE.2C_Michels_KB2005">Stuebe AM, Rich-Edwards JW, Willett WC, Manson JE, Michels KB (2005). "Duration of lactation and incidence of type&#160;2 diabetes". <i>JAMA</i> <b>294</b> (20): 2601–10. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1001%2Fjama.294.20.2601" class="external text" title="http://dx.doi.org/10.1001%2Fjama.294.20.2601" rel="nofollow">10.1001/jama.294.20.2601</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16304074" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16304074">PMID 16304074</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Duration+of+lactation+and+incidence+of+type%26nbsp%3B2+diabetes&amp;rft.jtitle=JAMA&amp;rft.aulast=Stuebe+AM%2C+Rich-Edwards+JW%2C+Willett+WC%2C+Manson+JE%2C+Michels+KB&amp;rft.au=Stuebe+AM%2C+Rich-Edwards+JW%2C+Willett+WC%2C+Manson+JE%2C+Michels+KB&amp;rft.date=2005&amp;rft.volume=294&amp;rft.issue=20&amp;rft.pages=2601%26ndash%3B10&amp;rft_id=info:doi/10.1001%2Fjama.294.20.2601&amp;rft_id=info:pmid/16304074&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-37"><b><a href="#cite_ref-37" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFAdlerStratton.2C_I._M..3B_Neil.2C_H.A..3B_.27.27et_al.27.272000">Adler, A.I.; Stratton, I. M.; Neil, H.A.; <i>et al</i> (2000). "<a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=27454&amp;rendertype=abstract" class="external text" title="http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=27454&amp;rendertype=abstract" rel="nofollow">Association of systolic blood pressure with macrovascular and microvascular complications of type&#160;2 diabetes (UKPDS 36): prospective observational study</a>". <i>BMJ</i> <b>321</b> (7258): 412–419. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1136%2Fbmj.321.7258.412" class="external text" title="http://dx.doi.org/10.1136%2Fbmj.321.7258.412" rel="nofollow">10.1136/bmj.321.7258.412</a></span>. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a href="http://worldcat.org/issn/0959-8146" class="external text" title="http://worldcat.org/issn/0959-8146" rel="nofollow">0959-8146</a>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10938049" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/10938049">PMID 10938049</a><span class="printonly">. <a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=27454&amp;rendertype=abstract" class="external free" title="http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=27454&amp;rendertype=abstract" rel="nofollow">http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=27454&amp;rendertype=abstract</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Association+of+systolic+blood+pressure+with+macrovascular+and+microvascular+complications+of+type%26nbsp%3B2+diabetes+%28UKPDS+36%29%3A+prospective+observational+study&amp;rft.jtitle=BMJ&amp;rft.aulast=Adler&amp;rft.aufirst=A.I.&amp;rft.au=Adler%2C+A.I.&amp;rft.au=Stratton%2C+I.+M.%3B+Neil%2C+H.A.%3B+%27%27et+al%27%27&amp;rft.date=2000&amp;rft.volume=321&amp;rft.issue=7258&amp;rft.pages=412%E2%80%93419&amp;rft_id=info:doi/10.1136%2Fbmj.321.7258.412&amp;rft_id=info:pmid/10938049&amp;rft.issn=0959-8146&amp;rft_id=http%3A%2F%2Fwww.pubmedcentral.nih.gov%2Farticlerender.fcgi%3Fartid%3D27454%26rendertype%3Dabstract&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Vinik-38">^ <a href="#cite_ref-Vinik_38-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Vinik_38-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Vinik_38-2" title=""><sup><i><b>c</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFVinik_AI.2C_Fishwick_DT.2C_Pittenger_G2004">Vinik AI, Fishwick DT, Pittenger G (2004). "Advances in diabetes for the millennium: toward a cure for diabetes". <i>MedGenMed&#160;: Medscape general medicine</i> <b>6</b> (3 Suppl): 12. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15647717" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15647717">PMID 15647717</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Advances+in+diabetes+for+the+millennium%3A+toward+a+cure+for+diabetes&amp;rft.jtitle=MedGenMed+%3A+Medscape+general+medicine&amp;rft.aulast=Vinik+AI%2C+Fishwick+DT%2C+Pittenger+G&amp;rft.au=Vinik+AI%2C+Fishwick+DT%2C+Pittenger+G&amp;rft.date=2004&amp;rft.volume=6&amp;rft.issue=3+Suppl&amp;rft.pages=12&amp;rft_id=info:pmid/15647717&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Stratta-39"><b><a href="#cite_ref-Stratta_39-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFStratta_RJ.2C_Alloway_RR.1998">Stratta RJ, Alloway RR. (1998). "Pancreas transplantation for diabetes mellitus: a guide to recipient selection and optimum immunosuppression". <i>BioDrugs.</i> <b>10</b> (5): 347–357. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.2165%2F00063030-199810050-00002" class="external text" title="http://dx.doi.org/10.2165%2F00063030-199810050-00002" rel="nofollow">10.2165/00063030-199810050-00002</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18020607" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/18020607">PMID 18020607</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Pancreas+transplantation+for+diabetes+mellitus%3A+a+guide+to+recipient+selection+and+optimum+immunosuppression&amp;rft.jtitle=BioDrugs.&amp;rft.aulast=Stratta+RJ%2C+Alloway+RR.&amp;rft.au=Stratta+RJ%2C+Alloway+RR.&amp;rft.date=1998&amp;rft.volume=10&amp;rft.issue=5&amp;rft.pages=347%E2%80%93357&amp;rft_id=info:doi/10.2165%2F00063030-199810050-00002&amp;rft_id=info:pmid/18020607&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-40"><b><a href="#cite_ref-40" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFShapiro_AM.2C_Ricordi_C.2C_Hering_BJ.2C_.27.27et_al.27.272006">Shapiro AM, Ricordi C, Hering BJ, <i>et al</i> (2006). "International trial of the Edmonton protocol for islet transplantation". <i>N. Engl. J. Med.</i> <b>355</b> (13): 1318–30. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJMoa061267" class="external text" title="http://dx.doi.org/10.1056%2FNEJMoa061267" rel="nofollow">10.1056/NEJMoa061267</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17005949" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17005949">PMID 17005949</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=International+trial+of+the+Edmonton+protocol+for+islet+transplantation&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.aulast=Shapiro+AM%2C+Ricordi+C%2C+Hering+BJ%2C+%27%27et+al%27%27&amp;rft.au=Shapiro+AM%2C+Ricordi+C%2C+Hering+BJ%2C+%27%27et+al%27%27&amp;rft.date=2006&amp;rft.volume=355&amp;rft.issue=13&amp;rft.pages=1318%E2%80%9330&amp;rft_id=info:doi/10.1056%2FNEJMoa061267&amp;rft_id=info:pmid/17005949&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-41"><b><a href="#cite_ref-41" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFVoltarelliCouri_CE.2C_Stracieri_AB.2C_Oliveira_MC.2C_Moraes_DA.2C_Pieroni_F.2C_Coutinho_M.2C_Malmegrim_KC.2C_Foss-Freitas_MC.2C_Simoes_BP.2C_Foss_MC.2C_Squiers_E.2C_Burt_RK.2007">Voltarelli, JC; Couri CE, Stracieri AB, Oliveira MC, Moraes DA, Pieroni F, Coutinho M, Malmegrim KC, Foss-Freitas MC, Simoes BP, Foss MC, Squiers E, Burt RK. (2007). "<a href="http://jama.ama-assn.org/cgi/content/full/297/14/1568" class="external text" title="http://jama.ama-assn.org/cgi/content/full/297/14/1568" rel="nofollow">Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type&#160;1 diabetes mellitus</a>". <i>JAMA</i> <b>297</b> (14): 1568–76. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1001%2Fjama.297.14.1568" class="external text" title="http://dx.doi.org/10.1001%2Fjama.297.14.1568" rel="nofollow">10.1001/jama.297.14.1568</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17426276" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17426276">PMID 17426276</a><span class="printonly">. <a href="http://jama.ama-assn.org/cgi/content/full/297/14/1568" class="external free" title="http://jama.ama-assn.org/cgi/content/full/297/14/1568" rel="nofollow">http://jama.ama-assn.org/cgi/content/full/297/14/1568</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Autologous+nonmyeloablative+hematopoietic+stem+cell+transplantation+in+newly+diagnosed+type%26nbsp%3B1+diabetes+mellitus&amp;rft.jtitle=JAMA&amp;rft.aulast=Voltarelli&amp;rft.aufirst=JC&amp;rft.au=Voltarelli%2C+JC&amp;rft.au=Couri+CE%2C+Stracieri+AB%2C+Oliveira+MC%2C+Moraes+DA%2C+Pieroni+F%2C+Coutinho+M%2C+Malmegrim+KC%2C+Foss-Freitas+MC%2C+Simoes+BP%2C+Foss+MC%2C+Squiers+E%2C+Burt+RK.&amp;rft.date=2007&amp;rft.volume=297&amp;rft.issue=14&amp;rft.pages=1568%E2%80%9376&amp;rft_id=info:doi/10.1001%2Fjama.297.14.1568&amp;rft_id=info:pmid/17426276&amp;rft_id=http%3A%2F%2Fjama.ama-assn.org%2Fcgi%2Fcontent%2Ffull%2F297%2F14%2F1568&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid12409659-42"><b><a href="#cite_ref-pmid12409659_42-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFRubinoGagner_M2002">Rubino, F; Gagner M (2002). "<a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=1422611" class="external text" title="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=1422611" rel="nofollow">Potential of surgery for curing type&#160;2 diabetes mellitus</a>". <i>Ann. Surg.</i> <b>236</b> (5): 554–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1097%2F00000658-200211000-00003" class="external text" title="http://dx.doi.org/10.1097%2F00000658-200211000-00003" rel="nofollow">10.1097/00000658-200211000-00003</a></span>. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a href="http://worldcat.org/issn/0003-4932" class="external text" title="http://worldcat.org/issn/0003-4932" rel="nofollow">0003-4932</a>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12409659" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12409659">PMID 12409659</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Potential+of+surgery+for+curing+type%26nbsp%3B2+diabetes+mellitus&amp;rft.jtitle=Ann.+Surg.&amp;rft.aulast=Rubino&amp;rft.aufirst=F&amp;rft.au=Rubino%2C+F&amp;rft.au=Gagner+M&amp;rft.date=2002&amp;rft.volume=236&amp;rft.issue=5&amp;rft.pages=554%E2%80%939&amp;rft_id=info:doi/10.1097%2F00000658-200211000-00003&amp;rft_id=info:pmid/12409659&amp;rft.issn=0003-4932&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17715409-43"><b><a href="#cite_ref-pmid17715409_43-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFAdamsGress_RE.2C_Smith_SC.2C_.27.27et_al.27.272007">Adams, TD; Gress RE, Smith SC, <i>et al</i> (2007). "Long-term mortality after gastric bypass surgery". <i>N. Engl. J. Med.</i> <b>357</b> (8): 753–61. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJMoa066603" class="external text" title="http://dx.doi.org/10.1056%2FNEJMoa066603" rel="nofollow">10.1056/NEJMoa066603</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17715409" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17715409">PMID 17715409</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Long-term+mortality+after+gastric+bypass+surgery&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.aulast=Adams&amp;rft.aufirst=TD&amp;rft.au=Adams%2C+TD&amp;rft.au=Gress+RE%2C+Smith+SC%2C+%27%27et+al%27%27&amp;rft.date=2007&amp;rft.volume=357&amp;rft.issue=8&amp;rft.pages=753%E2%80%9361&amp;rft_id=info:doi/10.1056%2FNEJMoa066603&amp;rft_id=info:pmid/17715409&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17386401-44"><b><a href="#cite_ref-pmid17386401_44-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFCohenSchiavon_CA.2C_Pinheiro_JS.2C_Correa_JL.2C_Rubino_F2007">Cohen, RV; Schiavon CA, Pinheiro JS, Correa JL, Rubino F (2007). "Duodenal-jejunal bypass for the treatment of type&#160;2 diabetes in patients with body mass index of 22-34 kg/m2: a report of 2 cases". <i>Surg Obes Relat Dis.</i> <b>3</b> (2): 195–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.soard.2007.01.009" class="external text" title="http://dx.doi.org/10.1016%2Fj.soard.2007.01.009" rel="nofollow">10.1016/j.soard.2007.01.009</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17386401" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17386401">PMID 17386401</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Duodenal-jejunal+bypass+for+the+treatment+of+type%26nbsp%3B2+diabetes+in+patients+with+body+mass+index+of+22-34+kg%2Fm2%3A+a+report+of+2+cases&amp;rft.jtitle=Surg+Obes+Relat+Dis.&amp;rft.aulast=Cohen&amp;rft.aufirst=RV&amp;rft.au=Cohen%2C+RV&amp;rft.au=Schiavon+CA%2C+Pinheiro+JS%2C+Correa+JL%2C+Rubino+F&amp;rft.date=2007&amp;rft.volume=3&amp;rft.issue=2&amp;rft.pages=195%E2%80%937&amp;rft_id=info:doi/10.1016%2Fj.soard.2007.01.009&amp;rft_id=info:pmid/17386401&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-NS-45"><b><a href="#cite_ref-NS_45-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFVasonconcelos2007">Vasonconcelos, Alberto (2007-09-01). "<a href="http://www.newscientist.com/channel/health/mg19526193.100-could-type-2-diabetes-be-reversed-using-surgery.html" class="external text" title="http://www.newscientist.com/channel/health/mg19526193.100-could-type-2-diabetes-be-reversed-using-surgery.html" rel="nofollow">Could type&#160;2 diabetes be reversed using surgery?</a>". <i><a href="/wiki/New_Scientist" title="New Scientist">New Scientist</a></i> (2619): 11–13<span class="printonly">. <a href="http://www.newscientist.com/channel/health/mg19526193.100-could-type-2-diabetes-be-reversed-using-surgery.html" class="external free" title="http://www.newscientist.com/channel/health/mg19526193.100-could-type-2-diabetes-be-reversed-using-surgery.html" rel="nofollow">http://www.newscientist.com/channel/health/mg19526193.100-could-type-2-diabetes-be-reversed-using-surgery.html</a></span><span class="reference-accessdate">. Retrieved on 2007-09-26</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Could+type%26nbsp%3B2+diabetes+be+reversed+using+surgery%3F&amp;rft.jtitle=%5B%5BNew+Scientist%5D%5D&amp;rft.aulast=Vasonconcelos&amp;rft.aufirst=Alberto&amp;rft.au=Vasonconcelos%2C+Alberto&amp;rft.date=2007-09-01&amp;rft.issue=2619&amp;rft.pages=11%E2%80%9313&amp;rft_id=http%3A%2F%2Fwww.newscientist.com%2Fchannel%2Fhealth%2Fmg19526193.100-could-type-2-diabetes-be-reversed-using-surgery.html&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-46"><b><a href="#cite_ref-46" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFNathanCleary_P.A..2C_Backlund_J.Y..2C_.27.27et_al.27.272005">Nathan, D.M.; Cleary P.A., Backlund J.Y., <i>et al</i> (2005). "Intensive diabetes treatment and cardiovascular disease in patients with type&#160;1 diabetes". <i>N. Engl. J. Med.</i> <b>353</b> (25): 2643–53. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJMoa052187" class="external text" title="http://dx.doi.org/10.1056%2FNEJMoa052187" rel="nofollow">10.1056/NEJMoa052187</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16371630" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16371630">PMID 16371630</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Intensive+diabetes+treatment+and+cardiovascular+disease+in+patients+with+type%26nbsp%3B1+diabetes&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.aulast=Nathan&amp;rft.aufirst=D.M.&amp;rft.au=Nathan%2C+D.M.&amp;rft.au=Cleary+P.A.%2C+Backlund+J.Y.%2C+%27%27et+al%27%27&amp;rft.date=2005&amp;rft.volume=353&amp;rft.issue=25&amp;rft.pages=2643%E2%80%9353&amp;rft_id=info:doi/10.1056%2FNEJMoa052187&amp;rft_id=info:pmid/16371630&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-47"><b><a href="#cite_ref-47" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFThe_Diabetes_Control_and_Complications_Trial_Research_Group1995">The Diabetes Control and Complications Trial Research Group (1995). "<a href="http://www.annals.org/cgi/content/abstract/122/8/561" class="external text" title="http://www.annals.org/cgi/content/abstract/122/8/561" rel="nofollow">The effect of intensive diabetes therapy on the development and progression of neuropathy</a>". <i>Annals of Internal Medicine</i> <b>122</b> (8): 561–568. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a href="http://worldcat.org/issn/0003-4819" class="external text" title="http://worldcat.org/issn/0003-4819" rel="nofollow">0003-4819</a>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/7887548" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/7887548">PMID 7887548</a><span class="printonly">. <a href="http://www.annals.org/cgi/content/abstract/122/8/561" class="external free" title="http://www.annals.org/cgi/content/abstract/122/8/561" rel="nofollow">http://www.annals.org/cgi/content/abstract/122/8/561</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+effect+of+intensive+diabetes+therapy+on+the+development+and+progression+of+neuropathy&amp;rft.jtitle=Annals+of+Internal+Medicine&amp;rft.aulast=The+Diabetes+Control+and+Complications+Trial+Research+Group&amp;rft.au=The+Diabetes+Control+and+Complications+Trial+Research+Group&amp;rft.date=1995&amp;rft.volume=122&amp;rft.issue=8&amp;rft.pages=561%E2%80%93568&amp;rft_id=info:pmid/7887548&amp;rft.issn=0003-4819&amp;rft_id=http%3A%2F%2Fwww.annals.org%2Fcgi%2Fcontent%2Fabstract%2F122%2F8%2F561&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-health-48">^ <a href="#cite_ref-health_48-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-health_48-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFHarris_MI.2C_Flegal_KM.2C_Cowie_CC.2C_.27.27et_al.27.271998">Harris MI, Flegal KM, Cowie CC, <i>et al</i> (1998). "Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994". <i>Diabetes Care</i> <b>21</b> (4): 518–24. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.2337%2Fdiacare.21.4.518" class="external text" title="http://dx.doi.org/10.2337%2Fdiacare.21.4.518" rel="nofollow">10.2337/diacare.21.4.518</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9571335" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/9571335">PMID 9571335</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Prevalence+of+diabetes%2C+impaired+fasting+glucose%2C+and+impaired+glucose+tolerance+in+U.S.+adults.+The+Third+National+Health+and+Nutrition+Examination+Survey%2C+1988-1994&amp;rft.jtitle=Diabetes+Care&amp;rft.aulast=Harris+MI%2C+Flegal+KM%2C+Cowie+CC%2C+%27%27et+al%27%27&amp;rft.au=Harris+MI%2C+Flegal+KM%2C+Cowie+CC%2C+%27%27et+al%27%27&amp;rft.date=1998&amp;rft.volume=21&amp;rft.issue=4&amp;rft.pages=518%E2%80%9324&amp;rft_id=info:doi/10.2337%2Fdiacare.21.4.518&amp;rft_id=info:pmid/9571335&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-ajp-49"><b><a href="#cite_ref-ajp_49-0" title="">^</a></b> <cite style="font-style:normal" class="web" id="CITEREFAnnette_M._Chang_and_Jeffrey_B._Halter2003">Annette M. Chang and Jeffrey B. Halter (2003). <a href="http://ajpendo.physiology.org/cgi/content/full/284/1/E7?ck=nck" class="external text" title="http://ajpendo.physiology.org/cgi/content/full/284/1/E7?ck=nck" rel="nofollow">"Aging and insulin secretion"</a>. AJP - Endocrinology and Metabolism<span class="printonly">. <a href="http://ajpendo.physiology.org/cgi/content/full/284/1/E7?ck=nck" class="external free" title="http://ajpendo.physiology.org/cgi/content/full/284/1/E7?ck=nck" rel="nofollow">http://ajpendo.physiology.org/cgi/content/full/284/1/E7?ck=nck</a></span><span class="reference-accessdate">. Retrieved on 2007-05-14</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Aging+and+insulin+secretion&amp;rft.atitle=&amp;rft.aulast=Annette+M.+Chang+and+Jeffrey+B.+Halter&amp;rft.au=Annette+M.+Chang+and+Jeffrey+B.+Halter&amp;rft.date=2003&amp;rft.pub=AJP+-+Endocrinology+and+Metabolism&amp;rft_id=http%3A%2F%2Fajpendo.physiology.org%2Fcgi%2Fcontent%2Ffull%2F284%2F1%2FE7%3Fck%3Dnck&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-nidkk-50"><b><a href="#cite_ref-nidkk_50-0" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://diabetes.niddk.nih.gov/about/dateline/spri02/8.htm" class="external text" title="http://diabetes.niddk.nih.gov/about/dateline/spri02/8.htm" rel="nofollow">"Diabetes and Aging"</a>. <i>Diabetes Dateline</i>. National Institute of Diabetes and Digestive and Kidney Diseases. 2002<span class="printonly">. <a href="http://diabetes.niddk.nih.gov/about/dateline/spri02/8.htm" class="external free" title="http://diabetes.niddk.nih.gov/about/dateline/spri02/8.htm" rel="nofollow">http://diabetes.niddk.nih.gov/about/dateline/spri02/8.htm</a></span><span class="reference-accessdate">. Retrieved on 2007-05-14</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Diabetes+and+Aging&amp;rft.atitle=Diabetes+Dateline&amp;rft.date=2002&amp;rft.pub=National+Institute+of+Diabetes+and+Digestive+and+Kidney+Diseases&amp;rft_id=http%3A%2F%2Fdiabetes.niddk.nih.gov%2Fabout%2Fdateline%2Fspri02%2F8.htm&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-51"><b><a href="#cite_ref-51" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFWeiss_J.2C_Sumpio_B2006">Weiss J, Sumpio B (2006). "Review of prevalence and outcome of vascular disease in patients with diabetes mellitus". <i>Eur J Vasc Endovasc Surg</i> <b>31</b> (2): 143–50. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2Fj.ejvs.2005.08.015" class="external text" title="http://dx.doi.org/10.1016%2Fj.ejvs.2005.08.015" rel="nofollow">10.1016/j.ejvs.2005.08.015</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16203161" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/16203161">PMID 16203161</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Review+of+prevalence+and+outcome+of+vascular+disease+in+patients+with+diabetes+mellitus&amp;rft.jtitle=Eur+J+Vasc+Endovasc+Surg&amp;rft.aulast=Weiss+J%2C+Sumpio+B&amp;rft.au=Weiss+J%2C+Sumpio+B&amp;rft.date=2006&amp;rft.volume=31&amp;rft.issue=2&amp;rft.pages=143%E2%80%9350&amp;rft_id=info:doi/10.1016%2Fj.ejvs.2005.08.015&amp;rft_id=info:pmid/16203161&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-52"><b><a href="#cite_ref-52" title="">^</a></b> <cite style="font-style:normal" class="book" id="CITEREFAristides_Veves2007">Aristides Veves, Rayaz A. Malik (2007). <i>Diabetic Neuropathy: Clinical Management (Clinical Diabetes), Second Edition</i>. New York: <a href="/wiki/Humana_Press" title="Humana Press">Humana Press</a>. pp.&#160;188–198. <a href="/wiki/Special:BookSources/1588296261" class="internal">ISBN 1-58-829626-1</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Diabetic+Neuropathy%3A+Clinical+Management+%28Clinical+Diabetes%29%2C+Second+Edition&amp;rft.aulast=Aristides+Veves&amp;rft.aufirst=Rayaz+A.+Malik&amp;rft.au=Aristides+Veves%2C+Rayaz+A.+Malik&amp;rft.date=2007&amp;rft.pages=pp.%26nbsp%3B188%E2%80%93198&amp;rft.place=New+York&amp;rft.pub=%5B%5BHumana+Press%5D%5D&amp;rft.isbn=1-58-829626-1&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-cspd-53"><b><a href="#cite_ref-cspd_53-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFGispen_WH.2C_Biessels_GJ2000">Gispen WH, Biessels GJ (November 2000). "Cognition and synaptic plasticity in diabetes mellitus". <i>Trends Neurosci.</i> <b>23</b> (11): 542–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0166-2236%2800%2901656-8" class="external text" title="http://dx.doi.org/10.1016%2FS0166-2236%2800%2901656-8" rel="nofollow">10.1016/S0166-2236(00)01656-8</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/11074263" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/11074263">PMID 11074263</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Cognition+and+synaptic+plasticity+in+diabetes+mellitus&amp;rft.jtitle=Trends+Neurosci.&amp;rft.aulast=Gispen+WH%2C+Biessels+GJ&amp;rft.au=Gispen+WH%2C+Biessels+GJ&amp;rft.date=November+2000&amp;rft.volume=23&amp;rft.issue=11&amp;rft.pages=542%E2%80%939&amp;rft_id=info:doi/10.1016%2FS0166-2236%2800%2901656-8&amp;rft_id=info:pmid/11074263&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Wild2004-54">^ <a href="#cite_ref-Wild2004_54-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Wild2004_54-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Wild2004_54-2" title=""><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Wild2004_54-3" title=""><sup><i><b>d</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFWild_S.2C_Roglic_G.2C_Green_A.2C_Sicree_R.2C_King_H2004">Wild S, Roglic G, Green A, Sicree R, King H (May 2004). "<a href="http://care.diabetesjournals.org/cgi/content/full/27/5/1047" class="external text" title="http://care.diabetesjournals.org/cgi/content/full/27/5/1047" rel="nofollow">Global prevalence of diabetes: estimates for the year 2000 and projections for 2030</a>". <i>Diabetes Care</i> <b>27</b> (5): 1047–53. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.2337%2Fdiacare.27.5.1047" class="external text" title="http://dx.doi.org/10.2337%2Fdiacare.27.5.1047" rel="nofollow">10.2337/diacare.27.5.1047</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15111519" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15111519">PMID 15111519</a><span class="printonly">. <a href="http://care.diabetesjournals.org/cgi/content/full/27/5/1047" class="external free" title="http://care.diabetesjournals.org/cgi/content/full/27/5/1047" rel="nofollow">http://care.diabetesjournals.org/cgi/content/full/27/5/1047</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Global+prevalence+of+diabetes%3A+estimates+for+the+year+2000+and+projections+for+2030&amp;rft.jtitle=Diabetes+Care&amp;rft.aulast=Wild+S%2C+Roglic+G%2C+Green+A%2C+Sicree+R%2C+King+H&amp;rft.au=Wild+S%2C+Roglic+G%2C+Green+A%2C+Sicree+R%2C+King+H&amp;rft.date=May+2004&amp;rft.volume=27&amp;rft.issue=5&amp;rft.pages=1047%E2%80%9353&amp;rft_id=info:doi/10.2337%2Fdiacare.27.5.1047&amp;rft_id=info:pmid/15111519&amp;rft_id=http%3A%2F%2Fcare.diabetesjournals.org%2Fcgi%2Fcontent%2Ffull%2F27%2F5%2F1047&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-55"><b><a href="#cite_ref-55" title="">^</a></b> hhttp://www.cdc.gov/Features/diabetesfactsheet/</li>
<li id="cite_note-56"><b><a href="#cite_ref-56" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.cdc.gov/Diabetes/news/docs/010126.htm" class="external text" title="http://www.cdc.gov/Diabetes/news/docs/010126.htm" rel="nofollow">"CDC's Diabetes Program - News and Information - Press Releases - October 26 2000"</a><span class="printonly">. <a href="http://www.cdc.gov/Diabetes/news/docs/010126.htm" class="external free" title="http://www.cdc.gov/Diabetes/news/docs/010126.htm" rel="nofollow">http://www.cdc.gov/Diabetes/news/docs/010126.htm</a></span><span class="reference-accessdate">. Retrieved on 2008-06-23</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=CDC%27s+Diabetes+Program+-+News+and+Information+-+Press+Releases+-+October+26+2000&amp;rft.atitle=&amp;rft_id=http%3A%2F%2Fwww.cdc.gov%2FDiabetes%2Fnews%2Fdocs%2F010126.htm&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-57"><b><a href="#cite_ref-57" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFNarayan_K.2C_Boyle_J.2C_Thompson_T.2C_Sorensen_S.2C_Williamson_D2003">Narayan K, Boyle J, Thompson T, Sorensen S, Williamson D (2003). "Lifetime risk for diabetes mellitus in the United States". <i>JAMA</i> <b>290</b> (14): 1884–90. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1001%2Fjama.290.14.1884" class="external text" title="http://dx.doi.org/10.1001%2Fjama.290.14.1884" rel="nofollow">10.1001/jama.290.14.1884</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/14532317" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/14532317">PMID 14532317</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Lifetime+risk+for+diabetes+mellitus+in+the+United+States&amp;rft.jtitle=JAMA&amp;rft.aulast=Narayan+K%2C+Boyle+J%2C+Thompson+T%2C+Sorensen+S%2C+Williamson+D&amp;rft.au=Narayan+K%2C+Boyle+J%2C+Thompson+T%2C+Sorensen+S%2C+Williamson+D&amp;rft.date=2003&amp;rft.volume=290&amp;rft.issue=14&amp;rft.pages=1884%E2%80%9390&amp;rft_id=info:doi/10.1001%2Fjama.290.14.1884&amp;rft_id=info:pmid/14532317&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-AA2005-Stats-58"><b><a href="#cite_ref-AA2005-Stats_58-0" title="">^</a></b> <cite style="font-style:normal" class="web" id="CITEREFAmerican_Diabetes_Association2005">American Diabetes Association (2005). <a href="http://www.diabetes.org/diabetes-statistics/prevalence.jsp" class="external text" title="http://www.diabetes.org/diabetes-statistics/prevalence.jsp" rel="nofollow">"Total Prevalence of Diabetes &amp; Pre-diabetes"</a><span class="printonly">. <a href="http://www.diabetes.org/diabetes-statistics/prevalence.jsp" class="external free" title="http://www.diabetes.org/diabetes-statistics/prevalence.jsp" rel="nofollow">http://www.diabetes.org/diabetes-statistics/prevalence.jsp</a></span><span class="reference-accessdate">. Retrieved on 2006-03-17</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Total+Prevalence+of+Diabetes+%26+Pre-diabetes&amp;rft.atitle=&amp;rft.aulast=American+Diabetes+Association&amp;rft.au=American+Diabetes+Association&amp;rft.date=2005&amp;rft_id=http%3A%2F%2Fwww.diabetes.org%2Fdiabetes-statistics%2Fprevalence.jsp&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-dlife-59"><b><a href="#cite_ref-dlife_59-0" title="">^</a></b> <cite style="font-style:normal" class="web"><a href="http://www.dlife.com/dLife/do/ShowContent/daily_living/seniors/" class="external text" title="http://www.dlife.com/dLife/do/ShowContent/daily_living/seniors/" rel="nofollow">"Seniors and Diabetes"</a>. <i>Elderly And Diabetes - Diabetes and Seniors</i>. LifeMed Media. 2006<span class="printonly">. <a href="http://www.dlife.com/dLife/do/ShowContent/daily_living/seniors/" class="external free" title="http://www.dlife.com/dLife/do/ShowContent/daily_living/seniors/" rel="nofollow">http://www.dlife.com/dLife/do/ShowContent/daily_living/seniors/</a></span><span class="reference-accessdate">. Retrieved on 2007-05-14</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Seniors+and+Diabetes&amp;rft.atitle=Elderly+And+Diabetes+-+Diabetes+and+Seniors&amp;rft.date=2006&amp;rft.pub=LifeMed+Media&amp;rft_id=http%3A%2F%2Fwww.dlife.com%2FdLife%2Fdo%2FShowContent%2Fdaily_living%2Fseniors%2F&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-60"><b><a href="#cite_ref-60" title="">^</a></b> <cite style="font-style:normal" class="web" id="CITEREFAustralian_Institute_for_Health_and_Welfare">Australian Institute for Health and Welfare. <a href="http://www.aihw.gov.au/indigenous/health/diabetes.cfm" class="external text" title="http://www.aihw.gov.au/indigenous/health/diabetes.cfm" rel="nofollow">"Diabetes, an overview"</a><span class="printonly">. <a href="http://www.aihw.gov.au/indigenous/health/diabetes.cfm" class="external free" title="http://www.aihw.gov.au/indigenous/health/diabetes.cfm" rel="nofollow">http://www.aihw.gov.au/indigenous/health/diabetes.cfm</a></span><span class="reference-accessdate">. Retrieved on 2008-06-23</span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.btitle=Diabetes%2C+an+overview&amp;rft.atitle=&amp;rft.aulast=Australian+Institute+for+Health+and+Welfare&amp;rft.au=Australian+Institute+for+Health+and+Welfare&amp;rft_id=http%3A%2F%2Fwww.aihw.gov.au%2Findigenous%2Fhealth%2Fdiabetes.cfm&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-61"><b><a href="#cite_ref-61" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFDobson1776">Dobson, M. (1776). "Nature of the urine in diabetes". <i>Medical Observations and Inquiries</i> <b>5</b>: 298–310.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Nature+of+the+urine+in+diabetes&amp;rft.jtitle=Medical+Observations+and+Inquiries&amp;rft.aulast=Dobson&amp;rft.aufirst=M.&amp;rft.au=Dobson%2C+M.&amp;rft.date=1776&amp;rft.volume=5&amp;rft.pages=298%E2%80%93310&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-62"><b><a href="#cite_ref-62" title="">^</a></b> Medvei (1993). History of Clinical Endocrinology. 23-34</li>
<li id="cite_note-Dwivedi.26Dwivedi07-63">^ <a href="#cite_ref-Dwivedi.26Dwivedi07_63-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Dwivedi.26Dwivedi07_63-1" title=""><sup><i><b>b</b></i></sup></a> Dwivedi, Girish &amp; Dwivedi, Shridhar (2007). <a href="http://medind.nic.in/iae/t07/i4/iaet07i4p243.pdf" class="external text" title="http://medind.nic.in/iae/t07/i4/iaet07i4p243.pdf" rel="nofollow"><i>History of Medicine: Sushruta – the Clinician – Teacher par Excellence</i></a>. <a href="/wiki/National_Informatics_Centre" title="National Informatics Centre">National Informatics Centre (Government of India)</a>.</li>
<li id="cite_note-64"><b><a href="#cite_ref-64" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFNabipour2003">Nabipour, I. (2003), "Clinical Endocrinology in the Islamic Civilization in Iran", <i>International Journal of Endocrinology and Metabolism</i> <b>1</b>: 43–45 [44–5]</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Clinical+Endocrinology+in+the+Islamic+Civilization+in+Iran&amp;rft.jtitle=International+Journal+of+Endocrinology+and+Metabolism&amp;rft.aulast=Nabipour&amp;rft.aufirst=I.&amp;rft.au=Nabipour%2C+I.&amp;rft.date=2003&amp;rft.volume=1&amp;rft.pages=43%E2%80%9345+%5B44%E2%80%935%5D&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-FASEBJ2002-Patlak-65">^ <a href="#cite_ref-FASEBJ2002-Patlak_65-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FASEBJ2002-Patlak_65-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-FASEBJ2002-Patlak_65-2" title=""><sup><i><b>c</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFPatlak_M2002">Patlak M (2002). "<a href="http://www.fasebj.org/cgi/content/full/16/14/1853e" class="external text" title="http://www.fasebj.org/cgi/content/full/16/14/1853e" rel="nofollow">New weapons to combat an ancient disease: treating diabetes</a>". <i>Faseb J</i> <b>16</b> (14): 1853. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1096%2Ffj.02-0974bkt" class="external text" title="http://dx.doi.org/10.1096%2Ffj.02-0974bkt" rel="nofollow">10.1096/fj.02-0974bkt</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12468446" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12468446">PMID 12468446</a><span class="printonly">. <a href="http://www.fasebj.org/cgi/content/full/16/14/1853e" class="external free" title="http://www.fasebj.org/cgi/content/full/16/14/1853e" rel="nofollow">http://www.fasebj.org/cgi/content/full/16/14/1853e</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=New+weapons+to+combat+an+ancient+disease%3A+treating+diabetes&amp;rft.jtitle=Faseb+J&amp;rft.aulast=Patlak+M&amp;rft.au=Patlak+M&amp;rft.date=2002&amp;rft.volume=16&amp;rft.issue=14&amp;rft.pages=1853&amp;rft_id=info:doi/10.1096%2Ffj.02-0974bkt&amp;rft_id=info:pmid/12468446&amp;rft_id=http%3A%2F%2Fwww.fasebj.org%2Fcgi%2Fcontent%2Ffull%2F16%2F14%2F1853e&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-66"><b><a href="#cite_ref-66" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFVon_Mehring_J.2C_Minkowski_O.1890">Von Mehring J, Minkowski O. (1890). "Diabetes mellitus nach pankreasexstirpation". <i>Arch Exp Pathol Pharmakol</i> <b>26</b>: 371–387. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1007%2FBF01831214" class="external text" title="http://dx.doi.org/10.1007%2FBF01831214" rel="nofollow">10.1007/BF01831214</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Diabetes+mellitus+nach+pankreasexstirpation&amp;rft.jtitle=Arch+Exp+Pathol+Pharmakol&amp;rft.aulast=Von+Mehring+J%2C+Minkowski+O.&amp;rft.au=Von+Mehring+J%2C+Minkowski+O.&amp;rft.date=1890&amp;rft.volume=26&amp;rft.pages=371%E2%80%93387&amp;rft_id=info:doi/10.1007%2FBF01831214&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-CanadMedAssocJ1922-Banting-67"><b><a href="#cite_ref-CanadMedAssocJ1922-Banting_67-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFBanting_FG.2C_Best_CH.2C_Collip_JB.2C_Campbell_WR.2C_Fletcher_AA1922">Banting FG, Best CH, Collip JB, Campbell WR, Fletcher AA (1922). "<a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=1933711" class="external text" title="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=1933711" rel="nofollow">Pancreatic extracts in the treatment of diabetes mellitus</a>". <i>Canad Med Assoc J</i> <b>12</b>: 141–146. <a href="http://www.ncbi.nlm.nih.gov/pubmed/1933711" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/1933711">PMID 1933711</a><span class="printonly">. <a href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=1933711" class="external free" title="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=1933711" rel="nofollow">http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=1933711</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Pancreatic+extracts+in+the+treatment+of+diabetes+mellitus&amp;rft.jtitle=Canad+Med+Assoc+J&amp;rft.aulast=Banting+FG%2C+Best+CH%2C+Collip+JB%2C+Campbell+WR%2C+Fletcher+AA&amp;rft.au=Banting+FG%2C+Best+CH%2C+Collip+JB%2C+Campbell+WR%2C+Fletcher+AA&amp;rft.date=1922&amp;rft.volume=12&amp;rft.pages=141%26ndash%3B146&amp;rft_id=info:pmid/1933711&amp;rft_id=http%3A%2F%2Fwww.pubmedcentral.nih.gov%2Farticlerender.fcgi%3Ftool%3Dpubmed%26pubmedid%3D1933711&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Lancet1936-Himsworth-68"><b><a href="#cite_ref-Lancet1936-Himsworth_68-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHimsworth1936">Himsworth (1936). "<i>Diabetes mellitus: its differentiation into insulin-sensitive and insulin-insensitive types".</i> Lancet <i><b>i</b>: 127–130. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1016%2FS0140-6736%2801%2936134-2" class="external text" title="http://dx.doi.org/10.1016%2FS0140-6736%2801%2936134-2" rel="nofollow">10.1016/S0140-6736(01)36134-2</a></span>.</i></cite><i><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=%27%27Diabetes+mellitus%3A+its+differentiation+into+insulin-sensitive+and+insulin-insensitive+types&amp;rft.jtitle=Lancet&amp;rft.aulast=Himsworth&amp;rft.au=Himsworth&amp;rft.date=1936&amp;rft.volume=i&amp;rft.pages=127%26ndash%3B130&amp;rft_id=info:doi/10.1016%2FS0140-6736%2801%2936134-2&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></i></li>
<li id="cite_note-69"><b><a href="#cite_ref-69" title="">^</a></b> Department of Health (Malta), 1897–1972:Annual Reports.</li>
<li id="cite_note-70"><b><a href="#cite_ref-70" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFYalow_RS.2C_Berson_SA1960">Yalow RS, Berson SA (1960). "Immunoassay of endogenous plasma insulin in man". <i>J. Clin. Invest.</i> <b>39</b>: 1157–75. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1172%2FJCI104130" class="external text" title="http://dx.doi.org/10.1172%2FJCI104130" rel="nofollow">10.1172/JCI104130</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/13846364" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/13846364">PMID 13846364</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Immunoassay+of+endogenous+plasma+insulin+in+man&amp;rft.jtitle=J.+Clin.+Invest.&amp;rft.aulast=Yalow+RS%2C+Berson+SA&amp;rft.au=Yalow+RS%2C+Berson+SA&amp;rft.date=1960&amp;rft.volume=39&amp;rft.pages=1157%E2%80%9375&amp;rft_id=info:doi/10.1172%2FJCI104130&amp;rft_id=info:pmid/13846364&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-71"><b><a href="#cite_ref-71" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFThe_Diabetes_Control_And_Complications_Trial_Research_Group.2C1993">The Diabetes Control And Complications Trial Research Group, (1993). "The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group". <i>N Engl J Med</i> <b>329</b> (14): 977–86. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJM199309303291401" class="external text" title="http://dx.doi.org/10.1056%2FNEJM199309303291401" rel="nofollow">10.1056/NEJM199309303291401</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8366922" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/8366922">PMID 8366922</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+effect+of+intensive+treatment+of+diabetes+on+the+development+and+progression+of+long-term+complications+in+insulin-dependent+diabetes+mellitus.+The+Diabetes+Control+and+Complications+Trial+Research+Group&amp;rft.jtitle=N+Engl+J+Med&amp;rft.aulast=The+Diabetes+Control+And+Complications+Trial+Research+Group%2C&amp;rft.au=The+Diabetes+Control+And+Complications+Trial+Research+Group%2C&amp;rft.date=1993&amp;rft.volume=329&amp;rft.issue=14&amp;rft.pages=977%E2%80%9386&amp;rft_id=info:doi/10.1056%2FNEJM199309303291401&amp;rft_id=info:pmid/8366922&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-72"><b><a href="#cite_ref-72" title="">^</a></b> <cite style="font-style:normal" class="book" id="CITEREFTheodore_H._Tulchinsky2008">Theodore H. Tulchinsky, Elena A. Varavikova (2008). <i>The New Public Health, Second Edition</i>. New York: <a href="/wiki/Academic_Press" title="Academic Press">Academic Press</a>. p.&#160;200. <a href="/wiki/Special:BookSources/0123708907" class="internal">ISBN 0-12-370890-7</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=The+New+Public+Health%2C+Second+Edition&amp;rft.aulast=Theodore+H.+Tulchinsky&amp;rft.aufirst=Elena+A.+Varavikova&amp;rft.au=Theodore+H.+Tulchinsky%2C+Elena+A.+Varavikova&amp;rft.date=2008&amp;rft.pages=p.%26nbsp%3B200&amp;rft.place=New+York&amp;rft.pub=%5B%5BAcademic+Press%5D%5D&amp;rft.isbn=0-12-370890-7&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-73"><b><a href="#cite_ref-73" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFPiwernetz_K.2C_Home_PD.2C_Snorgaard_O.2C_Antsiferov_M.2C_Staehr-Johansen_K.2C_Krans_M.1993">Piwernetz K, Home PD, Snorgaard O, Antsiferov M, Staehr-Johansen K, Krans M. (1993). "Monitoring the targets of the St Vincent Declaration and the implementation of quality management in diabetes care: the DIABCARE initiative. The DIABCARE Monitoring Group of the St Vincent Declaration Steering Committee.". <i>Diabet Med.</i> <b>10</b> (4): 303–4. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8508624" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/8508624">PMID 8508624</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Monitoring+the+targets+of+the+St+Vincent+Declaration+and+the+implementation+of+quality+management+in+diabetes+care%3A+the+DIABCARE+initiative.+The+DIABCARE+Monitoring+Group+of+the+St+Vincent+Declaration+Steering+Committee.&amp;rft.jtitle=Diabet+Med.&amp;rft.aulast=Piwernetz+K%2C+Home+PD%2C+Snorgaard+O%2C+Antsiferov+M%2C+Staehr-Johansen+K%2C+Krans+M.&amp;rft.au=Piwernetz+K%2C+Home+PD%2C+Snorgaard+O%2C+Antsiferov+M%2C+Staehr-Johansen+K%2C+Krans+M.&amp;rft.date=1993&amp;rft.volume=10&amp;rft.issue=4&amp;rft.pages=303%E2%80%934&amp;rft_id=info:pmid/8508624&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-EO005-Dubois.26Bankauskaite-74"><b><a href="#cite_ref-EO005-Dubois.26Bankauskaite_74-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFDubois.2C_HFW_and_Bankauskaite.2C_V2005">Dubois, HFW and Bankauskaite, V (2005). "<a href="http://www.euro.who.int/Document/Obs/EuroObserver7_3.pdf" class="external text" title="http://www.euro.who.int/Document/Obs/EuroObserver7_3.pdf" rel="nofollow">Type&#160;2 diabetes programmes in Europe</a>" (PDF). <i>Euro Observer</i> <b>7</b> (2): 5–6<span class="printonly">. <a href="http://www.euro.who.int/Document/Obs/EuroObserver7_3.pdf" class="external free" title="http://www.euro.who.int/Document/Obs/EuroObserver7_3.pdf" rel="nofollow">http://www.euro.who.int/Document/Obs/EuroObserver7_3.pdf</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Type%26nbsp%3B2+diabetes+programmes+in+Europe&amp;rft.jtitle=Euro+Observer&amp;rft.aulast=Dubois%2C+HFW+and+Bankauskaite%2C+V&amp;rft.au=Dubois%2C+HFW+and+Bankauskaite%2C+V&amp;rft.date=2005&amp;rft.volume=7&amp;rft.issue=2&amp;rft.pages=5%26ndash%3B6&amp;rft_id=http%3A%2F%2Fwww.euro.who.int%2FDocument%2FObs%2FEuroObserver7_3.pdf&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid17563611-75"><b><a href="#cite_ref-pmid17563611_75-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFStewart_WF.2C_Ricci_JA.2C_Chee_E.2C_Hirsch_AG.2C_Brandenburg_NA2007">Stewart WF, Ricci JA, Chee E, Hirsch AG, Brandenburg NA (2007). "Lost productive time and costs due to diabetes and diabetic neuropathic pain in the US workforce". <i>J. Occup. Environ. Med.</i> <b>49</b> (6): 672–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1097%2FJOM.0b013e318065b83a" class="external text" title="http://dx.doi.org/10.1097%2FJOM.0b013e318065b83a" rel="nofollow">10.1097/JOM.0b013e318065b83a</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17563611" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/17563611">PMID 17563611</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Lost+productive+time+and+costs+due+to+diabetes+and+diabetic+neuropathic+pain+in+the+US+workforce&amp;rft.jtitle=J.+Occup.+Environ.+Med.&amp;rft.aulast=Stewart+WF%2C+Ricci+JA%2C+Chee+E%2C+Hirsch+AG%2C+Brandenburg+NA&amp;rft.au=Stewart+WF%2C+Ricci+JA%2C+Chee+E%2C+Hirsch+AG%2C+Brandenburg+NA&amp;rft.date=2007&amp;rft.volume=49&amp;rft.issue=6&amp;rft.pages=672%E2%80%939&amp;rft_id=info:doi/10.1097%2FJOM.0b013e318065b83a&amp;rft_id=info:pmid/17563611&amp;rfr_id=info:sid/en.wikipedia.org:Diabetes_mellitus"><span style="display: none;">&#160;</span></span></li>
</ol>
</div>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Diabetes_mellitus&amp;action=edit&amp;section=24" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<ul>
<li><a href="http://www.diabetes.org/" class="external text" title="http://www.diabetes.org/" rel="nofollow">American Diabetes Association</a></li>
<li><a href="http://www.nlm.nih.gov/medlineplus/diabetes.html" class="external text" title="http://www.nlm.nih.gov/medlineplus/diabetes.html" rel="nofollow">MedlinePlus Diabetes from the U.S. National Library of Medicine</a></li>
<li><a href="http://ndep.nih.gov/" class="external text" title="http://ndep.nih.gov/" rel="nofollow">National Diabetes Education Program</a></li>
<li><a href="http://www.diabeteseducator.org/" class="external text" title="http://www.diabeteseducator.org/" rel="nofollow">American Association of Diabetes Educators</a></li>
<li><a href="http://www.peersforprogress.org/" class="external text" title="http://www.peersforprogress.org/" rel="nofollow">Peers for Progress: Diabetes</a></li>
<li><a href="http://www.etoolsage.com/converter/Blood_Sugar_conversion.asp?toolsort=1500" class="external text" title="http://www.etoolsage.com/converter/Blood_Sugar_conversion.asp?toolsort=1500" rel="nofollow">Blood Sugar Conversion</a></li>
</ul>
<table class="navbox" cellspacing="0" style=";">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks collapsible autocollapse" style="width:100%;background:transparent;color:inherit;;">
<tr>
<th style=";background:Silver" colspan="2" class="navbox-title">
<div style="float:left; width:6em;text-align:left;">
<div class="noprint plainlinksneverexpand navbar" style="background:none; padding:0; font-weight:normal;;background:Silver;border:none;; font-size:xx-small;"><a href="/wiki/Template:Endocrine_pathology" title="Template:Endocrine pathology"><span title="View this template" style=";background:Silver;border:none;">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="/wiki/Template_talk:Endocrine_pathology" title="Template talk:Endocrine pathology"><span title="Discussion about this template" style=";background:Silver;border:none;">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org/w/index.php?title=Template:Endocrine_pathology&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Template:Endocrine_pathology&amp;action=edit" rel="nofollow"><span title="Edit this template" style=";background:Silver;border:none;;">e</span></a></div>
</div>
<span style="font-size:110%;"><a href="/wiki/Endocrinology" title="Endocrinology">Endocrine</a> <a href="/wiki/Pathology" title="Pathology">pathology</a>: <a href="/wiki/Endocrine_disease" title="Endocrine disease">endocrine diseases</a> (<a href="/wiki/ICD-10_Chapter_IV:_Endocrine,_nutritional_and_metabolic_diseases#E00-E35_-_Endocrine_diseases" title="ICD-10 Chapter IV: Endocrine, nutritional and metabolic diseases">E00-35</a>, <a href="/wiki/List_of_ICD-9_codes_240-279:_Endocrine,_nutritional_and_metabolic_diseases,_and_immunity_disorders#disorders_of_thyroid_gland_.28240-246.29" title="List of ICD-9 codes 240-279: Endocrine, nutritional and metabolic diseases, and immunity disorders" class="mw-redirect">240-259</a>)</span></th>
</tr>
<tr style="height:2px;">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background:#efefef;;"><a href="/wiki/Pancreatic_disease" title="Pancreatic disease">Pancreas</a>/<br />
<a href="/wiki/Glucose_metabolism_disorder" title="Glucose metabolism disorder" class="mw-redirect">glucose<br />
metabolism</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:#efefef;;">
<div style="padding:0em 0.75em;">Hypofunction</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><strong class="selflink">Diabetes mellitus</strong> <i>types:</i> (<a href="/wiki/Diabetes_mellitus_type_1" title="Diabetes mellitus type 1">type 1</a>, <a href="/wiki/Diabetes_mellitus_type_2" title="Diabetes mellitus type 2">type 2</a>, <a href="/wiki/Maturity_onset_diabetes_of_the_young" title="Maturity onset diabetes of the young">MODY</a>)<span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/Diabetes_complication" title="Diabetes complication">complications</a></i> (<a href="/wiki/Diabetic_coma" title="Diabetic coma">coma</a>, <a href="/wiki/Diabetic_angiopathy" title="Diabetic angiopathy">angiopathy</a>, <a href="/wiki/Diabetic_ketoacidosis" title="Diabetic ketoacidosis">ketoacidosis</a>, <a href="/wiki/Diabetic_nephropathy" title="Diabetic nephropathy">nephropathy</a>, <a href="/wiki/Diabetic_neuropathy" title="Diabetic neuropathy">neuropathy</a>, <a href="/wiki/Diabetic_retinopathy" title="Diabetic retinopathy">retinopathy</a>, <a href="/wiki/Diabetic_cardiomyopathy" title="Diabetic cardiomyopathy">cardiomyopathy</a>)<br />
<i>insulin receptor</i> (<a href="/wiki/Rabson-Mendenhall_syndrome" title="Rabson-Mendenhall syndrome">Rabson-Mendenhall syndrome</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Insulin_resistance" title="Insulin resistance">Insulin resistance</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:#efefef;;">
<div style="padding:0em 0.75em;">Hyperfunction</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Hypoglycemia" title="Hypoglycemia">Hypoglycemia</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Hyperinsulinism" title="Hyperinsulinism">Hyperinsulinism</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Zollinger-Ellison_syndrome" title="Zollinger-Ellison syndrome">Zollinger-Ellison syndrome</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background:#efefef;;"><a href="/wiki/Hypothalamic" title="Hypothalamic" class="mw-redirect">Hypothalamic</a>/<br />
<a href="/wiki/Pituitary" title="Pituitary" class="mw-redirect">pituitary</a> axes</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: #efefef;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Hypothalamic_disease" title="Hypothalamic disease">Hypothalamus</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Neurogenic_diabetes_insipidus" title="Neurogenic diabetes insipidus">Neurogenic diabetes insipidus</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Hypothalamic_hamartoma" title="Hypothalamic hamartoma">Hypothalamic hamartoma</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Adiposogenital_dystrophy" title="Adiposogenital dystrophy">Adiposogenital dystrophy</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Kallmann_syndrome" title="Kallmann syndrome">Kallmann syndrome</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: #efefef;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Pituitary_disease" title="Pituitary disease">Pituitary</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: #efefef;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Hyperpituitarism" title="Hyperpituitarism">Hyperpituitarism</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><i>anterior</i> (<a href="/wiki/Acromegaly" title="Acromegaly">Acromegaly</a>, <a href="/wiki/Hyperprolactinaemia" title="Hyperprolactinaemia">Hyperprolactinaemia</a>, <a href="/wiki/Pituitary_ACTH_hypersecretion" title="Pituitary ACTH hypersecretion">Pituitary ACTH hypersecretion</a>)<span style="font-weight:bold;">&#160;·</span> <i>posterior</i> (<a href="/wiki/Syndrome_of_inappropriate_antidiuretic_hormone" title="Syndrome of inappropriate antidiuretic hormone">SIADH</a>)<span style="font-weight:bold;">&#160;·</span> <i>general</i> (<a href="/wiki/Nelson%27s_syndrome" title="Nelson's syndrome">Nelson's syndrome</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: #efefef;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Hypopituitarism" title="Hypopituitarism">Hypopituitarism</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><i>anterior</i> (<a href="/wiki/Kallmann_syndrome" title="Kallmann syndrome">Kallmann syndrome</a>, <a href="/wiki/Growth_hormone_deficiency" title="Growth hormone deficiency">Growth hormone deficiency</a>, <a href="/wiki/Adrenocorticotropic_hormone_deficiency" title="Adrenocorticotropic hormone deficiency">ACTH deficiency</a>)<span style="font-weight:bold;">&#160;·</span> <i>posterior</i> (<a href="/wiki/Neurogenic_diabetes_insipidus" title="Neurogenic diabetes insipidus">Neurogenic</a> <a href="/wiki/Diabetes_insipidus" title="Diabetes insipidus">diabetes insipidus</a>)<span style="font-weight:bold;">&#160;·</span> <i>general</i> (<a href="/wiki/Empty_sella_syndrome" title="Empty sella syndrome">Empty sella syndrome</a>, <a href="/wiki/Pituitary_apoplexy" title="Pituitary apoplexy">Pituitary apoplexy</a>, <a href="/wiki/Sheehan%27s_syndrome" title="Sheehan's syndrome">Sheehan's syndrome</a>, <a href="/wiki/Lymphocytic_hypophysitis" title="Lymphocytic hypophysitis" class="mw-redirect">Lymphocytic hypophysitis</a>)</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: #efefef;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Thyroid_disease" title="Thyroid disease">Thyroid</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: #efefef;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Hypothyroidism" title="Hypothyroidism">Hypothyroidism</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Iodine_deficiency" title="Iodine deficiency">Iodine deficiency</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Cretinism" title="Cretinism">Cretinism</a> (<a href="/wiki/Congenital_hypothyroidism" title="Congenital hypothyroidism">Congenital hypothyroidism</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Myxedema" title="Myxedema">Myxedema</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Euthyroid_sick_syndrome" title="Euthyroid sick syndrome">Euthyroid sick syndrome</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: #efefef;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Hyperthyroidism" title="Hyperthyroidism">Hyperthyroidism</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Hyperthyroxinemia" title="Hyperthyroxinemia">Hyperthyroxinemia</a> (<a href="/wiki/Thyroid_hormone_resistance" title="Thyroid hormone resistance">Thyroid hormone resistance</a>, <a href="/wiki/Familial_dysalbuminemic_hyperthyroxinemia" title="Familial dysalbuminemic hyperthyroxinemia">Familial dysalbuminemic hyperthyroxinemia</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Hashitoxicosis" title="Hashitoxicosis">Hashitoxicosis</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Thyrotoxicosis_factitia" title="Thyrotoxicosis factitia">Thyrotoxicosis factitia</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Graves%27_disease" title="Graves' disease">Graves' disease</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: #efefef;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Thyroiditis" title="Thyroiditis">Thyroiditis</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Acute_infectious_thyroiditis" title="Acute infectious thyroiditis">Acute infectious</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Subacute_thyroiditis" title="Subacute thyroiditis">Subacute</a> (<a href="/wiki/De_Quervain%27s_thyroiditis" title="De Quervain's thyroiditis">De Quervain's</a>, <a href="/wiki/Subacute_lymphocytic_thyroiditis" title="Subacute lymphocytic thyroiditis">Subacute lymphocytic</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Autoimmune_thyroiditis" title="Autoimmune thyroiditis">Autoimmune</a>/chronic (<a href="/wiki/Hashimoto%27s_thyroiditis" title="Hashimoto's thyroiditis">Hashimoto's</a>, <a href="/wiki/Postpartum_thyroiditis" title="Postpartum thyroiditis">Postpartum</a>, <a href="/wiki/Riedel%27s_thyroiditis" title="Riedel's thyroiditis">Riedel's</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: #efefef;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Goitre" title="Goitre">Goitre</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Endemic_goitre" title="Endemic goitre">Endemic goitre</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Toxic_nodular_goitre" title="Toxic nodular goitre">Toxic nodular goitre</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Toxic_multinodular_goitre" title="Toxic multinodular goitre">Toxic multinodular goitre</a><br />
<a href="/wiki/Thyroid_nodule" title="Thyroid nodule">Thyroid nodule</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: #efefef;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Parathyroid_disease" title="Parathyroid disease">Parathyroid</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:#efefef;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Hypoparathyroidism" title="Hypoparathyroidism">Hypoparathyroidism</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Pseudohypoparathyroidism" title="Pseudohypoparathyroidism">Pseudohypoparathyroidism</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:#efefef;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Hyperparathyroidism" title="Hyperparathyroidism">Hyperparathyroidism</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Primary_hyperparathyroidism" title="Primary hyperparathyroidism">Primary</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Secondary_hyperparathyroidism" title="Secondary hyperparathyroidism">Secondary</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Tertiary_hyperparathyroidism" title="Tertiary hyperparathyroidism">Tertiary</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Osteitis_fibrosa_cystica" title="Osteitis fibrosa cystica">Osteitis fibrosa cystica</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: #efefef;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Adrenal_gland_disease" title="Adrenal gland disease">Adrenal</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:#efefef;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Adrenocortical_hyperfunction" title="Adrenocortical hyperfunction">Hyperfunction</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><i><a href="/wiki/Aldosterone" title="Aldosterone">aldosterone</a>:</i> <a href="/wiki/Hyperaldosteronism" title="Hyperaldosteronism">Hyperaldosteronism</a>/<a href="/wiki/Primary_aldosteronism" title="Primary aldosteronism">Primary aldosteronism</a> (<a href="/wiki/Conn_syndrome" title="Conn syndrome" class="mw-redirect">Conn syndrome</a>, <a href="/wiki/Bartter_syndrome" title="Bartter syndrome">Bartter syndrome</a>, <a href="/wiki/Glucocorticoid_remediable_aldosteronism" title="Glucocorticoid remediable aldosteronism">Glucocorticoid remediable aldosteronism</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Apparent_mineralocorticoid_excess_syndrome" title="Apparent mineralocorticoid excess syndrome">AME</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Liddle%27s_syndrome" title="Liddle's syndrome">Liddle's syndrome</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Congenital_adrenal_hyperplasia_due_to_17_alpha-hydroxylase_deficiency" title="Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency">17α CAH</a>
<p><i><a href="/wiki/Cortisol" title="Cortisol">cortisol</a>:</i> <a href="/wiki/Cushing%27s_syndrome" title="Cushing's syndrome">Cushing's syndrome</a> (<a href="/wiki/Pseudo-Cushing%27s_syndrome" title="Pseudo-Cushing's syndrome">Pseudo-Cushing's syndrome</a>)</p>
<i><a href="/wiki/Sex_hormone" title="Sex hormone" class="mw-redirect">sex hormones</a>:</i> <a href="/wiki/Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency" title="Congenital adrenal hyperplasia due to 21-hydroxylase deficiency">21α CAH</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Congenital_adrenal_hyperplasia_due_to_11%CE%B2-hydroxylase_deficiency" title="Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency">11β CAH</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background:#efefef;;">
<div style="padding:0em 0.75em;">Hypofunction/<br />
<a href="/wiki/Adrenal_insufficiency" title="Adrenal insufficiency">Adrenal insufficiency</a><br />
(<a href="/wiki/Addison%27s_disease" title="Addison's disease">Addison's</a>, <a href="/wiki/Waterhouse-Friderichsen_syndrome" title="Waterhouse-Friderichsen syndrome">WF</a>)</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><i>aldosterone:</i> <a href="/wiki/Hypoaldosteronism" title="Hypoaldosteronism">Hypoaldosteronism</a> (<a href="/wiki/Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency" title="Congenital adrenal hyperplasia due to 21-hydroxylase deficiency">21α CAH</a>, <a href="/wiki/Congenital_adrenal_hyperplasia_due_to_11%CE%B2-hydroxylase_deficiency" title="Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency">11β CAH</a>)
<p><i>cortisol:</i> <a href="/wiki/Congenital_adrenal_hyperplasia" title="Congenital adrenal hyperplasia">CAH</a> (<a href="/wiki/Lipoid_congenital_adrenal_hyperplasia" title="Lipoid congenital adrenal hyperplasia">Lipoid</a>, <a href="/wiki/Congenital_adrenal_hyperplasia_due_to_3_beta-hydroxysteroid_dehydrogenase_deficiency" title="Congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency">3β</a>, <a href="/wiki/Congenital_adrenal_hyperplasia_due_to_11%CE%B2-hydroxylase_deficiency" title="Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency">11β</a>, <a href="/wiki/Congenital_adrenal_hyperplasia_due_to_17_alpha-hydroxylase_deficiency" title="Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency">17α</a>, <a href="/wiki/Congenital_adrenal_hyperplasia_due_to_21-hydroxylase_deficiency" title="Congenital adrenal hyperplasia due to 21-hydroxylase deficiency">21α</a>)</p>
<i>sex hormones:</i> <a href="/wiki/Congenital_adrenal_hyperplasia_due_to_17_alpha-hydroxylase_deficiency" title="Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency">17α CAH</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: #efefef;;">
<div style="padding:0em 0.75em;"><a href="/wiki/Gonadal_disorder" title="Gonadal disorder" class="mw-redirect">Gonads</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><i><a href="/wiki/Ovarian_disease" title="Ovarian disease">ovarian</a></i> (<a href="/wiki/Polycystic_ovary_syndrome" title="Polycystic ovary syndrome">Polycystic ovary syndrome</a>, <a href="/wiki/Premature_ovarian_failure" title="Premature ovarian failure">Premature ovarian failure</a>)
<p><i><a href="/wiki/Testicular_disease" title="Testicular disease">testicular</a></i> (<a href="/wiki/5-alpha-reductase_deficiency" title="5-alpha-reductase deficiency">5-alpha-reductase deficiency</a>, <a href="/wiki/17-beta-hydroxysteroid_dehydrogenase_deficiency" title="17-beta-hydroxysteroid dehydrogenase deficiency">17-beta-hydroxysteroid dehydrogenase deficiency</a>)<span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/Androgen_receptor" title="Androgen receptor">Androgen receptor</a></i> (<a href="/wiki/Androgen_insensitivity_syndrome" title="Androgen insensitivity syndrome">Androgen insensitivity syndrome</a>)</p>
<i>general</i> (<a href="/wiki/Hypogonadism" title="Hypogonadism">Hypogonadism</a>, <a href="/wiki/Delayed_puberty" title="Delayed puberty">Delayed puberty</a>, <a href="/wiki/Precocious_puberty" title="Precocious puberty">Precocious puberty</a>)</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background:#efefef;;">Height</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Gigantism" title="Gigantism">Gigantism</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Dwarfism" title="Dwarfism">Dwarfism</a>/<a href="/wiki/Short_stature" title="Short stature">Short stature</a> (<a href="/wiki/Laron_syndrome" title="Laron syndrome">Laron syndrome</a>, <a href="/wiki/Psychogenic_dwarfism" title="Psychogenic dwarfism">Psychogenic dwarfism</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background:#efefef;;">Multiple</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Autoimmune_polyendocrine_syndrome" title="Autoimmune polyendocrine syndrome">Autoimmune polyendocrine syndrome</a> (<a href="/wiki/Autoimmune_polyendocrine_syndrome_type_1" title="Autoimmune polyendocrine syndrome type 1">APS1</a>, <a href="/wiki/Autoimmune_polyendocrine_syndrome_type_2" title="Autoimmune polyendocrine syndrome type 2">APS2</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Carcinoid_syndrome" title="Carcinoid syndrome">Carcinoid syndrome</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Multiple_endocrine_neoplasia" title="Multiple endocrine neoplasia">Multiple endocrine neoplasia</a> (<a href="/wiki/Multiple_endocrine_neoplasia_type_1" title="Multiple endocrine neoplasia type 1">1</a>, <a href="/wiki/Multiple_endocrine_neoplasia_type_2" title="Multiple endocrine neoplasia type 2">2A</a>, <a href="/wiki/Multiple_endocrine_neoplasia_type_2b" title="Multiple endocrine neoplasia type 2b">2B</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Progeria" title="Progeria">Progeria</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Woodhouse-Sakati_syndrome" title="Woodhouse-Sakati syndrome">Woodhouse-Sakati syndrome</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td colspan="2" style="width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><i>see also <a href="/wiki/Template:Congenital_endocrine_disorders" title="Template:Congenital endocrine disorders">congenital</a>, <a href="/wiki/Template:Endocrine_gland_neoplasia" title="Template:Endocrine gland neoplasia">neoplasia</a></i></div>
</td>
</tr>
</table>
</td>
</tr>
</table>
<p><span id="interwiki-sr-fa"></span> <span id="interwiki-ar-fa"></span></p>


<!-- 
NewPP limit report
Preprocessor node count: 38592/1000000
Post-expand include size: 443620/2048000 bytes
Template argument size: 196951/2048000 bytes
Expensive parser function count: 0/500
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:44677-0!1!0!default!!en!2 and timestamp 20090405115326 -->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org/wiki/Diabetes_mellitus">http://en.wikipedia.org/wiki/Diabetes_mellitus</a>"</div>
			<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks"><a href="/wiki/Special:Categories" title="Special:Categories">Categories</a>:&#32;<span dir='ltr'><a href="/wiki/Category:Diabetes" title="Category:Diabetes">Diabetes</a></span> | <span dir='ltr'><a href="/wiki/Category:Medical_conditions_related_to_obesity" title="Category:Medical conditions related to obesity">Medical conditions related to obesity</a></span> | <span dir='ltr'><a href="/wiki/Category:Nutrition" title="Category:Nutrition">Nutrition</a></span></div><div id="mw-hidden-catlinks" class="mw-hidden-cats-hidden">Hidden categories:&#32;<span dir='ltr'><a href="/wiki/Category:Articles_containing_non-English_language_text" title="Category:Articles containing non-English language text">Articles containing non-English language text</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_containing_Greek_language_text" title="Category:Articles containing Greek language text">Articles containing Greek language text</a></span></div></div>			<!-- end content -->
						<div class="visualClear"></div>
		</div>
	</div>
		</div>
		<div id="column-one">
	<div id="p-cactions" class="portlet">
		<h5>Views</h5>
		<div class="pBody">
			<ul>
	
				 <li id="ca-nstab-main" class="selected"><a href="/wiki/Diabetes_mellitus" title="View the content page [c]" accesskey="c">Article</a></li>
				 <li id="ca-talk"><a href="/wiki/Talk:Diabetes_mellitus" title="Discussion about the content page [t]" accesskey="t">Discussion</a></li>
				 <li id="ca-edit"><a href="/w/index.php?title=Diabetes_mellitus&amp;action=edit" title="You can edit this page. &#10;Please use the preview button before saving. [e]" accesskey="e">Edit this page</a></li>
				 <li id="ca-history"><a href="/w/index.php?title=Diabetes_mellitus&amp;action=history" title="Past versions of this page [h]" accesskey="h">History</a></li>			</ul>
		</div>
	</div>
	<div class="portlet" id="p-personal">
		<h5>Personal tools</h5>
		<div class="pBody">
			<ul>
				<li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Diabetes_mellitus" title="You are encouraged to log in; however, it is not mandatory. [o]" accesskey="o">Log in / create account</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-logo">
		<a style="background-image: url(http://upload.wikimedia.org/wikipedia/en/b/bc/Wiki.png);" href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
	<div class='generated-sidebar portlet' id='p-navigation'>
		<h5>Navigation</h5>
		<div class='pBody'>
			<ul>
				<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li>
				<li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li>
				<li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content — the best of Wikipedia">Featured content</a></li>
				<li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li>
				<li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li>
			</ul>
		</div>
	</div>
	<div id="p-search" class="portlet">
		<h5><label for="searchInput">Search</label></h5>
		<div id="searchBody" class="pBody">
			<form action="/w/index.php" id="searchform"><div>
				<input type='hidden' name="title" value="Special:Search"/>
				<input id="searchInput" name="search" type="text" title="Search Wikipedia [f]" accesskey="f" value="" />
				<input type='submit' name="go" class="searchButton" id="searchGoButton"	value="Go" title="Go to a page with this exact name if one exists" />&nbsp;
				<input type='submit' name="fulltext" class="searchButton" id="mw-searchButton" value="Search" title="Search Wikipedia for this text" />
			</div></form>
		</div>
	</div>
	<div class='generated-sidebar portlet' id='p-interaction'>
		<h5>Interaction</h5>
		<div class='pBody'>
			<ul>
				<li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li>
				<li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li>
				<li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="The list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li>
				<li id="n-contact"><a href="/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia">Contact Wikipedia</a></li>
				<li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Donate" title="Support us">Donate to Wikipedia</a></li>
				<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-tb">
		<h5>Toolbox</h5>
		<div class="pBody">
			<ul>
				<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Diabetes_mellitus" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li>
				<li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Diabetes_mellitus" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li>
<li id="t-upload"><a href="/wiki/Wikipedia:Upload" title="Upload files [u]" accesskey="u">Upload file</a></li>
<li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</a></li>
				<li id="t-print"><a href="/w/index.php?title=Diabetes_mellitus&amp;printable=yes" rel="alternate" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>				<li id="t-permalink"><a href="/w/index.php?title=Diabetes_mellitus&amp;oldid=281758282" title="Permanent link to this version of the page">Permanent link</a></li><li id="t-cite"><a href="/w/index.php?title=Special:Cite&amp;page=Diabetes_mellitus&amp;id=281758282">Cite this page</a></li>			</ul>
		</div>
	</div>
	<div id="p-lang" class="portlet">
		<h5>Languages</h5>
		<div class="pBody">
			<ul>
				<li class="interwiki-af"><a href="http://af.wikipedia.org/wiki/Diabetes_mellitus">Afrikaans</a></li>
				<li class="interwiki-ar"><a href="http://ar.wikipedia.org/wiki/%D8%A7%D9%84%D8%B3%D9%83%D8%B1%D9%8A">العربية</a></li>
				<li class="interwiki-ast"><a href="http://ast.wikipedia.org/wiki/Diabetes">Asturianu</a></li>
				<li class="interwiki-az"><a href="http://az.wikipedia.org/wiki/Diabet">Azərbaycan</a></li>
				<li class="interwiki-zh-min-nan"><a href="http://zh-min-nan.wikipedia.org/wiki/Thn%CC%82g-ji%C5%8D-p%C4%93%E2%81%BF">Bân-lâm-gú</a></li>
				<li class="interwiki-bs"><a href="http://bs.wikipedia.org/wiki/Diabetes_mellitus">Bosanski</a></li>
				<li class="interwiki-bg"><a href="http://bg.wikipedia.org/wiki/%D0%94%D0%B8%D0%B0%D0%B1%D0%B5%D1%82">Български</a></li>
				<li class="interwiki-ca"><a href="http://ca.wikipedia.org/wiki/Diabetis_mellitus">Català</a></li>
				<li class="interwiki-cs"><a href="http://cs.wikipedia.org/wiki/Diabetes_mellitus">Česky</a></li>
				<li class="interwiki-cy"><a href="http://cy.wikipedia.org/wiki/Clefyd_y_siwgr">Cymraeg</a></li>
				<li class="interwiki-da"><a href="http://da.wikipedia.org/wiki/Sukkersyge">Dansk</a></li>
				<li class="interwiki-de"><a href="http://de.wikipedia.org/wiki/Diabetes_mellitus">Deutsch</a></li>
				<li class="interwiki-et"><a href="http://et.wikipedia.org/wiki/Suhkurt%C3%B5bi">Eesti</a></li>
				<li class="interwiki-el"><a href="http://el.wikipedia.org/wiki/%CE%94%CE%B9%CE%B1%CE%B2%CE%AE%CF%84%CE%B7%CF%82">Ελληνικά</a></li>
				<li class="interwiki-es"><a href="http://es.wikipedia.org/wiki/Diabetes_mellitus">Español</a></li>
				<li class="interwiki-eo"><a href="http://eo.wikipedia.org/wiki/Diabeto">Esperanto</a></li>
				<li class="interwiki-eu"><a href="http://eu.wikipedia.org/wiki/Diabete">Euskara</a></li>
				<li class="interwiki-fa"><a href="http://fa.wikipedia.org/wiki/%D9%85%D8%B1%D8%B6_%D9%82%D9%86%D8%AF">فارسی</a></li>
				<li class="interwiki-fr"><a href="http://fr.wikipedia.org/wiki/Diab%C3%A8te_sucr%C3%A9">Français</a></li>
				<li class="interwiki-ga"><a href="http://ga.wikipedia.org/wiki/Diaib%C3%A9iteas">Gaeilge</a></li>
				<li class="interwiki-gl"><a href="http://gl.wikipedia.org/wiki/Diabetes_mellitus">Galego</a></li>
				<li class="interwiki-ko"><a href="http://ko.wikipedia.org/wiki/%EB%8B%B9%EB%87%A8%EB%B3%91">한국어</a></li>
				<li class="interwiki-hi"><a href="http://hi.wikipedia.org/wiki/%E0%A4%AE%E0%A4%A7%E0%A5%81%E0%A4%AE%E0%A5%87%E0%A4%B9">हिन्दी</a></li>
				<li class="interwiki-hr"><a href="http://hr.wikipedia.org/wiki/Diabetes_mellitus">Hrvatski</a></li>
				<li class="interwiki-id"><a href="http://id.wikipedia.org/wiki/Diabetes_mellitus">Bahasa Indonesia</a></li>
				<li class="interwiki-ia"><a href="http://ia.wikipedia.org/wiki/Diabete">Interlingua</a></li>
				<li class="interwiki-is"><a href="http://is.wikipedia.org/wiki/Sykurs%C3%BDki">Íslenska</a></li>
				<li class="interwiki-it"><a href="http://it.wikipedia.org/wiki/Diabete_mellito">Italiano</a></li>
				<li class="interwiki-he"><a href="http://he.wikipedia.org/wiki/%D7%A1%D7%95%D7%9B%D7%A8%D7%AA">עברית</a></li>
				<li class="interwiki-pam"><a href="http://pam.wikipedia.org/wiki/Diabetes_mellitus">Kapampangan</a></li>
				<li class="interwiki-ka"><a href="http://ka.wikipedia.org/wiki/%E1%83%A8%E1%83%90%E1%83%A5%E1%83%A0%E1%83%98%E1%83%A1_%E1%83%93%E1%83%98%E1%83%90%E1%83%91%E1%83%94%E1%83%A2%E1%83%98">ქართული</a></li>
				<li class="interwiki-sw"><a href="http://sw.wikipedia.org/wiki/Kisukari">Kiswahili</a></li>
				<li class="interwiki-la"><a href="http://la.wikipedia.org/wiki/Diabetes_mellitus">Latina</a></li>
				<li class="interwiki-lv"><a href="http://lv.wikipedia.org/wiki/Cukura_diab%C4%93ts">Latviešu</a></li>
				<li class="interwiki-lb"><a href="http://lb.wikipedia.org/wiki/Diabetes_mellitus">Lëtzebuergesch</a></li>
				<li class="interwiki-lt"><a href="http://lt.wikipedia.org/wiki/Cukrinis_diabetas">Lietuvių</a></li>
				<li class="interwiki-hu"><a href="http://hu.wikipedia.org/wiki/Cukorbetegs%C3%A9g">Magyar</a></li>
				<li class="interwiki-ml"><a href="http://ml.wikipedia.org/wiki/%E0%B4%AA%E0%B5%8D%E0%B4%B0%E0%B4%AE%E0%B5%87%E0%B4%B9%E0%B4%82">മലയാളം</a></li>
				<li class="interwiki-arz"><a href="http://arz.wikipedia.org/wiki/%D9%85%D8%B1%D8%B6_%D8%A7%D9%84%D8%B3%D9%83%D8%B1">مصرى</a></li>
				<li class="interwiki-mk"><a href="http://mk.wikipedia.org/wiki/%D0%A8%D0%B5%D1%9C%D0%B5%D1%80%D0%BD%D0%B0_%D0%B1%D0%BE%D0%BB%D0%B5%D1%81%D1%82">Македонски</a></li>
				<li class="interwiki-ms"><a href="http://ms.wikipedia.org/wiki/Penyakit_kencing_manis">Bahasa Melayu</a></li>
				<li class="interwiki-nl"><a href="http://nl.wikipedia.org/wiki/Diabetes_mellitus">Nederlands</a></li>
				<li class="interwiki-ne"><a href="http://ne.wikipedia.org/wiki/%E0%A4%AE%E0%A4%A7%E0%A5%81%E0%A4%AE%E0%A5%87%E0%A4%B9">नेपाली</a></li>
				<li class="interwiki-new"><a href="http://new.wikipedia.org/wiki/%E0%A4%AE%E0%A4%A7%E0%A5%81%E0%A4%AE%E0%A5%87%E0%A4%B9">नेपाल भाषा</a></li>
				<li class="interwiki-ja"><a href="http://ja.wikipedia.org/wiki/%E7%B3%96%E5%B0%BF%E7%97%85">日本語</a></li>
				<li class="interwiki-no"><a href="http://no.wikipedia.org/wiki/Diabetes_mellitus">‪Norsk (bokmål)‬</a></li>
				<li class="interwiki-nn"><a href="http://nn.wikipedia.org/wiki/Diabetes_mellitus">‪Norsk (nynorsk)‬</a></li>
				<li class="interwiki-om"><a href="http://om.wikipedia.org/wiki/Diabetes">Oromoo</a></li>
				<li class="interwiki-pl"><a href="http://pl.wikipedia.org/wiki/Cukrzyca">Polski</a></li>
				<li class="interwiki-pt"><a href="http://pt.wikipedia.org/wiki/Diabetes_mellitus">Português</a></li>
				<li class="interwiki-ro"><a href="http://ro.wikipedia.org/wiki/Diabet_zaharat">Română</a></li>
				<li class="interwiki-qu"><a href="http://qu.wikipedia.org/wiki/Misk%27i_unquy">Runa Simi</a></li>
				<li class="interwiki-ru"><a href="http://ru.wikipedia.org/wiki/%D0%A1%D0%B0%D1%85%D0%B0%D1%80%D0%BD%D1%8B%D0%B9_%D0%B4%D0%B8%D0%B0%D0%B1%D0%B5%D1%82">Русский</a></li>
				<li class="interwiki-sq"><a href="http://sq.wikipedia.org/wiki/Diabetes_mellitus">Shqip</a></li>
				<li class="interwiki-simple"><a href="http://simple.wikipedia.org/wiki/Diabetes_mellitus">Simple English</a></li>
				<li class="interwiki-sk"><a href="http://sk.wikipedia.org/wiki/Cukrovka">Slovenčina</a></li>
				<li class="interwiki-sl"><a href="http://sl.wikipedia.org/wiki/Sladkorna_bolezen">Slovenščina</a></li>
				<li class="interwiki-so"><a href="http://so.wikipedia.org/wiki/Sokorow">Soomaaliga</a></li>
				<li class="interwiki-sr"><a href="http://sr.wikipedia.org/wiki/%D0%A8%D0%B5%D1%9B%D0%B5%D1%80%D0%BD%D0%B0_%D0%B1%D0%BE%D0%BB%D0%B5%D1%81%D1%82">Српски / Srpski</a></li>
				<li class="interwiki-sh"><a href="http://sh.wikipedia.org/wiki/Dijabetes">Srpskohrvatski / Српскохрватски</a></li>
				<li class="interwiki-su"><a href="http://su.wikipedia.org/wiki/Diab%C3%A9tes_m%C3%A9litus">Basa Sunda</a></li>
				<li class="interwiki-fi"><a href="http://fi.wikipedia.org/wiki/Diabetes">Suomi</a></li>
				<li class="interwiki-sv"><a href="http://sv.wikipedia.org/wiki/Diabetes">Svenska</a></li>
				<li class="interwiki-ta"><a href="http://ta.wikipedia.org/wiki/%E0%AE%A8%E0%AF%80%E0%AE%B0%E0%AE%BF%E0%AE%B4%E0%AE%BF%E0%AE%B5%E0%AF%81_%E0%AE%A8%E0%AF%8B%E0%AE%AF%E0%AF%8D">தமிழ்</a></li>
				<li class="interwiki-te"><a href="http://te.wikipedia.org/wiki/%E0%B0%AE%E0%B0%A7%E0%B1%81%E0%B0%AE%E0%B1%87%E0%B0%B9%E0%B0%82">తెలుగు</a></li>
				<li class="interwiki-th"><a href="http://th.wikipedia.org/wiki/%E0%B9%80%E0%B8%9A%E0%B8%B2%E0%B8%AB%E0%B8%A7%E0%B8%B2%E0%B8%99">ไทย</a></li>
				<li class="interwiki-vi"><a href="http://vi.wikipedia.org/wiki/%C4%90%C3%A1i_th%C3%A1o_%C4%91%C6%B0%E1%BB%9Dng">Tiếng Việt</a></li>
				<li class="interwiki-tr"><a href="http://tr.wikipedia.org/wiki/Diyabet">Türkçe</a></li>
				<li class="interwiki-uk"><a href="http://uk.wikipedia.org/wiki/%D0%A6%D1%83%D0%BA%D1%80%D0%BE%D0%B2%D0%B8%D0%B9_%D0%B4%D1%96%D0%B0%D0%B1%D0%B5%D1%82">Українська</a></li>
				<li class="interwiki-yi"><a href="http://yi.wikipedia.org/wiki/%D7%93%D7%99%D7%A2%D7%91%D7%99%D7%98%D7%99%D7%A1">ייִדיש</a></li>
				<li class="interwiki-bat-smg"><a href="http://bat-smg.wikipedia.org/wiki/Sokraus_diabets">Žemaitėška</a></li>
				<li class="interwiki-zh"><a href="http://zh.wikipedia.org/wiki/%E7%B3%96%E5%B0%BF%E7%97%85">中文</a></li>
			</ul>
		</div>
	</div>
		</div><!-- end of the left (by default at least) column -->
			<div class="visualClear"></div>
			<div id="footer">
				<div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="/skins-1.5/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>
				<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="/images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>
			<ul id="f-list">
					<li id="lastmod"> This page was last modified on 4 April 2009, at 19:59.</li>
					<li id="copyright">All text is available under the terms of the <a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Text_of_the_GNU_Free_Documentation_License" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Copyrights" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc.</a>, a U.S. registered <a class='internal' href="http://en.wikipedia.org/wiki/501%28c%29#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="http://en.wikipedia.org/wiki/Non-profit_organization" title="Non-profit organization">nonprofit</a> <a href="http://en.wikipedia.org/wiki/Charitable_organization" title="Charitable organization">charity</a>.<br /></li>
					<li id="privacy"><a href="http://wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
					<li id="about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
					<li id="disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
			</ul>
		</div>
</div>

		<script type="text/javascript">if (window.runOnloadHook) runOnloadHook();</script>
<!-- Served by srv182 in 0.067 secs. --></body></html>
